Publications Library

JOURNAL ARTICLES

  1. Brennan, A. T., Davies, M.-A., Bor, J., Wandeler, G., Stinson, K., Wood, R., ... Fox, M. P. (2017).Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?AIDS (London, England), 31(1), 147-157.
  2. Rosenberg, M. S., Gomez-Olive, F. X., Rohr, J. K., Houle, B. C., Kabudula, C. W., Wagner, R. G., ... Barnighausen, T. (2017).Sexual Behaviors and HIV Status: A Population-Based Study Among Older Adults in Rural South Africa.Journal of Acquired Immune Deficiency Syndromes (1999), 74(1), e9-e17.

JOURNAL ARTICLES

  1. Ahmed, S., Barnighausen, T., Daniels, N., Marlink, R., & Roberts, M. J. (2016). How providers influence the implementation of provider-initiated HIV testing and counseling in Botswana: a qualitative study.Implementation Science:IS,11.
  2. Assessment of viral diversity during viral rebound in a HIV-1 elite controller.2016). HIV Medicine, 15, 46-47
  3. Atun, R., Chang, A. Y., Ogbuoji, O., Silva, S., Resch, S., Hontelez, J., & Bärnighausen, T. (2016). Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study. BMJ Open, 6(3), e009656.
  4. Barnhart, D., Hertzmark, E., Liu, E., Mungure, E., Muya, A. N., Sando, D.,Spiegelman, D. (2016).Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam, Tanzania.Contemporary Clinical Trials Communications, 4, 161-169.
  5. Barnighausen, T., Bloom, D. E., & Humair, S. (2016). Human Resources for Treating HIV/AIDS. Are the Preventive Effects of Antiretroviral Treatment a Game Changer? PloS One, 11(10), e0163960.
  6. Booth, J. W., Hamzah, L., Jose, S., Horsfield, C., O’Donnell, P., McAdoo, S., … HIV/CKD Study and the UK CHIC Study. (2016). Clinical characteristics and outcomes of HIV-associated immune complex kidney disease. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association. http://doi.org/10.1093/ndt/gfv436
  7. Boyer, S., Iwuji, C., Gosset, A., Protopopescu, C., Okesola, N., Plazy, M., … ANRS 12249 TasP study group.(2016). Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa. AIDS Care , 28 Suppl 3 , 39–51. http://doi.org/10.1080/09540121.2016.1164808
  8. Channon, M., Hosegood, V., & McGrath, N. (2016). A longitudinal population-based analysis of relationship status and mortality in KwaZulu-Natal, South Africa 2001-2011. Journal of Epidemiology and Community Health 70(1), 56-64.
  9. Chetty, T., Thorne, C., Tanser, F., Barnighausen, T., & Coutsoudis, A. (2016). Cohort profile: the Hlabisa pregnancy cohort, KwaZulu-Natal, South Africa.BMJ Open, 6(10).
  10. Chikovore, J., Gillespie, N., McGrath, N., Orne-Gliemann, J., Zuma, T., & On Behalf of the ANRS 12249 TasP Study Group. (2016). Men, masculinity, and engagement with treatment as prevention in KwaZulu-Natal, South Africa. AIDS Care , 28 (sup3), 74–82. http://doi.org/10.1080/09540121.2016.1178953
  11. Collins, C., Orne-Gliemann, J., Larmarange, J., Okesola, N., Tanser, F., Thiebaut, R., … Dabis, F. (2016). Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS 12249 TasP Cluster-Randomised Trial. PLOS Medicine . Retrieved from http://eprints.soton.ac.uk/397643/
  12. Conroy, A. A., McGrath, N., van Rooyen, H., Hosegood, V., Johnson, M. O., Fritz, K., … Darbes, L. A. (2016). Power and the association with relationship quality in South African couples: Implications for HIV/AIDS interventions. Social Science & Medicine, 153, 1–11. http://doi.org/10.1016/j.socscimed.2016.01.035
  13. D'Ambruoso, L., Boerma, J. T., Byass, P., Fottrell, E., Herbst, K., Kallander, K., & Mullan, Z. (2016). The case for verbal autopsy in health systems strengthening.Lancet Global Health.
  14. de Oliveira, T., Kharsany, A. B. M., Graf, T., Cawood, C., Khanyile, D., Grobler, A., Karim, S. S. A. (2016). Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. The Lancet. HIV.
  15. Dobra, A., Barnighausen, T., Vandormael, A., & Tanser, F. (2016).Space-time migration patterns and risk of HIV acquisition in rural South Africa: a population-based cohort study.AIDS (London, England), Epub ahead of print.
  16. El Bouzidi, K., White, E., Mbisa, J. L., Sabin, C. A., Phillips, A. N., Mackie, N., Dunn, D. T. (2016).HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK.Journal of Antimicrobial Chemotherapy, 71(12), 3487-3494.
  17. Evangeli, M., Newell, M.-L., & McGrath, N. (2016). Factors associated with pre-ART loss-to-follow up in adults in rural KwaZulu-Natal, South Africa: a prospective cohort study. BMC Public Health, 16(1). http://doi.org/10.1186/s12889-016-3025-x
  18. Feigl, A. B., Bloom, D. E., Danaei, G., Pillay, D., Salomon, J. A., Tanser, F., & Bärnighausen, T. W. (2016). The Effect of HIV and the Modifying Effect of Anti-Retroviral Therapy (ART) on Body Mass Index (BMI) and Blood Pressure Levels in Rural South Africa. PLOS ONE, 11(8), e0158264. http://doi.org/10.1371/journal.pone.0158264
  19. Ferns, R. B., Tarr, A. W., Hue, S., Urbanowicz, R. A., McClure, C. P., Gilson, R., … Pillay, D. (2016). Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals. Virology, 492, 213–224. http://doi.org/10.1016/j.virol.2016.02.003
  20. Fox, M. P., Rosen, S., Geldsetzer, P., Bärnighausen, T., Negussie, E., & Beanland, R. (2016). Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness. Journal of the International AIDS Society, 19(1). http://doi.org/10.7448/IAS.19.1.20888
  21. Garrett, N. J., McGrath, N., & Mindel, A. (2016). Advancing STI care in low/middle-income countries: has STI syndromic management reached its use-by date? Sexually Transmitted Infections. http://doi.org/10.1136/sextrans-2016-052581
  22. GBD 2015 Child Mortality Collaborators. (2016). Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet (London, England), 388(10053), 1725-1774.
  23. GBD 2015 DALYs and HALE Collaborators. (2016).Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (London, England), 388(10053), 1603-1658.
  24. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. (2016). Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 310 Acute and Chronic Diseases and Injuries, 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1545-1602
  25. GBD 2015 Maternal Mortality Collaborators. (2016).Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet (London, England), 388(10053), 1775-1812.
  26. GBD 2015 Mortality and Causes of Death Collaborators. (2016).). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet (London, England), 388(10053), 1459-1544.
  27. Geldsetzer, P., Feigl, A. B., Tanser, F., Gareta, D., Pillay, D., & Barnighausen, T. (2016b). Population-level decline in BMI and systolic blood pressure following mass HIV treatment: Evidence from rural KwaZulu-Natal. Obesity (Silver Spring, Md.).
  28. Geldsetzer, P., Fink, G., Vaikath, M., & Barnighausen, T. (2016). Sampling for Patient Exit Interviews: Assessment of Methods Using Mathematical Derivation and Computer Simulations. Health Services Research.
  29. Geldsetzer, P., Ortblad, K., & Bärnighausen, T. (2016). The efficiency of chronic disease care in sub-Saharan Africa. BMC Medicine, 14(1). http://doi.org/10.1186/s12916-016-0675-6
  30. Geldsetzer, P., Yapa, H. M. N., Vaikath, M., Ogbuoji, O., Fox, M. P., Essajee, S. M., … Bärnighausen, T. (2016). A systematic review of interventions to improve postpartum retention of women in PMTCT and ART care. Journal of the International AIDS Society, 19(1). http://doi.org/10.7448/IAS.19.1.20679
  31. Ginsburg, C., Bocquier, P., Béguy, D., Afolabi, S., Augusto, O., Derra, K., … Collinson, M. A. (2016). Healthy or unhealthy migrants? Identifying internal migration effects on mortality in Africa using health and demographic surveillance systems of the INDEPTH network. Social Science & Medicine , 164 , 59–73. http://doi.org/10.1016/j.socscimed.2016.06.035
  32. Giovanetti, M., Faria, N. R., Nunes, M. R. T., de Vasconcelos, J. M., Lourenço, J., Rodrigues, S. G., … Alcantara, L. C. (2016). Zika virus complete genome from Salvador, Bahia, Brazil. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 41, 142–145. http://doi.org/10.1016/j.meegid.2016.03.030
  33. Gregson, J., Kaleebu, P., Marconi, V. C., van Vuuren, C., Ndembi, N., Hamers, R. L., Gupta, R. K. (2016). Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.The Lancet. Infectious Diseases.
  34. Haber, N., Pillay, D., Porter, K., & Bärnighausen, T. (2016). Constructing the cascade of HIV care: methods for measurement. Current Opinion in HIV and AIDS , 11 (1), 102–108. http://doi.org/10.1097/COH.0000000000000212
  35. Harling, G., & Bärnighausen, T. (2016). The role of partners’ educational attainment in the association between HIV and education amongst women in seven sub-Saharan African countries. Journal of the International AIDS Society, 19(1). http://doi.org/10.7448/IAS.19.1.20038
  36. Herbeck, J., & Tanser, F. (2016). Community viral load as an index of HIV transmission potential. The Lancet HIV , 3 (4), e152–e154. http://doi.org/10.1016/S2352-3018(16)00036-9
  37. Hontelez, J. A., Tanser, F. C., Naidu, K., Pillay, D., & Barnighausen, T. W. (2016). The effect of antiretroviral treatment on health care utition in rural South Africa: a population-based cohort study. PLOS One , 11 (7), e0158015–?
  38. Iwuji, C. C., Orne-Gliemann, J., Larmarange, J., Okesola, N., Tanser, F., Thiebaut, R., … for the ANRS 12249 TasP trial group. (2016). Challenges for treatment as HIV prevention: the first phase of the ANRS 12249 TasP Cluster-randomized trial in rural KwaZulu-Natal, South Africa. PLoS Medicine, In press.
  39. Manasa, J., Danaviah, S., Lessells, R. J., Elshareef, M., Tanser, F., Wilkinson, E., … de Oliveira, T. (2016). Increasing HIV-1 drug resistance between 2010 and 2012 in adults participating in population-based HIV surveillance in rural KwaZulu-Natal South Africa. AIDS Research and Human Retroviruses. http://doi.org/10.1089/AID.2015.0225
  40. Manne-Goehler, J., Atun, R., Stokes, A., Goehler, A., Houinato, D., Houehanou, C., Barnighausen, T. (2016). Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries.
  41. Marston, M., Nakiyingi-Miiro, J., Hosegood, V., Lutalo, T., Mtenga, B., Zaba, B., … others. (2016). Measuring the Impact of Antiretroviral Therapy Roll-Out on Population Level Fertility in Three African Countries. PloS One, 11(3), e0151877.
  42. Maughan-Brown, B., Lloyd, N., Bor, J., & Venkataramani, A. S. (2016). Changes in self-reported HIV testing during South Africa’s 2010/2011 national testing campaign: gains and shortfalls.Journal of the International AIDS Society, 19(1).
  43. May, M. T., Gill, M. J., Wittkop, L., Klein, M., Sabin, C., Harrigan, P. R., & et al. (2016). Mortality of treated HIV-1 positive individuals according to viral subtype in Euroand Canada: collaborative cohort analysis. AIDS , 30 (3), 503–513. http://doi.org/10.1097/QAD.0000000000000941
  44. McGovern, M., Herbst, K., Tanser, F., Mutevedzi, T., Canning, D., Gareta, D., … Barnighausen, T. (2016). Do gifts increase consent to home-based HIV testing? A difference-in-differences study in rural KwaZulu-Natal, South Africa. International Journal of Epidemiology, In press.
  45. Mitchell, J. M., Rochat, T. J., Houle, B., Stein, A., Newell, M. L., & Bland, R. M. (2016). The effect of maternal and child early life factors on grade repetition among HIV exposed and unexposed children in rural KwaZulu-Natal, South Africa. Journal of Developmental Origins of Health and Disease, 7(2), 185–196. http://doi.org/10.1017/S2040174415007230
  46. Mitchell, J., Wight, M., Van Heerden, A., & Rochat, T. J. (2016). Intimate partner violence, HIV, and mental health: a triple epidemic of global proportions. International Review of Psychiatry, 28(5), 452-463.
  47. Moshabela, M., Zuma, T., Orne-Gliemann, J., Iwuji, C., Larmarange, J., McGrath, N., & on behalf of the ANRS 12249 TasP Study Group. (2016). “It is better to die”: experiences of traditional health practitioners within the HIV treatment as prevention trial communities in rural South Africa (ANRS 12249 TasP trial). AIDS Care , 28 (sup3), 24–32. http://doi.org/10.1080/09540121.2016.1181296
  48. Moyo, S., Vandormael, A., Wilkinson, E., Engelbrecht, S., Gaseitsiwe, S., Kotokwe, K. P., … Oliveira, T.de. (2016). Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana. PLOS ONE, 11(8), e0160649. http://doi.org/10.1371/journal.pone.0160649
  49. Mulder, N. J., Christoffels, A., de Oliveira, T., Gamieldien, J., Hazelhurst, S., Joubert, F., … Tiffin, N. (2016). The Development of Computational Biology in South Africa: Successes Achieved and Lessons Learnt. PLOS Computational Biology, 12(2), e1004395. http://doi.org/10.1371/journal.pcbi.1004395
  50. Naburi, H., Mujinja, P., Kilewo, C., Barnighausen, T., Orsini, N., Manji, K., Ekstrom, A. M. (2016). Predictors of Patient Dissatisfaction with Services for Prevention of Mother-To-Child Transmission of HIV in Dar es Salaam, Tanzania. PloS One, 11(10), e0165121.
  51. NCD Risk Factor Collaboration (NCD-RisC), Di Cesare, M., Bentham, J., Stevens, G. A., Zhou, B., Danaei, G., … Ezzati, M. (2016). Trends in adult body-mass index in 200 countries from 1975< to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet (London, England), 387(10026), 1377–1396. http://doi.org/10.1016/S0140-6736(16)30054-X
  52. Newell, M.-L., & Iwuji, C. (2016). HIV treatment as prevention: applicable in sub-Saharan Africa? The Lancet Infectious Diseases. http://doi.org/10.1016/S1473-3099(16)30057-3
  53. Noor, R. A., Geldsetzer, P., Barnighausen, T., & Fawzi, W. (2016).Do countries rely on the World Health Organization for translating research findings into clinical guidelines? A case study. Globalization and Health, 12(1), 58.
  54. Oldenburg, C. E., Moscoe, E., & Bärnighausen, T. (2016). Regression Discontinuity for Causal Effect Estimation in Epidemiology. Current Epidemiology Reports, 3(3), 233–241. http://doi.org/10.1007/s40471-016-0080-x
  55. Oldenburg, C. E., Bärnighausen, T., Tanser, F., Iwuji, C. C., De Gruttola, V., Seage, G. R., … Harling, G. (2016). Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/ciw335
  56. Oldenburg, C. E., Bärnighausen, T., Tanser, F., Iwuji, C. C., De Gruttola, V., Seage, G. R., … Harling, G. (2016). Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/ciw335
  57. Oldenburg, C. E., Perez-Brumer, A. G., Reisner, S. L., Mayer, K. H., Mimiaga, M. J., Hatzenbuehler, M. L., & Bärnighausen, T. (2016). Human rights protections and HIV prevalence among MSM who sell sex: Cross-country comparisons from a systematic review and meta-analysis. Global Public Health, 1–12. http://doi.org/10.1080/17441692.2016.1149598
  58. Orne-Gliemann, J., Zuma, T., Chikovore, J., Gillespie, N., Grant, M., Iwuji, C., … On Behalf of the TasP Study Group. (2016). Community perceptions of repeat HIV-testing: experiences of the ANRS 12249 Treatment as Prevention trial in rural South Africa. AIDS Care , 28 (sup3), 14–23. http://doi.org/10.1080/09540121.2016.1164805
  59. Ortblad, K. F., Salomon, J. A., & Barnighausen, T. (2016, July). Predictor’s of circumcision uptake in a high HIV prevslence sub-Saharan African population. Presented at the International AIDS 2016, Durban.
  60. Palma, P., Foster, C., Rojo, P., Zangari, P., Yates, A., Cotugno, N., … Rossi, P. (2016). The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children. Journal of Virus Eradication , 1 (3), 134–139.
  61. Pediatric AIDS-Defining Cancer Project Working Group for IeDEA Southern Africa, TApHOD and COHERE in EuropCoord. (2016). Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clinical Infectious Diseases, ciw519. http://doi.org/10.1093/cid/ciw519
  62. Power, R. A., Davaniah, S., Derache, A., Wilkinson, E., Tanser, F., Gupta, R. K., de Oliveira, T. (2016).Genome-Wide Association Study of HIV Whole Genome Sequences Validated using Drug Resistance.PLOS ONE, 11(9), e0163746.
  63. Power, R. A., Parkhill, J., & de Oliveira, T. (2016a).Microbial genome-wide association studies: lessons from human GWAS.Nature Reviews. Genetics, epub ahead of print.
  64. Power, R. A., Parkhill, J., & de Oliveira, T. (2016b).Microbial genome-wide association studies: lessons from human GWAS.Nature Reviews. Genetics.
  65. Power, R. A., Tansey, K. E., Buttenschøn, H. N., Cohen-Woods, S., Bigdeli, T., Hall, L. S., … Lewis, C. M. (2016). Genome-wide association for major depression through age at onset stratification. Biological Psychiatry. http://doi.org/10.1016/j.biopsych.2016.05.010
  66. Reniers, G., Blom, S., Calvert, C., Martin-Onraet, A., Herbst, A. J., Eaton, J. W., Hosegood, V. (2016).Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort study.The Lancet HIV, 0(0).
  67. Reniers, G., Wamukoya, M., Urassa, M., Nyaguara, A., Nakiyingi-Miiro, J., Lutalo, T., … Zaba, B. (2016). Data Resource Profile: Network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA Network). International Journal of Epidemiology, 45(1), 83–93. http://doi.org/10.1093/ije/dyv343
  68. Rochat, T. J., Mitchell, J., Lubbe, A. M., Stein, A., Tomlinson, M., & Bland, R. M. (2016).Communication about HIV and death: Maternal reports of primary school-aged children’s questions after maternal HIV disclosure in rural South Africa.Social Science & Medicine.
  69. Rochat, T. J., Mitchell, J., Stein, A., Mkwanazi, N. B., & Bland, R. M. (2016).The Amagugu Intervention: A Conceptual Framework for Increasing HIV Disclosure and Parent-Led Communication about Health among HIV-Infected Parents with HIV-Uninfected Primary School-Aged Children.Frontiers in Public Health, 4.
  70. Rossouw, T., Nieuwoudt, M., Manasa, J., Malherbe, G., Lessells, R., Pillay, S., … de Oliveira, T. (2016). HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa. HIV Medicine , n/a-n/a. http://doi.org/10.1111/hiv.12400
  71. Schomaker, M., Davies, M.-A., Malateste, K., Renner, L., Sawry, S., N’Gbeche, S., … IeDEA West Africa and IeDEA Southern Africa collaboration. (2016). Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis. Epidemiology (Cambridge, Mass.) , 27 (2), 237–246. http://doi.org/10.1097/EDE.0000000000000412
  72. Schomaker, M., Leroy, V., Wolfs, T., Technau, K.-G., Renner, L., Judd, A., … Davies, M.-A. (2016). Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe. International Journal of Epidemiology , dyw097. http://doi.org/10.1093/ije/dyw097
  73. Taylor, J. G., Yates, T. A., Mthethwa, M., Tanser, F., Abubakar, I., & Altamirano, H. (2016). Measuring ventilation and modelling M.tuberculosis transmission in indoor congregate settings, rural KwaZulu-Natal. International Journal of Tuberculosis and Lung Disease, In press.
  74. Tenores Study Group, & PILLAY, D. (2016). Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. The Lancet. Infectious Diseases , 16 (5), 565–575. http://doi.org/10.1016/S1473-3099(15)00536-8
  75. The EuroCoord-CHAIN-EPPICC joint project study group, Ngo-Giang-Huong, N., Wittkop, L., Judd, A., Reiss, P., Goetghebuer, T., Lallemant, M. (2016).Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.BMC Infectious Diseases, 16(1).
  76. The Subnational Estimates Working Group of the HIV Modelling Consortium. (2016). Evaluation of geospatial methods to generate subnational HIV prevalence estimates for local level planning. AIDS (London, England) , 30 (9), 1467–1474. http://doi.org/10.1097/QAD.0000000000001075
  77. The Tenores Study Group. (2016).Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study.The Lancet Infectious Diseases.
  78. Tlou, B., Sartorius, B., & Tanser, F. (2016). Spatial-temporal dynamics and structural determinants of child and maternal mortality in a rural, high HIV burdened South African population, 2003-2014: a study protocol. BMJ Open, In press.
  79. Treffry-Goatley, A., Lessells, R., Sykes, P., Bärnighausen, T., de Oliveira, T., Moletsane, R., & Seeley, J. (2016). Understanding Specific Contexts of Antiretroviral Therapy Adherence in Rural South Africa: A Thematic Analysis of Digital Stories from a Community with High HIV Prevalence. PLOS ONE, 11(2), e0148801. http://doi.org/10.1371/journal.pone.0148801
  80. Van Rooyen, H., Essack, Z., Rochat, T., Wight, D., Knight, L., Bland, R., & Celum, C. (2016). Taking HIV Testing to Families: Designing a Family-Based Intervention to Facilitate HIV Testing, Disclosure, and Intergenerational Communication. Frontiers in Public Health, 4. http://doi.org/10.3389/fpubh.2016.00154
  81. Vollmer, S., Harttgen, K., Alfven, T., Padayachy, J., Ghys, P., & Barnighausen, T. (2016).The HIV Epidemic in Sub-Saharan Africa is Aging: Evidence from the Demographic and Health Surveys in Sub-Saharan Africa.AIDS and Behavior.
  82. Wang, H., Wolock, T. M., Carter, A., Nguyen, G., Kyu, H. H., Gakidou, E., … others. (2016). Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. The Lancet. HIV , 3 (8). Retrieved from http://www.diva-portal.org/smash/record.jsf?pid=diva2:950523
  83. Watters, S. A., Mlcochova, P., Maldarelli, F., Goonetilleke, N., Pillay, D., & GUPTA, R. K. (2016). Sequential CCR5- Tropic HIV-1 reactivation from distinct cellular reservoirs following perturbation of elite control. PLOS One. , 11 (7), e0158854.
  84. White, E., Smit, E., Churchill, D., Collins, S., Booth, C., Tostevin, A., Aitken, C. (2016).No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.Journal of Infectious Diseases, 214(9), 1302-1308.
  85. Yates, T. A., Khan, P. Y., Knight, G. M., Taylor, J. G., McHugh, T. D., Lipman, M., … Abubakar, I. (2016). The transmission of Mycobacterium tuberculosis in high burden settings. The Lancet Infectious Diseases, 16(2), 227–238.
  86. Yates, T. A., Tanser, F., & Abubakar, I. (2016). Plan Beta for tuberculosis: it’s time to think seriously about poorly ventilated congregate settings. The International Journal of Tuberculosis and Lung Disease, 20(1), 5–10. http://doi.org/10.5588/ijtld.15.0494
  87. Zuma, T., Wight, D., Rochat, T., & Moshabela, M. (2016). The role of traditional health practitioners in Rural KwaZulu-Natal, South Africa: generic or mode specific? BMC Complementary and Alternative Medicine, 16(1). http://doi.org/10.1186/s12906-016-1293-8

CONFERENCE PRESENTATIONS

  1. Barnighausen, T., Escudero, & Poole. (2016, July). The role of religion in the South African HIV epidemic. Presented at the International AIDS Conference, Durban.
  2. Barnighausen, T. W., & Patenaude, B. N. (2016, July). The causal impact of ART on household food security. Presented at the International AIDS Conference, Durban.
  3. Bor, J., Ahmed, S., Fox, M. P., Rosen, S., Tanser, F. C., Pillay, D., & Barrnighausen. (CROI 2016, February). Effect of eliminating CD4 thresholds on number of new ART initiators in South Africa. Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  4. Bor, J., Fox, M. P., Rosen, S., Tanser, F., Pillay, D., & Barnighausen, T. (2016, February). The real world impact of CD4-eligibility criteria on retention in HIV care. Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  5. Bor, J., Fox, M. P., Rosen, S., & Venkataramani, A. (2016, July). Eliminating CD4thresholds in South Africa will result in modest increases in persons receiving ART without further changes to initiation procedures. Presented at the International AIDS Conference, Durban.
  6. Bor, J., Fox, M. P., Rosen, S., Venkataramani, A. S., Tanser, F. C., Pillay, D., & Barnighausen, T. (2016, July). Immediate ART eligibility dramatically increases patient retention HIV care. Presented at the International AIDS Conference, Durban.
  7. Bor, J., Mead, O., Chiu, C., Meyer-Rath, G., Tanser, F. C., Pillay, D., & Barnighausen, T. W. (2016, July). Distance elasticity of demand for HIV treatment: a barrier for women, but not for men. Presented at the International AIDS Confernece 2016, Durban.
  8. Bor, J., Oldenburg, C. E., Tanser, F. C., Mutevedzi, T., Shahmenesh, M., Pillay, D., & Barnighausen, T. (2016, July). Immediate HIV treatment reduces all-cause mortality: causal evidence on the real world impact of immediate versus deferred ART in rural South Africa. Immediate HIV treatment reduces mortality and improves long-term immune health causal evidence on the real world impact of immediate versus deferred ART in rural South Africa. Presented at the International AIDS Conference, Durban.
  9. Brennan, A. T., Fox, M. P., Davies, M.-A., Stinson, K., Wood, R., Prozesky, H., … Bor, J. (2016, February). Clinical outcomes with tenofovir use in ART: regression discontinuity analysis. Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  10. Dolling, D., & et al. (2016, February). High rate of viral suppression in late mortality on first-line ART in Uganda/Zimbabwe. Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  11. Geldsetzer, P., Feigl, A. B., Tanser, F. C., Gareta, D., Pillay, D., & Barnighausen, T. (2016, February). Population-level declines in BMI and Blood Pressure Following Mass HIV Treatment. Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston.
  12. Gumede, D., Mutevedzi, T., McGrath, N., Barnighausen, T., Pillay, D., Seeley, J., & Harling, G. (2016, July). Exploring participants’ understanding and concerns relating to questions about anal sex in a rural KwaZulu-Natal setting : a cognitive interviewing approach. Presented at the International AIDS Conference, Durban
  13. Haber, N., Salomon, J. A., & Barnighausen, T. (2016, July). Mortality associated with transitions along the cascade of care in KwaZulu-Natal. Presented at the International AIDS Conference, Durban.
  14. Kluberg, S. (2016, February). Do ART eligibility expansions crowd out the sickest? Evidence from South Africa. Presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  15. Lange, C., & et al. (2016, February). Independent lineages of HIV-1 multi drug resistance in children falling early ART. Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  16. Marcelin, A.-G., et al., Grude, M., Derache, A., Pillay, D., Barin, F., … Marcelin, A.-G. (2016, February). HIV antibodies and reservoir size in perinatally infected children on HAART. Poster Presentation presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  17. Moshabela, M., Dlamini, V., Odengo, P., Wamoyi, J., Seeley, J., Hosegood, V., & Skovdal, M. (2016, July). When “bad” patients transform into “good” patients: mediating agency in the therapeutic alliance to overcome bottlenecks along the HIV cascade of care. Poster Presentation presented at the International AIDS Conference, Durban.
  18. Oldenburg, C. E., Barnighausen, T., Tanser, F., De Gruttola, V., Seage, G., Mimiaga, M. J., … Harling, G. (2016, February). Antiretroviral therapy and HIV acquisition in a South African population-based cohort. Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  19. Patenaude, B. N., Chimbindi, N. Z., Pillay, D., & Bärnighausen, T. W. (2016, 25February). The Causal Impact of ART initiation on Hosehold Food Security. Presented at the Conference on Retroviruses and Opportunistic Infections, Boston.
  20. J., Stein, A., Cortina-Borja, M., Tanser, F. C., & Bland, R. M. (2016, July). Efficacy of the Amagugu intervention to increase maternal HIV disclosure to HIV-uninfected primary-school aged children in Southen Africa: a randomised trial. Presented at the International AIDS Conference, Durban.
  21. Slaymaker, E., Marston, M., Calvert, C., McLean, E., Kanjala, C., Takaruza, A., … Zaba, B. (2016, July). Factors associated with acquisition of HIV during 2005-014 among men and women in 7 cohorts that participate in the network for analysisng longitudinal population-based HIV/AIDS data on Africa. Abstract presented at the International AIDS Conference, Durban.
  22. Switzer, W., & et al. (2016, February). Comparing three HIV-1 subtyping tools and a novel phylogenetic-based method. Marcelin, A.-G., et al., Grude, M., Derache, A., Pillay, D., Barin, F., … Marcelin, A.-G. (2016, February). HIV antibodies and reservoir size in perinatally infected children on HAART. Poster Presentation presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  1. Ahmed, S., Bärnighausen, T., Daniels, N., Marlink, R., & Roberts, M. J. (2016). How providers influence the implementation of provider-initiated HIV testing and counseling in Botswana: a qualitative study.Implementation Science:IS,11.
  2. Aleluia, M.M., Mello, M.A.G., Alcântara, L.C.J., Rego, F.F.A., de Souza Santos, L.P., Galvão-Castro, B., de Souza Gonçalves, M., de Oliveira, T., Marin, L.J., Sousa, S.M.B., Gadelha, S.R., (2015). The origin of HTLV-1 in southern Bahia by phylogenetic, mtDNA and β-globin analysis. Virology Reports. 
  3. Anekwe, T.D., Newell, M.-L., Tanser, F., Pillay, D., Bärnighausen, T., 2015. The effect of childhood measles vaccination on educational attainment: A mother-fixed-effects study in rural South Africa. Vaccine. doi:10.1016/j.vaccine.2015.04.072
  4. Ardington, C., Menendez, A., & Mutevedzi, T. (2015). Early childbearing, human capital attainment and mortality risk: Evidence from a longitudinal demographic surveillance area in rural-KwaZulu-Natal, South Africa. Economic Development and Cultural Change, 63(2), 281–317
  5. Atun, R., Chang, A. Y., Ogbuoji, O., Silva, S., Resch, S., Hontelez, J., & Bärnighausen, T. (2016). Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study. BMJ Open, 6(3), e009656.
  6. Baggaley, R., Johnson, C., Garcia Calleja, J. M., Sabin, K., Obermeyer, C., Taegtmeyer, M., Zaba, B., El-Hayek, C., & Singh, J. A. (2015). Routine feedback of test results to participants in clinic- and survey-based surveillance of HIV. Bulletin of the World Health Organization, 93(5), 352–355.
  7. Bärnighausen, T., Eyal, N., & Wikler, D. (2015). HIV Treatment-As-Prevention Research: Authors’ Reply. PLoS Medicine, 12(3).
  8. Basson, A. E., Rhee, S.-Y., Parry, C. M., El-Khatib, Z., Charalambous, S., De Oliveira, T., Pillay, D., Hoffmann, C., Katzenstein, D., Shafer, R.W., & Morris, L. (2015). The impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors. Antimicrobial Agents and Chemotherapy, 59(2), 960–971.
  9. Bennett, R., Hosegood, V., Newell, M.-L., & McGrath, N. (2015). An Approach to Measuring Dispersed Families with a Particular Focus on Children “Left Behind” by Migrant Parents: Findings from Rural South Africa: An Approach to Measuring Dispersed Family Relationships in South Africa. Population, Space and Place, 21(4), 322–334.
  10. Bennett, R., Hosegood, V., Newell, M.-L., & McGrath, N. (2015). Understanding Family Migration in Rural South Africa: Exploring Children’s Inclusion in the Destination Households of Migrant Parents. Family Migration in Rural South Africa: Exploring Children’s Inclusion in the Destination Households of Migrant Parents. Population, Space and Place, 21(4), 310–321.
  11. Booth, J. W., Hamzah, L., Jose, S.,Horsfield, C., O’Donnell, P., McAdoo, S., … HIV/CKD Study and the UK CHIC Study. (2016). Clinical characteristics and outcomes of HIV-associated immune complex kidney disease. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association.
  12. Bor, J., Geldsetzer, P., Venkataramani, A., & Bärnighausen, T. (2015). Quasi-experiments to establish causal effects of HIV care and treatment and improve the cascade of care. Current Opinion in HIV and AIDS.
  13. Bor, J., Moscoe, E., & Bärnighausen, T. (2015). Three approaches to causal inference in regression discontinuity designs. Epidemiology (Cambridge, Mass.), 26(2), e28–30; discussion e30. 
  14. Bor, J., Rosen, S., Chimbindi, N., Haber, N., Herbst, K., Mutevedzi, T., Tanser, F., Pillay, D., & Bärnighausen, T. (2015). Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa. PLoS Medicine, 12(11).
  15. Byass, P., Herbst, K., Fottrell, E., Ali, M. M., Odhiambo, F., Amek, N., Hamel, M.J., Laserson, K.F., Kahn, K., Kabudula, C., Mee, P., Bird, J., Jakob, R., Sankoh, O., & Tollman, S. M. (2015). Comparing verbal autopsy cause of death findings as determined by physician coding and probabilistic modelling: a public health analysis of 54 000 deaths in Africa and Asia. Journal of Global Health, 5(1), 1–9.
  16. Channon, M., Hosegood, V., & McGrath, N. (2015). A longitudinal population-based analysis of relationship status and mortality in KwaZulu-Natal, South Africa 2001–2011. Journal of Epidemiology and Community Health, jech–2014–205408.
  17. Chimbindi, N., Bor, J., Newell, M.-L., Tanser, F., Baltusen, R., Hontelez, J., de Vlas, S., Lurie, M., Pillay, D., & Bärnighausen, T. (2015). Time and money: the true costs of health care utilization for patients receiving “free” HIV/TB care and treatment in rural KwaZulu-Natal. JAIDS Journal of Acquired Immune Deficiency Syndromes, 1.
  18. Conroy, A. A., McGrath, N., van Rooyen, H., Hosegood, V., Johnson, M. O., Fritz, K., … Darbes, L. A. (2016). Power and the association with relationship quality in South African couples: Implications for HIV/AIDS interventions. Social Science & Medicine, 153, 1–11.
  19. Cornell, M., Johnson, L. F., Schomaker, M., Tanser, F., Maskew, M., Wood, R., Prozesky, H., Giddy, J., Stinson, K., Egger, M., Boulle, Andrew, & Myer, L. for the International Epidemiologic Databases to Evaluate AIDS-Southern Africa Collaboration. (2015). Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study. The Lancet HIV.
  20. Cournil, A., Van de Perre, P., Cames, C., de Vincenzi, I., Read, J. S., Luchters, S., Meda, N., Naidu, K., Newell, M.-L., & Bork, K. for the Kesho Bora Study Group. (2015). Early infant feeding patterns and HIV-free survival: findings from the Kesho-Bora trial (Burkina Faso, Kenya, South Africa). The Pediatric Infectious Disease Journal, 34(2), 168–174. 
  21. Danaviah, S., de Oliveira, T., Bland, R., Viljoen, J., Pillay, S., Tuaillon, E., Van de Perre, P., & Newell, M.-L. (2015). Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission. PLoS ONE, 10(3), e0120389.
  22. Danaviah, S., de Oliveira, T., Gordon, M., Govender, S., Chelule, P., Pillay, S., Naicker, T., Cassol, S., & Ndung’u, T. (2015). Analysis of dominant HIV quasispecies suggests independent viral evolution within spinal granulomas co-infected with Mycobacterium tuberculosis and HIV-1 subtype C. AIDS Research and Human Retroviruses.
  23. Eaton, J. W., Bacaër, N., Bershteyn, A., Cambiano, V., Cori, A., Dorrington, R. E., Fraser, C., Gopalappa, C., Hontelez, J.A., Johnson, L.F., Klein, D.J., Phillips, A.N., Pretorius, C.,  Stover, J.,  Rehle, T.M., & Hallett, T.B. (2015). Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era. The Lancet Global Health, 3(10), e598–e608.
  24. Elkies, N., Fink, G., & Bärnighausen, T. (2015). “Scrambling” geo-referenced data to protect privacy induces bias in distance estimation. Population and Environment, 1–16.
  25. Evangeli, M., Newell, M.-L., & McGrath, N. (2016). Factors associated with pre-ART loss-to-follow up in adults in rural KwaZulu-Natal, South Africa: a prospective cohort study. BMC Public Health, 16(1).
  26. Ferns, R. B.,Tarr, A. W., Hue, S.,Urbanowicz, R. A., McClure, C. P., Gilson, R., … Pillay, D. (2016). Hepatitis C virusquasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals. Virology, 492, 213–224.
  27. Fladseth, K., Gafos, M., Newell, M. L., & McGrath, N. (2015). The Impact of Gender Norms on Condom Use among HIV-Positive Adults in KwaZulu-Natal, South Africa. PLoS ONE, 10(4).
  28. Foster, D. W., Khalil, G. E., Farris, S. G., Bärnighausen, T. W., & Prokhorov, A. V. (2015). Effects of Readiness to Change, Quit History, and Health Perceptions on Depressive Symptoms among Young Adult Smokers. International Journal of Psychology and Psychoanalysis, 1(003).
  29. Frost, S. D. W., & Pillay, D. (2015). Understanding drivers of phylogenetic clustering in molecular epidemiological studies of HIV. The Journal of Infectious Diseases, 211(6), 856–858.
  30. Garrett, N. J., McGrath, N., &Mindel, A. (2016). Advancing STI care in low/middle-income countries: has STI syndromic management reached its use-by date? Sexually Transmitted Infections.
  31. Geldsetzer, P., Yapa, H. M. N.,Vaikath, M., Ogbuoji, O., Fox, M. P.,Essajee, S. M., … Bärnighausen, T. (2016). A systematic review of interventions to improve postpartum retention of women in PMTCT and ART care. Journal of the International AIDS Society, 19(1).
  32. Geldsetzer, P., Bloom, D. E., Humair, S., & Bärnighausen, T. (2015). Benefits and Costs of the HIV/AIDS Targets for the Post-2015 Development Agenda (Working Paper) (p. 24). Copenhagen: Copenhagen Consensus Center.
  33. Geldsetzer, P., Bloom, D. E., Humair, S., & Bärnighausen, T. (2015). Increasing Coverage of Antiretroviral Therapy and Male Medical Circumcision in HIV Hyperendemic Countries: A Cost-Benefit Analysis. Institute for the Study of Labor (IZA).
  34. Giovanetti, M., Faria, N. R., Nunes, M. R. T., deVasconcelos, J. M.,Lourenço, J., Rodrigues, S. G., … Alcantara, L. C. (2016). Zika virus complete genome from Salvador, Bahia, Brazil. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 41, 142–145.
  35. Govender, V., Fried, J., Birch, S., Chimbindi, N., & Cleary, S. (2015). Disability Grant: a precarious lifeline for HIV/AIDS patients in South Africa. BMC Health Services Research, 15(1).
  36. Gray, A., Conradie, F., Crowley, T., Gaede, B., Gils, T., Shroufi, A., Hwang, B., Kegakilwe, D., Nash, J., Pillay, P., Stende, Stacie C., Venter, Fs, & Matthews, Philippa. (2015). Improving access to antiretrovirals in rural South Africa-a call to action. SAMJ: South African Medical Journal, 105(8), 638–640.
  37. Grimsrud, A., Cornell, M., Schomaker, M., Fox, M. P., Orrell, C., Prozesky, H., Stinson, K., Tanser, F., Egger, M., & Myer, L. (2015). : CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up results from a multicentre cohort study. Journal of Epidemiology and Community Health, jech–2015–206629.
  38. Haber, N., Pillay, D., Porter, K., & Bärnighausen, T. (2015). Constructing the cascade of HIV care: methods for measurement. Current Opinion in HIV and AIDS.
  39. Harling, G., Newell, M., Tanser, F., & Bärnighausen, T. W. (2015). Partner-age disparity and HIV incidence risk for older women in rural South Africa. AIDS and Behavior.
  40. Harling, G., & Bärnighausen, T. (2016). The role of partners’ educational attainment in the association between HIV and education amongst women in seven sub-Saharan African countries. Journal of the International AIDS Society, 19(1).
  41. Harling, G., Tanser, F., Mutevedzi, T., & Bärnighausen, T. (2015). Assessing the validity of respondents’ reports of their partners’ ages in a rural South African population-based cohort. BMJ Open, 5(3), e005638.
  42. Herbst, K., Juvekar, S., Bhattacharjee, T., Bangha, M., Patharia, N., Tei, T., Gilbert, B., & Sankoh, O. (2015). The INDEPTH Data Repository An International Resource for Longitudinal Population and Health Data From Health and Demographic Surveillance Systems. Journal of Empirical Research on Human Research Ethics, 10(3), 324–333.
  43. Herbst, K., Law, M., Geldsetzer, P., Tanser, F., Harling, G., & Bärnighausen, T. (2015). Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies. Current Opinion in HIV and AIDS.
  44. Hosegood, V., Richter, L., & Clarke, L. (2015). “ . . . I Should Maintain a Healthy Life Now and Not Just Live as I Please . . . ”: Men’s Health and Fatherhood in Rural South Africa. American Journal of Men’s Health.
  45. Huntington, S., Thorne, C., Newell, M.-L., Anderson, J., Taylor, G. P., Pillay, D., Hill, T., Tookey, P.A., Sabin, C., The UK Collaborative HIV Cohort (UK CHIC) Study, & the Ireland National Study of HIV in Pregnancy Childhood (NSHPC). (2015). Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy. AIDS.
  46. Huntington, S., Thorne, C., Newell, M.-L., Anderson, J., Taylor, G. P., Pillay, D., Hill, T., Tookey, P.A., & Sabin, C. (2015). The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy. AIDS, 29(17), 2269–2278.
  47. INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, Lundgren, J., Babiker, A., Gordin, F., Emery, S., Fätkenheuer, G., Molina, J.-M., Wood, R., & Neaton, J. D. (2015). Why START? Reflections that led to the conduct of this large long-term strategic HIV trial. HIV Medicine, 16 Suppl 1, 1–9.
  48. Iwuji, C., McGrath, N., & Oliveira, T. de. (2015). The Art of HIV Elimination: Past and Present Science. Journal of AIDS & Clinical Research, 6(11).
  49. Jose, S., Quinn, K., Dunn, D., Cox, A., Sabin, C., Fidler, S., & the UK CHIC and UK HDRD Steering Committees. (2015). Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation. HIV Medicine, n/a–n/a.
  50. Kayondo, J., Ndembi, N., Parry, C. M., Cane, P. A., Hue, S., Goodall, R., Dunn, D., Kaleebu, P., Pillay, D., & Mbisa, J. L. (2015). Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors. AIDS Research and Human Retroviruses.
  51. Kilimba, T., Nimako, G., & Herbst, K. (2015). Data everywhere: an integrated longitudinal data visualization platform for health and demographic surveillance sites. In Proceeding BCB ’15 Proceedings of the 6th ACM Conference on Bioinformatics, Computational Biology and Health Informatics (pp. 551–552). ACM Press.
  52. Klein, N., Palma, P., Luzuriaga, K., Pahwa, S., Nastouli, E., Gibb, D. M., Rojo, P., Borkowsky, W., Bernardi, S., Zangari, P., Calvez, V., Compagnucci, A., Wahren, B., Foster, C., Munoz-Fernández, M.Á., De Rossi, A., Ananworanich, J., Pillay, D., Giaquinto, C., & Rossi, P. (2015). Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission. The Lancet Infectious Diseases.
  53. Lambert-Niclot, S., George, E. C., Pozniak, A., White, E., Schwimmer, C., Jessen, H., Johnson, M., Dunn, D., Perno, C.F., Clotet, B., Plettenberg, A., Blaxhult, A., Palmisano, L., Wittkop, L., Calvez, V., Marcelin, A.G., & Raffi, F. (2015). Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART. Journal of Antimicrobial Chemotherapy, dkv427.
  54. Lange, C. M., Hué, S., Violari, A., Cotton, M., Gibb, D., Babiker, A., Otwombe, K., Panchia, R., Dobbels, E., Jean-Philippe, P., McIntyre, J.A., Pillay, D., & Gupta, R. K. (2015). Single genome analysis reveals linked, multi-class drug resistance in HIV-1 infected children from the Children with HIV Early Antiretroviral (CHER) study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 1.
  55. Langlois, E. V., Ranson, M. K., Bärnighausen, T., Bosch-Capblanch, X., Daniels, K., El-Jardali, F., Ghaffar, A., Grimshaw, J., Haines, A., Lavis, J.N., Lewin, S., Meng, Q., Oliver, S., Pantoja, T., Straus, S., Shemilt, I., Tovey, D., Tugwell, P., Waddington, H., Wilson, M., Yuan, B., & Røttingen, J.-A. (2015). Advancing the field of health systems research synthesis. Systematic Reviews, 4(1).
  56. Larmarange, J., Mossong, J., Bärnighausen, T., & Newell, M. L. (2015). Participation Dynamics in Population-Based Longitudinal HIV Surveillance in Rural South Africa. PLOS ONE, 10(4), e0123345.
  57. Marston, M., Nakiyingi-Miiro, J., Hosegood, V., Lutalo, T.,Mtenga , B., Zaba, B., … others. (2016). Measuring the Impact of Antiretroviral Therapy Roll-Out on Population Level Fertility in Three African Countries. PloS One, 11(3), e0151877.
  58. Mbisa, J. L., Fearnhill, E., Dunn, D. T., Pillay, D., Asboe, D., Cane, P. A., & UK HIV Drug Resistance Database. (2015). Evidence of self-sustaining drug resistant HIV-1 lineages among untreated patients in the UK. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.
  59. McGovern, M. E., Bärnighausen, T., Marra, G., & Radice, R. (2015). On the assumption of bivariate normality in selection models: a Copula approach applied to estimating HIV prevalence. Epidemiology (Cambridge, Mass.), 26(2), 229–237.
  60. McGovern, M. E., Bärnighausen, T., Salomon, J. A., & Canning, D. (2015). Using interviewer random effects to remove selection bias from HIV prevalence estimates. BMC Medical Research Methodology, 15.
  61. McGovern, M. E., Marra, G., Radice, R., Canning, D., Newell, M.-L., & Bärnighausen, T. (2015). Adjusting HIV prevalence estimates for non-participation: an application to demographic surveillance. Journal of the International AIDS Society, 18(1).
  62. McGrath, N., Eaton, J. W., Newell, M.-L., & Hosegood, V. (2015). Migration, sexual behaviour, and HIV risk: a general population cohort in rural South Africa. The Lancet HIV.
  63. McGrath, N., Lessells, R. J., & Newell, M. L. (2015). Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa. HIV Medicine.
  64. Mitchell, J. M., Rochat, T. J., Houle, B., Stein, A., Newell, M. L., & Bland, R. M. (2016). The effect of maternal and child early life factors on grade repetition among HIV exposed and unexposed children in rural KwaZulu-Natal, South Africa. Journal of Developmental Origins of Health and Disease, 7(2), 185–196.
  65. Moscoe, E., Bor, J., & Bärnighausen, T. (2015). Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice. Journal of Clinical Epidemiology, 68(2), 122–133.
  66. Moyo, S., Wilkinson, E., Novitsky, V., Vandormael, A., Gaseitsiwe, S., Essex, M., Engelbrecht, S., & de Oliveira, T. (2015). Identifying Recent HIV Infections: From Serological Assays to Genomics. Viruses, 7(10), 5508–5524.
  67. Morrison, C. S., Chen, P.-L., Kwok, C., Baeten, J. M., Brown, J., Crook, A. M., Van Damme, L., Delany-Moretlwe, S., Francis, S.C., Friedland, B.A., Hayes, R.J., Heffron, R., Kapiga, S., Karim, Q.A., Karpoff, S., Kaul, R., McClelland, R.S., McCormack, S., McGrath, N., Myer, L., Rees, H., van der Straten, A., Watson-Jones, D., van de Wijgert, J.H.H.M., Stalter, R., & Low, N. (2015). Hormonal Contraception and the Risk of HIV Acquisition: An Individual Participant Data Meta-analysis. PLoS Medicine, 12(1).
  68. Mulder, N. J.,Christoffels , A., de Oliveira, T., Gamieldien , J.,Hazelhurst, S., Joubert, F., … Tiffin, N. (2016). The Development of Computational Biology in South Africa: Successes Achieved and Lessons Learnt. PLOS Computational Biology, 12(2), e1004395.
  69. NCD Risk Factor Collaboration (NCD-RisC), Di Cesare, M., Bentham, J., Stevens, G. A., Zhou, B.,Danaei, G., … Ezzati, M. (2016).Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet (London, England), 387(10026), 1377–1396.
  70. Nyirenda, M., Evandrou, M., Mutevedzi, P., Hosegood, V., Falkingham, J., & Newell, M.-L. (2015). Who cares? Implications of care-giving and -receiving by HIV-infected or -affected older people on functional disability and emotional wellbeing. Ageing and Society, 35(1), 169–202.
  71. Oldenburg, C. E., Perez-Brumer, A. G., Reisner, S. L., Mayer, K. H., Mimiaga, M. J., Hatzenbuehler, M. L., & Bärnighausen, T. (2016). Human rights protections and HIV prevalence among MSM who sell sex: Cross-country comparisons from a systematic review and meta-analysis. Global Public Health, 1–12.
  72. Orne-Gliemann, J., Larmarange, J., Boyer, S., Iwuji, C., McGrath, N., Bärnighausen, T., Zuma, T., Dray-Spira, R., Spire, B., Rochat, T., Lert, F., & Imrie, J. (2015). Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. BMC Public Health, 15(1), 209.
  73. Ortblad, K. F., Salomon, J. A., Bärnighausen, T., & Atun, R. (2015). Stopping tuberculosis: a biosocial model for sustainable development. The Lancet.
  74. Otieno, G., Marinda, E., Bärnighausen, T., & Tanser, F. (2015). High rates of homicide in a rural South African population (2000–2008): findings from a population-based cohort study. Population Health Metrics, 13(1).
  75. Pillay, D., Herbeck, J., Cohen, M. S., Oliveira, T. de, Fraser, C., Ratmann, O., Brown, A.L., Kellam, P., & PANGEA-HIV Consortium. (2015). PANGEA-HIV: phylogenetics for generalised epidemics in Africa. The Lancet. Infectious Diseases, 15(3), 259–261.
  76. Plazy, M., Dabis, F., Naidu, K., Orne-Gliemann, J., Barnighausen, T., & Dray-Spira, R. (2015). Change of treatment guidelines and evolution of ART initiation in rural South Africa: data of a large HIV care and treatment programme. BMC Infectious Diseases, 15(1).
  77. Porter, M., Davies, M.-A., Mapani, M. K., Rabie, H., Phiri, S., Nuttall, J., Fairlie, L., Technau, K.-G., Stinson, K., Wood, R., Wellington, M., Haas, A.D., Giddy, J., Tanser, F., & Eley, B. (2015). Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012. Journal of Acquired Immune Deficiency Syndromes (1999), 69(5), 593–601.
  78. Reniers, G., Wamukoya, M., Urassa, M., Nyaguara, A., Nakiyingi-Miiro, J., Lutalo, T., … Zaba, B. (2016). Data Resource Profile: Network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA Network). International Journal of Epidemiology, 45(1), 83–93.
  79. Rhee, S.-Y., Jordan, M. R., Raizes, E., Chua, A., Parkin, N., Kantor, R., van Zyl, G., Mukui, I., Hosseinipour, M.C., Frenkel, L.M., Ndembi, N., Hamers, R.L., Rinke de Wit, T.F., Wallis, C.L., Gupta, R.K., Fokam, J., Zeh, C., Schapiro, J.M., Carmona, S., Katzenstein, D., Tang, M., Aghokeng, A.F., De Oliveira, T., Wensing, A.M.J., Gallant, J.E., Wainberg, M.A., Richman, D.D., Fitzgibbon, J.E., Schito, M., Bertagnolio, S., Yang, C., & Shafer, R. W. (2015). HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing. PLOS ONE.
  80. Rochat, T.J, Mokomane, Z, Mitchell, J., & The Directorate. (2015). Public perceptions, beliefs and experiences of fostering and adoption: a national qualitative study in South Africa. Children  & Society. doi:10.1111/chso.12122
  81. Rochat, T. J., Arteche, A. X., Stein, A., Mitchell, J., & Bland, R. M. (2015). Maternal and child psychological outcomes of HIV disclosure to young children in rural South Africa: the Amagugu intervention. AIDS, 29, S67–S79.
  82. Rockers, P. C., Røttingen, J.-A., Shemilt, I., Tugwell, P., & Bärnighausen, T. (2015). Inclusion of Quasi-Experimental Studies in Systematic Reviews of Health Systems Research. Health Policy.
  83. Rosenberg, M., Pettifor, A., Nguyen, N., Westreich, D., Bor, J., Bärnighausen, T., Mee, P., Twine, R., Tollman, S., & Kahn, K. (2015). Relationship between Receipt of a Social Protection Grant for a Child and Second Pregnancy Rates among South African Women: A Cohort Study. PLoS ONE, 10(9).
  84. Sando, D., Spiegelman, D., Machumi, L., Mwanyika-Sando, M., Aris, E., Muya, A., Jackson, E., Baernighausen, T., Hertzmark, E., Chalamilla, G., & Fawzi, W. (2015). Time trends of baseline demographics and clinical characteristics of HIV infected children enrolled in care and treatment service in Dar es Salaam, Tanzania. BMC Infectious Diseases, 15. http://doi.org/10.1186/s12879-015-0875-2
  85. Schomaker, M., Davies, M., Malateste, K., Renner, L., Sawry, S., N’Gbeche, S., Technau, K., Eboua, F., Tanser, F., Sygnaté-Sy, H., Phiri, S., Amorissani-Folquet, M., Cox, V., Koueta, F., Chimbete, C., Lawson-Evi, A., Giddy, J., Amani-Bosse, C., Wood, R., Egger, M., & Leroy, V. (2015). Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children aged 1-5 Years: A Causal Modelling Analysis. Epidemiology (Cambridge, Mass.).
  86. Schomaker, M., Hogger, S., Johnson, L. F., Hoffmann, C. J., Bärnighausen, T., & Heumann, C. (2015). Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple Overimputation. Epidemiology (Cambridge, Mass.).
  87. Smith, N. M. G., Mlcochova, P., Watters, S. A., Aasa-Chapman, M. M. I., Rabin, N., Moore, S., Edwards, S.G., Garson, J.A., Grant, P.R., Ferns, R.B., Kashuba, A., Mayor, N.P., Schellekens, J., Marsh, S.G.E., McMichael, A.J., Perelson, A.S., Pillay, D., Goonetilleke, N., & Gupta, R. K. (2015). Proof-of-principle for immune control of global HIV-1 reactivation in vivo. Clinical Infectious Diseases, civ219.
  88. Sutherland, K. A., Goodall, R. L., McCormick, A., Kapaata, A., Lyagoba, F., Kaleebu, P., Thiltgen, G., Gilks, C.F., Spyer, M., Kityo, C., Pillay, D., Dunn, D., & Gupta, R. K. (2015). Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa. AIDS Research and Human Retroviruses.
  89. Sutherland, K. A., Parry, C. M., McCormick, A., Kapaata, A., Lyagoba, F., Kaleebu, P., Gilks, C.F., Goodall, R., Spyer, M., Kityo, C., Pillay, D., Gupta, R.K., & DART Virology Group. (2015). Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. PLOS ONE, 10(9), e0137834.
  90. Tanser, F., Bärnighausen, T., Vandormael, A., & Dobra, A. (2015). HIV treatment cascade in migrants and mobile populations. Current Opinion in HIV and AIDS, 1.
  91. The Tenores Study Group. (2016). Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. The Lancet Infectious Diseases.
  92. Treffry-Goatley, A., Lessells, R., Sykes, P., Bärnighausen, T., de Oliveira, T., Moletsane, R., & Seeley, J. (2016). Understanding Specific Contexts of Antiretroviral Therapy Adherence in Rural South Africa: A Thematic Analysis of Digital Stories from a Community with High HIV Prevalence. PLOS ONE, 11(2), e0148801.
  93. Vandormael, A., Boulware, D., Tanser, F., Bärnighuasen, T., Stott, K., & de Oliveira, T. (2015). Virologic monitoring can be a cost-effective strategy to diagnose treatment failure on first-line ART. Journal of Acquired Immune Deficiency Syndromes (1999).
  94. Vaz, S. N., Giovanetti, M., Rego, F. F. de A., de Oliveira, T., Danaviah, S., Gonçalves, M. L. F., Alcantara, L.C., & Alves, C. R. B. (2015). Molecular characterization of the Human Immunodeficiency Virus Type 1 in women and their vertically infected children. AIDS Research and Human Retroviruses, 150722062250000.
    78. Viljoen, J., Tuaillon, E., Nagot, N., Danaviah, S., Peries, M., Padayachee, P., Foulongne, V., Bland, R., Rollins, N., Newell, M.-L., & van de Perre, P. (2015). Cytomegalovirus, and possibly Epstein-Barr virus, shedding in breast milk is associated with HIV-1 transmission by breastfeeding. AIDS (London, England), 29(2), 145–153.
  95. Viljoen, J., Tuaillon, E., Nagot, N., Danaviah, S., Peries, M., Padayachee, P., Foulongne, V., Bland, R., Rollins, N., Newell, M.-L., & van de Perre, P. (2015). Cytomegalovirus, and possibly Epstein-Barr virus, shedding in breast milk is associated with HIV-1 transmission by breastfeeding. AIDS (London, England), 29(2), 145–153.
  96. Vollmer, S., Alfven, T., Padayachy, J., Harttgen, K., Ghys, P. D., & Bärnighausen, T. (2015). HIV surveys in older adults: better data, better health. The Lancet HIV, 2(2), e40–e41.
  97. Wensing, A. M., Calvez, V., Günthard, H. F., Johnson, V. A., Paredes, R., Pillay, D., Shafer, R.W., & Richman, D. D. (2015). 2015 Update of the Drug Resistance Mutations in HIV-1. Topics in Antiviral Medicine, 23(4), 132–141
  98. Wilkinson, E., Engelbrecht, S., & de Oliveira, T. (2015). History and origin of the HIV-1 subtype C epidemic in South Africa and the greater southern African region. Scientific Reports, 5.
  99. Wilkinson, E., Holzmayer, V., Jacobs, G. B., de Oliveira, T., Brennan, C. A., Hackett, J., van Rensburg, E.J., & Engelbrecht, S. (2015). Sequencing and Phylogenetic Analysis of Near Full-Length HIV-1 Subtypes A, B, G and Unique Recombinant AC and AD Viral Strains Identified in South Africa. AIDS Research and Human Retroviruses, 31(4), 412–420.
  100. Yates, T. A., Khan, P. Y., Knight, G. M., Taylor, J. G., McHugh, T. D., Lipman, M., … Abubakar, I. (2016). The transmission of Mycobacterium tuberculosis in high burden settings. The Lancet Infectious Diseases, 16(2), 227–238.
  101. Yates, T. A., Tanser, F., & Abubakar, I. (2016). Plan Beta for tuberculosis: it’s time to think seriously about poorly ventilated congregate settings. The International Journal of Tuberculosis and Lung Disease, 20(1), 5–10.
  102. Yates, T. A., Abubakar, I., & Tanser, F. (2015). HIV Infection and the Transmission of Tuberculosis. The Journal of Infectious Diseases, 211(9), 1510.
  103. Zaba, B., Reniers, G., Slaymaker, E., Todd, J., Glynn, J., Crampin, A., ., Urassa, M., Lutalo, T., Newell, M.L., Hosegood, V., Clark, S., & Gregson, S. (2015). Understanding why people participate in HIV surveillance. Bulletin of the World Health Organisation, 2015(93), 356.

 

Conference Abstracts / Posters

  1. Bärnighausen, T., Herbst, K., Tanser, F., Newell, M.-L., & Bor, J. (2015). Unequal benefits from ART: a growing male disadvantage in life expectancy in rural South Africa. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, Seattle.
  2. Bor, J., Ahmed, S., Fox, M. P., Rosen, S., Tanser, F. C., Pillay, D., & Barrnighausen. (2016, February). Effect of eliminating CD4 thresholds on number of new ART initiators in South Africa.
  3. Bor, J., Fox, M. P., Rosen, S., Tanser, F., Pillay, D., & Barnighausen, T. (2016, February). The real world impact of CD4-eligibility criteria on retention in HIV care. Conference Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  4. Bor, J., McLaren, Z., Tanser, F., & Bärnighausen, T. W. (2015). HIV Treatment as economic stimulus: community spillover effects of mass ART Provision in Rural South Africa. Presented at the Population Association of America 2015 Annual Meeting, San Diego.
  5. Bor, J., Moscoe, E., Chimbindi, N., & Herbst, K. (2015). The Cost-Effectiveness of Early ART Initiation in South Africa: A Quasi-Experiment. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, Seattle.
  6. Brennan, A. T., Fox, M. P., Davies, M.-A., Stinson, K., Wood, R., Prozesky, H., … Bor, J. (2016, February). Clinical outcomes with tenofovir use in ART: regression discontinuity analysis. Conference Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  7. Brennan, A. T., Bor, J., Davies, M.-A., Stinson, K., Wood, R., Prozesky, H., Tanser, F., Fatti, G., Bärnighausen, T.W., & Wandeler, G. (2015). Assessing the effects of initiating tenofovir on HIV treatment outcomes in adults in Southern Africa using the 2010 WHO ART guideline change as a natural experiment: a regression discontinuity analysis. Poster.
  8. Cornell, M., Johnson, L. F., Schomaker, M., Tanser, F., Maskew, M., Wood, R., Prozesky, H., Giddy, J., Stinson, K., & Egger, M. (2015). Age and mortality in ART programs in South Africa.
  9. Davies, M.-A., Fatti, G., Bolton-Moore, C., Sawry, S., Technau, K., Phiri, S., Tanser, F., Rabie, H., Chimbetete, C., & Wood, R. (2015). Charecteristics and outcomes of perinatally HIV-infected adolescents. Presented at the 19th International Workshop on HIV Observational Databases, Catania.
  10. Dolling, D., & et al. (2016, February). High rate of viral suppression in late mortality on first-line ART in Uganda/Zimbabwe. Conference Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  11. Druce, M., Sommer, P., Le Mercier, P., Hulo, C., Masson, P., & de Oliveira, T. (2015). Human immunodeficiency virus (HIV) proteomics resource at BioAfrica BCB '15 Proceedings of the 6th ACM Conference on Bioinformatics, Computational Biology and Health Informatics. ACM : New York, pp. 497–498.
  12. Geldsetzer, P., Feigl, A. B., Tanser, F. C., Gareta, D., Pillay, D., & Barnighausen, T. (2016, February). Population-level declines in BMI and Blood Pressure Following Mass HIV Treatment. Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston. Harling, G., & Newell, M.-L. (2015). Age-disparate relationships and HIV incidence amongst rural South African women. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, Seattle.
  13. Harling, G., Tanser, F., Mutevedzi, T., & Bärnighausen, T. W. (2015). Validity of Reports of Partner Age reports in a rural South African population-based cohort. Poster presented at the Population Association of America Annual Meeting 2015.
  14. Hontelez, J. A. C., de Vlas, S., Tanser, F., Naidu, K., Pillay, D., Bärnighausen, T., & Baltussen, R. (2015). Effects of antiretroviral treatment on health care utilization in rural South Africa. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, Seattle.
  15. Kluberg, S. (2016, February). Do ART eligibility expansions crowd out the sickest? Evidence from South Africa. Presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  16. Lange, C., & et al. (2016, February). Independent lineages of HIV-1 multi drug resistance in children falling early ART. Conference Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  17. Manasa, J., Danaviah, S., Tanser, F., Pillay, S., Mthiyane, H., Wilkinson, E., Pillay, D., & de Oliveira, T. (2015, February). Increase in HIV Primary Drug resistance in a demographic surveillance area in rural KwaZulu-Natal, South Africa. Poster Presentation. presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, Seattle.
  18. McGovern, M., Canning, D., Bärnighausen, T. W., & Tanser, F. (2015, February). A Household Food Voucher Increases Consent to Home-Based HIV Testing in Rural KwaZulu-Natal. Poster presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, Seattle.
  19. Marcelin, A.-G., et al.,Grude, M., Derache, A., Pillay, D.,Barin, F., … Marcelin, A.-G. (2016, February). HIV antibodies and reservoir size in perinatally infected children on HAART. Poster Presentation presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  20. Oldenburg, C. E., Barnighausen, T., Tanser, F., DeGruttola, V.,Seage, G., Mimiaga, M. J., … Harling, G. (2016, February). Antiretroviral therapy and HIV acquisition in a South African population-based cohort. Conference Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  21. Patenaude, B. N., Chimbindi, N. Z., Pillay, D., & Bärnighausen, T. W. (2016, 25 February). The Causal Impact of ART initiation on Household Food Security. Presented at the Conference on Retroviruses and Opportunistic Infections, Boston.
  22. Raifman, J., Chetty, T., Tanser, F., Mutevedzi, T., Matthews, P., Herbst, K., Pillay, D., & Bärnighausen, T. (2015, February). Preventing unintended pregnancy and HIV: the HIV treatment cascade and contraceptive choices. Poster presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, Seattle.
  23. Raifman, J., Chetty, T., Tanser, F., Mutevedzi, T., Matthews, P., Herbst, K., & Pillay, D. (2015). Preventing Unintended Pregnancy and HIV Transmission: the Effect of the HIV Treatment Cascade on Contraceptive Use and Choice in Rural Kwazulu-Natal. Presented at the Population Association of America 2015 Annual Meeting, San Diego.
  24. Schomaker, M., Davies, M.-A., Malateste, K., Renner, L., Sawry, S., N’Gbeche, S., Technau, K.-G., Eboua, F., Tanser, F., & Haby ... (2015). Growth and mortality outcomes for different ART criteria in children aged 1-5years: a causal modelling analysis from West and Southern Africa. Oral Presentation - IeDEA Abstracts at IWHOD 2015.
  25. Switzer, W., & et al. (2016, February). Comparing three HIV-1 subtyping tools and a novel phylogenetic-based method. Conference Abstract presented at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
  26. Tanser, F., De Oliveira, T., Bärnighausen, T. W., & Pillay, D. (2015, February). Use of Population Viral Load to Predict HIV-Incidence in a Hyperendemic Population in Rural KwaZulu-Natal, South Africa. Poster presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, Seattle.
  27. Wilkinson, E., Danaviah, S., Manasa, J., Tanser, F., Herbst, K., & Pillay, D., on behalf of the PANGEA_HIV Consortium. (2015, February). Exploring transmission dynamics of HIV in rural KwaZulu-Natal, using phylogenetics. Poster presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 Conference on Retroviruses and Opportunistic Infections (CROI) 2015, Seattle.

 

  1. Afolabi, M. O., Bojang, K., D’Alessandro, U., Imoukhuede, E. B., Ravinetto, R. M., Larson, H., … Chandramohan, D. (2014). Multimedia Informed Consent Tool for a Low Literacy African Research Population: Development and Pilot-Testing. Journal of Clinical Research & Bioethics, 05(03). http://doi.org/10.4172/2155-9627.1000178
  2. Afolabi, M. O., Okebe, J. U., McGrath, N., Larson, H. J., Bojang, K., & Chandramohan, D. (2014). Informed consent comprehension in African research settings.Tropical Medicine & International Health, n/a–n/a. http://doi.org/10.1111/tmi.12288
  3. Ardington, C., Bärnighausen, T., Case, A., & Menendez, A. (2014). The Economic Consequences of AIDS mortality in South Africa. Journal of Development Economics,111, 48–60. http://doi.org/10.1016/j.jdeveco.2014.08.001
  4. Bärnighausen, T., Berkley, S., Bhutta, Z. A., Bishai, D. M., Black, M. M., Bloom, D. E., … others. (2014). Reassessing the value of vaccines. The Lancet Global Health,2(5), e251–e252. http://doi.org/10.1016/S2214-109X(13)70170-0.
  5. Barnighausen, T., Bloom, D. E., Cafiero-Fonseca, E. T., & O’Brien, J. C. (2014). Valuing vaccination. Proceedings of the National Academy of Sciences, 111(34), 12313–12319. http://doi.org/10.1073/pnas.1400475111
  6. Bärnighausen, T., Eyal, N., & Wikler, D. (2014). HIV Treatment-as-Prevention Research at a Crossroads. PLoS Medicine, 11(6), e1001654.http://doi.org/10.1371/journal.pmed.1001654
  7. Basson, A. E., Rhee, S.-Y., Parry, C. M., El-Khatib, Z., Charalambous, S., Oliveira, T. D., … Morris, L. (2014). The Impact of Drug Resistance Associated Amino Acid Changes on HIV-1 Subtype C on Susceptibility to Newer NNRTIs. Antimicrobial Agents and Chemotherapy, 59(2), 960–971. http://doi.org/10.1128/AAC.04215-14
  8. Bennett, R., Hosegood, V., Newell, M.-L., & McGrath, N. (2014a). An Approach to Measuring Dispersed Families with a Particular Focus on Children “Left Behind” by Migrant Parents: Findings from Rural South Africa. Population, Space and Place, n/a–n/a. http://doi.org/10.1002/psp.1843
  9. Bennett, R., Hosegood, V., Newell, M.-L., & McGrath, N. (2014b). Understanding Family Migration in Rural South Africa: Exploring Children’s Inclusion in the Destination Households of Migrant Parents. Population, Space and Place, n/a–n/a. http://doi.org/10.1002/psp.1842
  10. Bor, J., Moscoe, E., Mutevedzi, P., Newell, M.-L., & Bärnighausen, T. (2014). Regression Discontinuity Designs in Epidemiology: Causal Inference Without Randomized Trials. Epidemiology, 25(5), 729–737. http://doi.org/10.1097/EDE.0000000000000138
  11. Bork, K. A., Cournil, A., Read, J. S., Newell, M.-L., Cames, C., Meda, N., … de Vincenzi, I. (2014). Morbidity in relation to feeding mode in African HIV-exposed, uninfected infants during the first 6 mo of life: the Kesho Bora study. The American Journal of Clinical Nutrition, 100(6), 1559–1568.http://doi.org/10.3945/ajcn.113.082149
  12. Brandt, P., Moodley, D., Pillay, A. W., Seebregts, C. J., & Oliveira, T. de. (2014). An Investigation of Classification Algorithms for Predicting HIV Drug Resistance without Genotype Resistance Testing. In J. Gibbons & W. MacCaull (Eds.), Foundations of Health Information Engineering and Systems (pp. 236–253). Springer Berlin Heidelberg. Retrieved from http://link.springer.com/chapter/10.1007/978-3-642-53956-5_16
  13. Brenner, S., Muula, A. S., Robyn, P. J., Bärnighausen, T., Sarker, M., Mathanga, D. P., … De Allegri, M. (2014). Design of an impact evaluation using a mixed methods model--an explanatory assessment of the effects of results-based financing mechanisms on maternal healthcare services in Malawi. BMC Health Services Research,14, 180. http://doi.org/10.1186/1472-6963-14-180
  14. Cambiano, V., Bertagnolio, S., Jordan, M. R., Pillay, D., Perriëns, J. H., Venter, F., … Phillips, A. (2014). Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation. AIDS, 28 Suppl 1, S15–23. http://doi.org/10.1097/QAD.0000000000000082
  15. Cames, C., Cournil, A., de Vincenzi, I., Gaillard, P., Meda, N., Luchters, S., … Kesho Bora Study Group. (2014). Postpartum weight change among HIV-infected mothers by antiretroviral prophylaxis and infant feeding modality in a research setting. AIDS (London, England), 28(1), 85–94.http://doi.org/10.1097/01.aids.0000433243.24481.c3
  16. Chaiyachati, K. H., Ogbuoji, O., Price, M., Suthar, A. B., Negussie, E. K., & Bärnighausen, T. (2014). Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS, 28, S187–S204. http://doi.org/10.1097/QAD.0000000000000252
  17. Chetty, T., Carter, R. J., Bland, R. M., & Newell, M.-L. (2014). HIV status, breastfeeding modality at 5 months and postpartum maternal weight changes over 24 months in rural South Africa. Tropical Medicine & International Health, 19(7), 852–862. http://doi.org/10.1111/tmi.12320
  18. Chimbindi, N., Bärnighausen, T., & Newell, M.-L. (2014). Patient satisfaction with HIV and TB treatment in a public programme in rural KwaZulu-Natal: evidence from patient-exit interviews. BMC Health Services Research, 14(1). http://doi.org/10.1186/1472-6963-14-32
  19. Coates, T. J., Kulich, M., Celentano, D. D., Zelaya, C. E., Chariyalertsak, S., Chingono, A., … Eshleman, S. H. (2014). Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial. The Lancet Global Health, 2(5), e267–e277. http://doi.org/10.1016/S2214-109X(14)70032-4
  20. Coetzee, B., Kagee, A., & Bland, R. (2014). Barriers and facilitators to paediatric adherence to antiretroviral therapy in rural South Africa: a multi-stakeholder perspective. AIDS Care, 1–7. http://doi.org/10.1080/09540121.2014.967658
  21. Craig, E., Bland, R., Ndirangu, J., & Reilly, J. J. (2014). Use of mid-upper arm circumference for determining overweight and overfatness in children and adolescents.Archives of Disease in Childhood, 99(8), 763–766. http://doi.org/10.1136/archdischild-2013-305137
  22. Crook, A. M., Ford, D., Gafos, M., Hayes, R., Kamali, A., Kapiga, S., … McCormack, S. (2014). Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial. Human Reproduction. http://doi.org/10.1093/humrep/deu113
  23. Darbes, L. A., van Rooyen, H., Hosegood, V., Ngubane, T., Johnson, M. O., Fritz, K., & McGrath, N. (2014). Uthando Lwethu (“our love”): a protocol for a couples-based intervention to increase testing for HIV: a randomized controlled trial in rural KwaZulu-Natal, South Africa. Trials, 15(1), 64–64. http://doi.org/10.1186/1745-6215-15-64
  24. Dennis, A. M., Herbeck, J. T., Brown, A. L., Kellam, P., de Oliveira, T., Pillay, D., … Cohen, M. S. (2014). Phylogenetic studies of transmission dynamics in generalized HIV epidemics: An essential tool where the burden is greatest? JAIDS Journal of Acquired Immune Deficiency Syndromes.http://doi.org/10.1097/QAI.0000000000000271
  25. Eaton, J. W., Menzies, N. A., Stover, J., Cambiano, V., Chindelevitch, L., Cori, A., … Hallett, T. B. (2014). Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. The Lancet Global Health, 2(1), e23–e34. http://doi.org/10.1016/S2214-109X(13)70172-4
  26. Evangeli, M., Newell, M.-L., Richter, L., & McGrath, N. (2014). The Association between Self-Reported Stigma and Loss-to-Follow Up in Treatment Eligible HIV Positive Adults in Rural Kwazulu-Natal, South Africa. PLoS ONE, 9(2), e88235. http://doi.org/10.1371/journal.pone.0088235
  27. Feigl, A. B., Tanser, F., & Bärnighausen, T. W. (2014). The effect of HIV and the modifying effect of antiretroviral therapy on body-mass index and blood pressure levels in rural South Africa. The Lancet Global Health, 2, Supplement 1, S21. http://doi.org/10.1016/S2214-109X(15)70043-4
  28. Foster, D. W., Young, C. M., & Bärnighausen, T. W. (2014). Self-Control as a Moderator of the Relationship Between Drinking Identity and Alcohol Use. Substance Use & Misuse, 49(10), 1340–1348. http://doi.org/10.3109/10826084.2014.901387
  29. Gafos, M., Francis, S., Crook, A., Mzimela, M., Ramjee, G., Morar, N. S., … McCormack, S. (2014). Post-coital intravaginal cleansing among women enrolled in MDP 301. Powerpoint presentation.
  30. Gafos, M., Pool, R., Mzimela, M. A., Ndlovu, H. B., McCormack, S., Elford, J., & MDP team. (2014). The implications of post-coital intravaginal cleansing for the introduction of vaginal microbicides in South Africa. AIDS and Behavior, 18(2), 297–310. http://doi.org/10.1007/s10461-013-0676-9
  31. Gafos, M., Pool, R., Mzimela, M. A., Ndlovu, H. B., McCormack, S., Elford, J., & The MDP Team. (2014). Communication about microbicide use between couples in KwaZulu-Natal, South Africa. AIDS Behaviour, Original paper, 1–15. http://doi.org/10.1007/s10461-0965-y
  32. Gore, R. J., Fox, A. M., Goldberg, A. B., & Bärnighausen, T. (2014). Bringing the state back in: Understanding and validating measures of governments’ political commitment to HIV. Global Public Health, 9(1-2), 98–120. http://doi.org/10.1080/17441692.2014.881523
  33. Gupta, R. K., Goodall, R. L., Ranopa, M., Kityo, C., Munderi, P., Lyagoba, F., … DART Virology Group and Trial Team. (2014). High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy. Clinical Infectious Diseases, 58(7), 1023–1026.http://doi.org/10.1093/cid/cit933
  34. Harling, G., Newell, M.-L., Tanser, F., Kawachi, I., Subramanian, S. V., & Bärnighausen, T. (2014). Do Age-Disparate Relationships Drive HIV Incidence in Young Women? Evidence from a Population Cohort in Rural KwaZulu-Natal, South Africa. Journal of Acquired Immune Deficiency Syndromes (1999), 66(4), 443–451.http://doi.org/10.1097/QAI.0000000000000198
  35. Harling, G., Subramanian, S. V., Bärnighausen, T., & Kawachi, I. (2014). Income inequality and sexually transmitted in the United States: who bears the burden?Social Science & Medicine (1982), 102, 174–182. http://doi.org/10.1016/j.socscimed.2013.11.025
  36. Hodcroft, E., Hadfield, J. D., Fearnhill, E., Phillips, A., Dunn, D., O’Shea, S., … UK CHIC Study. (2014). The contribution of viral genotype to plasma viral set-point in HIV infection. PLoS Pathogens, 10(5). http://doi.org/10.1371/journal.ppat.1004112
  37. Hontelez, J. A. C., & de Vlas, S. J. (2014). Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples. New England Journal of Medicine, 370(6), 581–582. http://doi.org/10.1056/NEJMc1314998
  38. Hope, R., Kendall, T., Langer, A., & Bärnighausen, T. (2014). Health Systems Integration of Sexual and Reproductive Health and HIV Services in Sub-Saharan Africa: A Scoping Study. Journal of Acquired Immune Deficiency Syndromes (1999), 67(Suppl 4), bri. http://doi.org/10.1097/QAI.0000000000000381
  39. Howard, L. M., Molyneaux, E., Dennis, C.-L., Rochat, T., Stein, A., & Milgrom, J. (2014). Non-psychotic mental disorders in the perinatal period. Lancet, 384(9956), 1775–1788. http://doi.org/10.1016/S0140-6736(14)61276-9
  40. Huntington, S., Thorne, C., Anderson, J., Newell, M.-L., Taylor, G., Pillay, D., … Sabin, C. (2014). Does pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women? Journal of the International AIDS Society, 17(4(Suppl 3)). http://doi.org/10.7448/IAS.17.4.19486
  41. Huntington, S., Thorne, C., Anderson, J., Newell, M.-L., Taylor, G. P., Pillay, D., … National Study of HIV in Pregnancy and Childhood (NSHPC). (2014). Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women. BMC Infectious Diseases, 14. http://doi.org/10.1186/1471-2334-14-127
  42. Jacobs, G. B., Wilkinson, E., Isaacs, S., Spies, G., de Oliveira, T., Seedat, S., & Engelbrecht, S. (2014). HIV-1 Subtypes B and C Unique Recombinant Forms (URFs) and Transmitted Drug Resistance Identified in the Western Cape Province, South Africa. PLoS ONE, 9(3). http://doi.org/10.1371/journal.pone.0090845
  43. Joseph, S., Abbai, N., Delany-Moretlwe, S., Gafos, M., Kapiga, S., Chisembele, M., … Crook, A. (2014, October). Bacterial vaginosis and HIV:an analysis of the MDP 301 trial. Poster presented at the HIV Research for Prevention, Cape Town. Retrieved from http://www.epostersonline.com/hivr4p2014/topic-posters?field_topics_target_id=All&page=15
  44. Jose, S., Quinn, K., Hill, T., Leen, C., Walsh, J., Hay, P., … UK CHIC Steering Committee. (2014). Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy. AIDS (London, England), 28(9), 1333–1339. http://doi.org/10.1097/QAD.0000000000000242
  45. Kania, D., Ottomani, L., Meda, N., Peries, M., Dujols, P., Bolloré, K., … Tuaillon, E. (2014). Performance of two real-time PCR assays for hepatitis B virus DNA detection and quantitation. Journal of Virological Methods, 201, 24–30. http://doi.org/10.1016/j.jviromet.2014.01.015
  46. Kendall, T., Bärnighausen, T., Fawzi, W. W., & Langer, A. (2014). Towards Comprehensive Womenʼs Healthcare in Sub-Saharan Africa: Addressing Intersections Between HIV, Reproductive and Maternal Health. JAIDS Journal of Acquired Immune Deficiency Syndromes, 67, S169–S172.http://doi.org/10.1097/QAI.0000000000000382
  47. Kiepiela, P., Manasa, J., Moosa, M.-Y., Moodley, P., Gordon, M., Parikh, U. M., … Ramjee, G. (2014). HIV Drug Resistance Patterns at the Epicentre of the HIV-1 Epidemic in Kwazulu-Natal, South Africa 2003-2013. Journal of AIDS & Clinical Research, 05(05). http://doi.org/10.4172/2155-6113.1000299
  48. Kityo, C., Gibb, D. M., Gilks, C. F., Goodall, R. L., Mambule, I., Kaleebu, P., … DART Trial Team. (2014). High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial. PLoS ONE, 9(3).http://doi.org/10.1371/journal.pone.0090772
  49. Knight, L., McGrath, N., van Rooyen, H., Humphries, H., van Heerden, A., & Richter, L. (2014). Characteristics of sexually experienced HIV testers aged 18 to 32 in rural South Africa: baseline results from a community-based trial, NIMH Project Accept (HPTN 043). BMC Public Health, 14(1), 1164. http://doi.org/10.1186/1471-2458-14-1164.
  50. Lema, I. A., Sando, D., Magesa, L., Machumi, L., Mungure, E., Mwanyika Sando, M., … Bärnighausen, T. (2014). Community Health Workers to Improve Antenatal Care and PMTCT Uptake in Dar es Salaam, Tanzania: A Quantitative Performance Evaluation. Journal of Acquired Immune Deficiency Syndromes (1999), 67(Suppl 4), S195–S201. http://doi.org/10.1097/QAI.0000000000000371
  51. Lessells, R. J., Mutevedzi, P. C., Iwuji, C. C., & Newell, M.-L. (2014). Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria. Journal of Acquired Immune Deficiency Syndromes (1999), 65(1), e17–24. http://doi.org/10.1097/QAI.0b013e31829ceb14
  52. Lessells, R. J., Stott, K. E., Manasa, J., Naidu, K. K., Skingsley, A., Rossouw, T., … Southern African Treatment and Resistance Network (SATuRN). (2014). Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges. BMC Health Services Research, 14(1), 116. http://doi.org/10.1186/1472-6963-14-116
  53. Low, A. J., Konate, I., Nagot, N., Weiss, H. A., Kania, D., Vickerman, P., … Yerelon Study Group. (2014). Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study. Journal of Acquired Immune Deficiency Syndromes (1999), 65(2), 237–245.http://doi.org/10.1097/QAI.0000000000000049
  54. Malherbe, G., Steel, H. C., Cassol, S., de Oliveira, T., Seebregts, C. J., Anderson, R., … Rossouw, T. M. (2014). Circulating Biomarkers of Immune Activation Distinguish Viral Suppression from Nonsuppression in HAART-Treated Patients with Advanced HIV-1 Subtype C Infection. Mediators of Inflammation, 2014.http://doi.org/10.1155/2014/198413
  55. Maman, S., van Rooyen, H., Stankard, P., Chingono, A., Muravha, T., Ntogwisangu, J., … and the NIMH Project Accept (HPTN 043) study team. (2014). NIMH Project Accept (HPTN 043): Results from In-Depth Interviews with a Longitudinal Cohort of Community Members. PLoS ONE, 9(1), e87091.http://doi.org/10.1371/journal.pone.0087091
  56. Manasa, J., Danaviah, S., Pillay, S., Padayachee, P., Mthiyane, H., Mkhize, C., … De Oliveira, T. (2014). An affordable HIV-1 drug resistance monitoring method for resource limited settings. Journal of Visualized Experiments: JoVE, (85). http://doi.org/10.3791/51242
  57. Manasa, J., Lessells, R., Rossouw, T., Naidu, K., Van Vuuren, C., Goedhals, D., … de Oliveira, T. (2014). Southern African Treatment Resistance Network (SATuRN) RegaDB HIV drug resistance and clinical management database: supporting patient management, surveillance and research in southern Africa. Database: The Journal of Biological Databases and Curation, 2014. http://doi.org/10.1093/database/bat082
  58. Mills, E. J., Lester, R., Thorlund, K., Lorenzi, M., Muldoon, K., Kanters, S., … others. (2014). Interventions to promote adherence to antiretroviral therapy in Africa: a network meta-analysis. The Lancet HIV, 1(3), e104–e111. http://dx.doi.org/10.1016/S2352-3018(14)00003-4
  59. Mossong, J., Byass, P., & Herbst, K. (2014). Who died of what in rural KwaZulu-Natal, South Africa: a cause of death analysis using InterVA-4. Global Health Action, 7.http://doi.org/10.3402/gha.v7.25496
  60. Oldenburg, C. E., Bärnighausen, T., Harling, G., Mimiaga, M. J., & Mayer, K. H. (2014). Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis. AIDS and Behavior, 18(2), 217–225. http://doi.org/10.1007/s10461-013-0567-0
  61. Oldenburg, C. E., Perez-Brumer, A. G., Reisner, S. L., Mattie, J., Bärnighausen, T., Mayer, K. H., & Mimiaga, M. J. (2014). Global Burden of HIV among Men Who Engage in Transactional Sex: A Systematic Review and Meta-Analysis. PLoS ONE, 9(7), e103549. http://doi.org/10.1371/journal.pone.0103549
  62. Olson, A. D., Guiguet, M., Zangerle, R., Gill, J., Perez-Hoyos, S., Lodi, S., … for CASCADE Collaboration in EuroCoord. (2014). Evaluation of rapid progressors in HIV infection as an extreme phenotype. Journal of Acquired Immune Deficiency Syndromes (1999), 67(1), 15–21. http://doi.org/10.1097/QAI.0000000000000240
  63. Oni, T., McGrath, N., BeLue, R., Roderick, P., Colagiuri, S., May, C. R., & Levitt, N. S. (2014). Chronic diseases and multi-morbidity - a conceptual modification to the WHO ICCC model for countries in health transition. BMC Public Health, 14, 575. http://doi.org/10.1186/1471-2458-14-575
  64. Ouedraogo, D. E., Bollore, K., Viljoen, J., Foulongne, V., Reynes, J., Cartron, G., … Tuaillon, E. (2014). Comparison of EBV DNA viral load in whole blood, plasma, B-cells and B-cell culture supernatant. Journal of Medical Virology, 86(5), 851–856. http://doi.org/10.1002/jmv.23858
  65. Pillay, S., Bland, R. M., Lessells, R. J., Manasa, J., de Oliveira, T., & Danaviah, S. (2014). Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort. AIDS Research and Therapy, 11(1). http://doi.org/10.1186/1742-6405-11-3
  66. Raffi, F., Babiker, A. G., Richert, L., Molina, J.-M., George, E. C., Antinori, A., … NEAT001/ANRS143 Study Group. (2014). Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. Lancet, 384(9958), 1942–1951. http://doi.org/10.1016/S0140-6736(14)61170-3
  67. Raifman, J., Chetty, T., Tanser, F., Mutevedzi, T., Matthews, P., Herbst, K., … Bärnighausen, T. (2014). Preventing Unintended Pregnancy and HIV Transmission: Effects of the HIV Treatment Cascade on Contraceptive Use and Choice in Rural KwaZulu-Natal. JAIDS Journal of Acquired Immune Deficiency Syndromes, 67, S218–S227. http://doi.org/10.1097/QAI.0000000000000373
  68. Reniers, G., Slaymaker, E., Nakiyingi-Miiro, J., Nyamukapa, C., Crampin, A. C., Herbst, K., … Zaba, B. (2014). Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA). AIDS (London, England), 28(4), S533–S542.http://doi.org/10.1097/QAD.0000000000000496
  69. Reynolds, L. J. (2014). “Low-hanging fruit”: counting and accounting for children in PEPFAR-funded HIV/AIDS programmes in South Africa. Global Public Health, 9(1-2), 124–143. http://doi.org/10.1080/17441692.2013.879670
  70. Richter, L., Rotheram-Borus, M. J., Van Heerden, A., Stein, A., Tomlinson, M., Harwood, J. M., … Tang, Z. (2014). Pregnant women living with HIV (WLH) supported at clinics by peer WLH: a cluster randomized controlled trial. AIDS and Behavior, 18(4), 706–715. http://doi.org/10.1007/s10461-014-0694-2
  71. Robyn, P. J., Bärnighausen, T., Souares, A., Traoré, A., Bicaba, B., Sié, A., & Sauerborn, R. (2014). Provider payment methods and health worker motivation in community-based health insurance: a mixed-methods study. Social Science & Medicine (1982), 108, 223–236. http://doi.org/10.1016/j.socscimed.2014.01.034
  72. Rochat, T. J., Arteche, A. X., Stein, A., Mkwanazi, N., & Bland, R. M. (2014). Maternal HIV disclosure to young HIV-uninfected children: an evaluation of a family-centred intervention in South Africa. AIDS (London, England), 28 Suppl 3, S331–341. http://doi.org/10.1097/QAD.0000000000000333
  73. Rockers, P. C., Røttingen, J.-A., Shemilt, I., Tugwell, P., & Bärnighausen, T. (2014). Inclusion of Quasi-Experimental Studies in Systematic Reviews of Health Systems Research. Health Policy. http://doi.org/10.1016/j.healthpol.2014.10.006
  74. Ross, E., Tanser, F., Pei, P., Newell, M.-L., Losina, E., Thiebaut, R., … Walensky, R. (2014). The Impact of the 2013 WHO Antiretroviral Therapy Guidelines on the Feasibility of HIV Population Prevention Trials. HIV Clinical Trials, 15(5), 185–198. http://doi.org/10.1310/hct1505-185
  75. Sando, D., Geldsetzer, P., Magesa, L., Lema, I. A., Machumi, L., Mwanyika-Sando, M., … others. (2014). Evaluation of a community health worker intervention and the Wold Health Organization’s Option B versus Option A to improve antenatal care and PMTCT outcomes in Dar es Salaam, Tanzania: a study protocol for a cluster-randomized controlled health systems implementation trial. Journal of Acquired Immune Deficiency Syndromes, 67(Suppl 4), S195–S201. http://doi:10.1186/1745-6215-15-359
  76. Sankoh, O., Sharrow, D., Herbst, K., Kabudula, C., Whiteson, Alam, N., Kant, S., … Clark, S. J. (2014). The INDEPTH standard population for low- and middle-income countries, 2013. Global Health Action, 7(0). http://doi.org/10.3402/gha.v7.23286
  77. Schultze, A., Paredes, R., Sabin, C., Phillips, A. N., Pillay, D., Kirk, O., … on behalf of EuroSIDA in EuroCOORD, UK CHIC and UK HDRD. (2014). Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure. Journal of the International AIDS Society, 17(4 (Suppl 3).http://doi.org/10.7448/IAS.17.4.19737
  78. Silal, S. P., Penn-Kekana, L., Bärnighausen, T., & Schneider, H. (2014). Local level inequalities in the use of hospital-based maternal delivery in rural South Africa.Globalization and Health, 10(1), 60. http://doi.org/10.1186/s12992-014-0060-1
  79. Slaymaker, E., Todd, J., Marston, M., Calvert, C., Michael, D., Nakiyingi-Miiro, J., … Zaba, B. (2014). How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa. Global Health Action, 7. http://doi.org/10.3402/gha.v7.22789
  80. Steen, R., Hontelez, J. A. C., Veraart, A., White, R. G., & de Vlas, S. J. (2014). Looking upstream to prevent HIV transmission: can interventions with sex workers alter the course of HIV epidemics in Africa as they did in Asia? AIDS (London, England), 28(6), 891–899. http://doi.org/10.1097/QAD.0000000000000176
  81. Stover, J., Andreev, K., Slaymaker, E., Gopalappa, C., Sabin, K., Velasquez, C., … Urassa, M. (2014). Updates to the Spectrum model to estimate key HIV indicators for adults and children. AIDS (London, England), 28(4), S427–S434. http://doi.org/10.1097/QAD.0000000000000483
  82. Streatfield, P. K., Alam, N., Compaoré, Y., Rossier, C., Soura, A. B., Bonfoh, B., … Byass, P. (2014). Pregnancy-related mortality in Africa and Asia: evidence from INDEPTH Health and Demographic Surveillance System sites. Global Health Action, 7. http://doi.org/10.3402/gha.v7.25368
  83. Streatfield, P. K., Khan, W. A., Bhuiya, A., Alam, N., Sié, A., Soura, A. B., … Byass, P. (2014). Cause-specific mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites. Global Health Action, 7. http://doi.org/10.3402/gha.v7.25362
  84. Streatfield, P. K., Khan, W. A., Bhuiya, A., Hanifi, S. M. A., Alam, N., Bagagnan, C. H., … Byass, P. (2014). Adult non-communicable disease mortality in Africa and Asia: evidence from INDEPTH Health and Demographic Surveillance System sites. Global Health Action, 7. http://doi.org/10.3402/gha.v7.25365
  85. Streatfield, P. K., Khan, W. A., Bhuiya, A., Hanifi, S. M. A., Alam, N., Diboulo, E., … Byass, P. (2014). Malaria mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance  system sites. Global Health Action, 7. http://doi.org/10.3402/gha.v7.25369
  86. Streatfield, P. K., Khan, W. A., Bhuiya, A., Hanifi, S. M. A., Alam, N., Diboulo, E., … Byass, P. (2014). Mortality from external causes in Africa and Asia: evidence from INDEPTH Health and Demographic Surveillance System Sites. Global Health Action, 7. http://doi.org/10.3402/gha.v7.25366
  87. Streatfield, P. K., Khan, W. A., Bhuiya, A., Hanifi, S. M. A., Alam, N., Millogo, O., … Byass, P. (2014). HIV/AIDS-related mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites. Global Health Action, 7, 25370.
  88. Streatfield, P. K., Khan, W. A., Bhuiya, A., Hanifi, S. M. A., Alam, N., Ouattara, M., … Byass, P. (2014). Cause-specific childhood mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites. Global Health Action, 7, 25363. http://doi.org/10.1097/QAD.0000000000000496.
  89. Sutherland, K. A., Mbisa, J. L., Cane, P. A., Pillay, D., & Parry, C. M. (2014). Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1. The Journal of General Virology, 95(Pt 1), 190–200.http://doi.org/10.1099/vir.0.055624-0
  90. Tanser, F., de Oliveira, T., Maheu-Giroux, M., & Bärnighausen, T. (2014). Concentrated HIV subepidemics in generalized epidemic settings. Current Opinion in HIV and AIDS, 9(2), 115–125. http://doi.org/10.1097/COH.0000000000000034
  91. Tenzer, S., Crawford, H., Pymm, P., Gifford, R., Sreenu, V. B., Weimershaus, M., … Iversen, A. K. N. (2014). HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification. Cell Reports, 7(2), 448–463. http://doi.org/10.1016/j.celrep.2014.03.031
  92. The UK Collaborative Group on HIV Drug Resistance. (2014). The increasing genetic diversity of HIV-1 in the UK, 2002–2010. AIDS (London, England), 28(5), 773–780.http://doi.org/10.1097/QAD.0000000000000119
  93. Vandormael, A., Newell, M.-L., Bärnighausen, T., & Tanser, F. (2014). Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004-12: a prospective cohort study. The Lancet Global Health, 2(4), e209–e215. http://doi.org/10.1016/S2214-109X(14)70018-X
  94. Van Panhuis, W. G., Paul, P., Emerson, C., Grefenstette, J., Wilder, R., Herbst, A. J., … Burke, D. S. (2014). A systematic review of barriers to data sharing in public health. BMC Public Health, 14(1), 1144. http://doi.org/10.1186/1471-2458-14-1144
  95. Venkatesan, M., Gadalla, N. B., Stepniewska, K., Dahal, P., Nsanzabana, C., Moriera, C., … Sibley, C. H. (2014). Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine. The American Journal of Tropical Medicine and Hygiene, 91(4), 833–843. http://doi.org/10.4269/ajtmh.14-0031
  96. Wensing, A. M., Calvez, V., Günthard, H. F., Johnson, V. A., Paredes, R., Pillay, D., … Richman, D. D. (2014). 2014 Update of the drug resistance mutations in HIV-1.Topics in Antiviral Medicine, 22(3), 642–650. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392881/
  97. Wilkinson, E., Engelbrecht, S., & de Oliveira, T. (2014). Detection of Transmission Clusters of HIV-1 Subtype C over a 21-Year Period in Cape Town, South Africa. PLoS ONE, 9(10), e109296. http://doi.org/10.1371/journal.pone.0109296
  98. Yates, T. A., Abubakar, I., & Tanser, F. (2014). HIV Infection and the Transmission of Tuberculosis. Journal of Infectious Diseases. http://doi.org/10.1093/infdis/jiu628
  99. Yeji, F., Klipstein-Grobusch, K., Newell, M.-L., Hirschhorn, L. R., Hosegood, V., & Bärnighausen, T. (2014). Are social support and HIV coping strategies associated with lower depression in adults on antiretroviral treatment? Evidence from rural KwaZulu-Natal, South Africa. AIDS Care, 26(12), 1482–1489.http://doi.org/10.1080/09540121.2014.931561

HIV dynamics and impact of ART roll-out programme

  1. Bor J, Herbst AJ, Newell ML, Bärnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 2013; 339: 961    PM23430655 / doi:10.1126/science.1230413
  2. Camlin CS, Snow RC, Hosegood V. Gendered patterns of migration in rural South Africa.  Population, Space and Place 2013; doi:10.1002/psp.1794
  3. Hoffmann CJ, Schomaker M, Fox MP, Mutevedzi P, Giddy J, Prozesky H, Wood R, Egger M, Boulle A for the IeDEA Southern Africa Collaboration. CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multi-cohort analysis from South Africa. JAIDS 2013; 63(1): 34-41 PM23344547 / doi:10.1097/QAI.0b013e318287c1fe
  4. Johnson LF, Mossong J, Dorrington RE, Hoffmann CJ, Keiser O, Fox MP, Wood R, Prozesky H, Giddy J, Garone DB, Cornell M, Boulle A. Life expectancies of South African adults starting antiretroviral treatment with high CD4 counts approach those in HIV-negative adults. PLoS Med 2013; 10(4): e1001418   PM23585736 / doi:10.1371/journal.pmed.1001418
  5. Johnson LF, Mossong J, Dorrington RE, Hoffmann CJ, Keiser O, Fox MP, Wood R, Prozesky H, Giddy J, Garone DB, Cornell M, Boulle A. Life expectancies of South African adults starting antiretroviral treatment. PLoS Med 10(4): PM: 23585736 e1001418. doi:10.1371/journal.pmed.1001418
  6. Knight L, Hosegood V, Timaeus IM. The South African disability grant: Influence on HIV treatment outcomes and household well-being in KwaZulu-Natal. Development Southern Africa. 2013; 30(1): 135-147  (Published online 30 Jan 2013) PM / doi: 10.1080/0376835X.2013.755767
  7. Malaza A, Mossong J, Bärnighausen T, Viljoen J, Newell ML. Population-based CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment coverage. PLoS ONE 2013 8(7): e70126. doi:10.1371/journal.pone.0070126
  8. Manasa J, McGrath N, Lessells R, Skingsley A, Newell ML, de Oliveira T. High levels of drug resistance after failure of first-line antiretroviral therapy in rural South Africa: impact on standardised second-line regimens. PLoS One 2013 8(8): e72152. doi:10.1371/journal.pone.0072152 
  9. Nyirenda M, Chattery S, Mutevedzi P, Rochat T, Newell ML. Prevalence and correlates of depression among HIV-infected and –affected older people in rural South Africa. J Affective Disorders [Epub 4 Jun 2013]  PM23726780 / doi:10.1016/j.jad.2013.05.005
  10. Nyirenda M, Newell ML, Mugisha J, Mutevedzi P, Seeley J, Scholten F, Kowal P. Health, wellbeing, and disability among older people infected or affected by HIV in Uganda and South Africa. Glob Health Action 2013; 6: 19201    PM23364075 / doi:10.3402/gha.v6i0.19201
  11. Rosenberg N, Westreich D, Miller W, Pettifor A, Behetts F, Mamman S, Bärnighausen T, Newell ML. Assessing the Effect of HIV Counseling and Testing on HIV Acquisition among South African Youth. AIDS 2013 (eprint before publication) DOI:10.1097/01.aids.0000432454.68357.6a PM23887069
  12. Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of acquiring HIV infection in rural KwaZulu-Natal, South Africa. Science 2013; 339 : 966   PM23430656 / doi:10.1126/science.1228160
  13. Tanser F, Jones KG, Imrie J, Viljoen J, Grapsa E, Newell ML. HPV sero-positivity and subsequent risk of HIV acquisition in rural South African women Sexually Transmitted Diseases 2013; 40: 601-606
  14. Zaidi J, Grapsa E, Tanser F, Newell ML, Bärnighausen T. Dramatic increases in HIV prevalence after scale-up of antiretroviral treatment: a longitudinal population-based HIV surveillance study in rural South Africa. AIDS 2013, May 10 (Epub ahead of print) PM:23669155 / doi: 10.1097/QAD.0b013e328362e832

Building interventions and understanding behaviour

  1. Bork K, Cames C, Cournil A, Musyoka F, Ayassou K, Naidu K, Mepham S, Gichuhi C, Read JS, Gaillard P, de Vincenzi I for the Kesho Bora Study Group. Infant Feeding Modes and Determinants among HIV-1 infected African women in the Kesho Bora Study. J Acquir Immune Defic Syndr 2013; 62(1): 109-118 PM23075919 / doi:10.1097/QAI.0b013e318277005e  
  2. Cournil A, De Vincenzi I, Gaillard P, Cames C, Fao P, Luchters S, Rollins N, Newell ML, Bork K, Read JS. Relationship between mortality and feeding modality among children born to HIV-infected mothers in a research setting: the Kesho Bora Study. AIDS 2013; 27 (10): 1621-1630 PM 23262499
  3. Pritchett, Rachel, et al. "Risk factors for vulnerable youth in urban townships in South Africa: The potential contribution of reactive attachment disorder."Vulnerable Children and Youth Studies ahead-of-print (2013): 1-11. doi:10.1080/17450128.2012.756569 
  4. Rochat TJ, Mkwanazi N, Bland RM. Maternal HIV disclosure to HIV-uninfected children in rural South Africa: a family-based intervention. BMC Pub Health 2013; 13(1): 147.  PM23418933/doi:10.1186/1471-2458-13-147 
  5. Rochat TJ. Tomlinson M. Newell M-L. Stein A. Detection of antenatal depression in rural HIV affected populations with short and ultra-short versions of the Edinburgh Postnatal depression Scale (EPDS) Arch Womens Ment Health [Epub 25 Apr 2013]  PM23615932 / doi:10.1007/s00737-013-0353-z    

Evaluation and implementation

  1. Bland R, Ndirangu J, Newell ML. Maximizing opportunities for increased antiretroviral treatment in children in an existing HIV programme in rural South Africa.  BMJ 2013; 346: f550   PM23447354 / doi:10.1136/bmj.f550    
  2. Chimbindi N, Bärnighausen T, Newell ML. An integrated approach to improving the availability and utilisation of Tuberculosis healthcare in rural South Africa. SAMJ 2013; 103(4): 237-240  doi:10.7196/SAMJ/6423     
  3. Iwuji C,  Orne-Gliemann J, Tanser F, Boyer S, Lessells R, Lert F, Imrie J, Bärnighausen T, Rekacewicz C, Bazin B, Newell ML, Dabis for the ANRS 12249 TasP study group. Evaluation of the impact of immediate versus WHO recommendations-guided ART initiation on HIV incidence. The ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, Kwazulu-Natal, South Africa: study protocol for a randomised controlled trial. Trials 2013, 14:230 PM 23880306 / doi: 10.1186/1745-6215-14-230.
  4. Lessells RJ, Mutevedzi PC, Iwuju C, Newell ML. Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4 cell count eligibility criteria. JAIDS [Epub 10 Jun 2013]  doi:10.1097/QAI.0b013e31829ceb14   
  5. Mutevedzi P, Lessells RJ, Newell ML. Disengagement from care in a decentralized primary health care antiretroviral treatment programme: cohort study in rural South Africa. Trop Med Int Health [Epub 3 Jun 2013]  PM23731253 / doi:10.1111/tmi.12135       
  6. Michel J, Matlkaka C, English R, Lessells R, Newell ML. Collective Patient behaviours derailing ART roll-out in KwaZulu-Natal: Perspectives of Health Care Providers. AIDS Research and Therapy 2013,10:20 PM 23870285 doi:10.1186/1742-6405-10-20

Other

  1. Bärnighausen T, Bloom D, Humair S. Alternative perspective: strengthening health systems. In: Rethinking HIV: Smarter ways to investing ending HIV in sub-Saharan Africa. Lomborg B. (Ed.) Cambridge University Press, 2012. http://www.amazon.co.uk/RethinkHIV-Smarter-Invest-Ending-Sub-Saharan/dp/110767932X#reader_110767932X
  2. Bärnighausen T, Bloom DE, Cafiero E, O’Brien J. Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil. Seminars in Immunology 2013; 25: 104-113 http://dx.doi.org/10.1016/j.smim.2013.04.010
  3. Benton L, Newell ML. Childbearing and the impact of HIV: the South African experience. In: Fertility Rates and Population Decline, No time for children?Eds. Buchanan A, Rotkirch A. Palgrave Macmillan 2013; Chapter 10, pg 166-184
  4. Chepngeno-Langat G, Hosegood V. Older people and sexuality: Double jeopardy of ageism and sexism in youth-dominated societies. Agenda 2013; 26(4): 93-99  PM / doi: 10.1080/10130950.2012.757864
  5. Cleary S, Birch S, Chimbindi N, Silal S, Mcintyre D. Investigating the affordability of key health services in South Africa. Soc Sci Med 2013; 80: 37-46 [Epub 2012 Dec12] PM23415590 / doi:10.1016/j.socscimed.2012.11.035
  6. Cobb G, Bland R. Nutritional supplementation: the additional costs of managing children infected with HIV in resource-constrained settings. Trop Med Int Health 2013; 18(1): 45-52   PM23107420 / doi:10.1111/tmi.12006    
  7. Crampin AC, Dube A, Mboma S, Price A, Mwinuka V, Mwaiyeghele E, Chihana M, Branson K, Floyd S, Jahn A, Baschieri A, Molesworth A, McGrath N, Fine PEM, French N, Glynn JR, Zaba B. Profile: The Karonga Health and Demographic Surveillance System. International Journal of Epidemiology 2012; 41:3. PM22729235 / doi: 10.1093/ije/dys088 
  8. Craig E, Bland R, Reilly J. Objectively measured physical activity levels of children and adolescents in rural South Africa: High volume of physical activity at low intensity. Appl Physiol Nutr Metab 2013; 38(1): 81-84   PM23368832 / doi:10.1139/apnm-2012-0115    
  9. De Oliveira T, Lessells R, Katzenstein D. Are subtype differences important in HIV drug resistance?" Current Opinion in Virology 2012; 5:636-643. PM 3006584 / doi: 10.1016/j.coviro.2012.08.006 
  10. Ettenger A, Bärnighausen T, Castro A. Health insurance for the poor decreases access to HIV testing in antenatal care: evidence of an unintended effect of health insurance reform in Colombia. Health Policy and Planning 2013; 1-7 http://tulane.edu/publichealth/ghsd/upload/2013-Ettenger-Barnighausen-Castro-HPP-on-insurance-and-HIV-testing-in-Colombia.pdf  PM23598426 /   doi:10.1093/heopd/czt021
  11. Harling G, Subramanian S, Bärnighausen T, Kawachi I (2013). Socioeconomic disparities in Sexually Transmitted Infections among young adults in the United States: examining interactions between income and race/ethnicity. Sexually Transmitted Diseases 2013; 40: 575-581 PM23965773 / doi: 10.1097/OLQ.0b013e31829529cf.
  12. HIV & TB: Drug Resistance & Clinical Management Case Book. Eds: Rossouw T, Lessells RJ, de Oliveira T. First published by the South African Medical Research Council, 2013. ISBN number 978-1-920014-91-9. Pg. 1-128  http://www.bioafrica.net/cases.php
  13. Huntington S, Thorne C, Bansi L, Anderson J, Newell ML, Taylor G, Pillay D, Hill T, Tookey P, Sabin C on behalf of the UK Collarobative HIV Cohort (UK CHIC) Study and the National Study of HIV in Pregnancy and Childhood (NSHPC). Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care at 13 large UK clinics. AIDS 2013; 27(1): 95-103  PM22713479 / doi:QAD.0b013e3283565df1 
  14. Imrie J, Hoddinott G, Fuller S, Olivier S, Newell ML. Why MSM in rural communities in South Africa should be an HIV prevention research priority. AIDS Behav 2013; 17(Suppl1): S70-S76. 2012 Nov 30 [Epub ahead of print]   PM23196857 / doi:10.1007/s10461-012-0356-1   
  15. Iwuji CC, Churchhill D, Gileece Y, Weiss H, Fisher M. Older HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study. BMC Public Health 2013; 13(1): 397    PM23622568 / doi:10.1186/1471-2458-13-397    
  16. Lee AC, Katz J, Blencowe H, Cousens S, Kozuki N, Vogel JP, Adair L, Baqui A, Bhutta Z, Caulfield LE, Christian P, Clarke S, Ezzati M, Fawzi W, Gonzalez R, Huybregts L, Kariuki S, Kolsteren P, Lusingu J, Marchant T, Merialdi M, Mongkolchati A, Mullany LC, Ndirangu J, Newell ML, Kae Nien J, Osrin D, Roberfroid D, Rosen H, Sania A, Silveira MF, Tielsch J, Vaidya A, Wiley BA, Lawn J, Black RE, for the CHERGIUGR-Preterm Working Group.National and regional estimates of term and preterm babies born small for gestational age in low-income and middle-income countries in 2010. Lancet Global Health 2013; 1(1): e26-36   PM / doi:10.1016/S2214-109X(13)70006-8 
  17. Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell ML, Godfrey-Faussett P. Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial. Trials 2013; 14: 170http://www.trialsjournal.com/content/14/1/170 PM23758662 / doi:10.1186/1745-6215-14-170
  18. Lewycka S, Mwansambo C, Rosato M, Kazembe P, Phiri T, Mganga A, Chapota H, Malamba F, Kainja E, Newell ML, Greco G, Pulkki-Brannstrom AM, Skordis-Worral J, Vergnano S, Osrin D, Costello A. Effect of women’s groups and volunteer peer counseloling on rates of mortality, morbidity, and health behaviours in mothers and children in rural Malawi(MaiMwana): a factorial, cluster-randomized controlled trial. Lancet 2013; 381(9879): 1721-1735http://press.thelancet.com/womensgroupsmalawi.pdf PM23683639 / doi:10.1016/S0140-6736(12)61959-X 
  19. Moat K, Lavis J, Wilson M, Røttingen J, Bärnighausen T. Twelve myths about systematic reviews for health system policymaking rebutted. J Health Serv Res Policy 2013; 18(1): 44-50   PM23393042 / doi:10.1258/jhsrp.2012.011175

  20. Moon SS, Tate JE, Ray P, Dennehy PH, Archary D, Coutsoudis A, Bland R, Newell ML, Glass RI, Parashar U, Jiang B. Differential profiles and inhibitory effect on Rotavirus vaccines of non-antibody components in breast milk from mothers in developing and developed countries. [SA4] Pediatr Inf Dis J 2013; Apr 11 [Epub ahead of print] PM23584581 / doi:10.1097/INF.0b013e318290646d[BN5] 
  21. Newell ML, Bunders MJ. Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child. Current Opinion in HIV and AIDS 2013, 8: 504-510;  PM23743789 Doi:10.1097/COH.0b013e3283632b88. http://www.ncbi.nlm.nih.gov/pubmed/23743789.
  22. Nozaki I, Kuriyama M, Manyepa P, Zyambo M, Kakimoto K, Bärnighausen T. False beliefs about ART effectiveness, side effects and the consequences of non-retention and non-adherence among ART patients in Livingstone, Zambia. AIDS and Behavior 2013; 17(1): 122-6   doi: 10.1007/s10461-012-0221-2    PM22714115 / doi:10.1007/s10461-012-0221-2 
  23. Ouedraogo DE, Makinson A, Vendrell JP, Casanova ML, Nagot N, Cezar R, Bollore K, Al Taaba Y, Foulongne V, Badiou S, Viljoen J, Reynes J, Van de Perre P, Tuaillon E. Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy. Blood 2013 PM23940281 / doi: 10.1182/blood-2012-12-470393
  24. Reynolds, L, Cousins T, Newell ML, Imrie J. The social dynamics of consent and refusal in HIV surveillance in rural South Africa. Soc Sci Med 2013; 77: 118-25   PM23219165 / doi: 10.1016/j.socscimed.2012.11.015. Epub 2012 Nov 19  
  25. Robyn J, Sauerborn R, Bärnighausen T. Provider payment in community-based health insurance in developing countries: a systematic review. Health Pol Plan 2013; 28(2): 111-22 PM22522770 / doi:10.1093/heapol/czs034  
  26. Robyn J, Bärnighausen T, Souares A, Savadogo G, Bicaba B, Sié A, Sauerborn R. Does enrollment status in community-based insurance lead to poorer quality of care? Evidence from Burkina Faso. IJEqH 2013; 12: 31    PM23680066 / doi:10.1186/1475-9276-12-31    
  27. Rochat T, Bland R, Tomlinson M, Stein A. Suicide ideation, depression and HIV among pregnant women in rural South Africa. Health 2013; 5(3A): 650-651   PM [BN3] / doi:10.4236/health.2013.56A086  http://www.scirp.org/Journal/PaperInformation.aspx?paperID=29610
  28. Rockers P, Bärnighausen T. Interventions for hiring, retaining and training district health systems managers in low and middle-income countries. Cochrane Database of Systematic Reviews 2013; Issue 4. Art No.: CD009035.  doi:10.1002/14651858.CD009035     
  29. Treffry-Goatley A, Mahlinza M, Imrie J. Public engagement with HIV in a rural South African context: an analysis of a small-media, taxi-based edutainment model applied in Jiving with Science. Critical Arts: South-North Cultural and Media Studies 2013; 27(1): 112-126  PM / doi:10.1080/02560046.2013.766976 
  30. Van Rooyen H, McGrath N, Chirowodza A, Joseph P, Gray G, Modiba P, Fiamma A, Richter L, Coates T. Mobile VCT: Reaching men and young people in urban and rural South African pilot studies (NIMH Project Accept, HPTN 043). AIDS and Behaviour 2013http://globalhealth.med.ucla.edu/publications/hvr.pdf PM23142856 
  31. Zaba B, Calvert C, Marston M, Isingo R, Nakiyingi-Miiro J, Lutalo T, Crampin A, Robertson L, Herbst K, Newell ML, Todd J, Byass P, Boerma T, Ronsmans C. Effect of HIV infection on pregnancy-related mortality sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing longitudinal Population-based HIV/AIDS data on Africa (ALPHA). Lancet 2013; 381(9879): 1763-71  PM23683643 / doi:10.1016/S0140-6736(13)60803-X

 

IN PRESS

HIV dynamics and impact of ART roll-out programme

  1. Cames C, Cournil A, de Vincenzi I, Gaillard P, Meda N, Luchters S, Nduati R, Rollins R, Naidu K, Newell ML, Read J, Bork K for the Kesho Bora Study Group. Factors associated with postpartum weight change in HIV-infected mothers receiving triple-antiretroviral prophylaxis: the Kesho Bora trial. AIDS
  2. McGrath N, Eaton JW, Bärnighausen T, Tanser F, Newell ML. Sexual behaviour in a rural high HIV prevalence South African community: time trends in the era of ART . Journal of the International AIDS Society
  3. Mossong J, Grapsa E, Tanser F, Bärnighausen T, Newell ML. Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale up in rural South Africa. AIDS 2013 PM 23842131
  4. Nyirenda M, Evandrou M, Mutevedzi P, Hosegood V, Falkingham J, Newell ML. Who cares? Implications of care-giving and –receiving by HIV-infected or -affected older people on functional disability and emotional well-being. Aging and Society

Building interventions and understanding behaviour

  1. Bennett R, Hosegood V, Newell ML, McGrath N. An approach to measuring dispersed families with a particular focus on children ‘left behind’ by migrant parents : Findings from rural South Africa. Population, Space and Place
  2. Bennett R, Hosegood V, Newell ML, McGrath N Understanding family migration in rural South Africa: Exploring children’s inclusion in the destination households of migrant parents. Population, Space and Place 
  3. Sherr L, Varrall R, Mueller J, Richter L, Desmond C, Wakhweya A, Adato M, Belsey M, Chandan U, Drimie S, Haour-Knipe M, Hosegood V, Kimou J, Madhavan S, Mathambo V. A systematic review of cognitive development and child HIV infection. Int J STD AIDS.

Evaluation and Implementation

Other

  1. Alcalde‐Rabanal JE, Bärnighausen T, Nigenda G, Velasco‐Mondragón E, Sosa‐Rubí S (2013). Estimación del número de profesionales para oferta servicios de prevención y promoción de la salud a la población de 20 años y más en unidades del primer nivel de atención. Salud Pública de México 
  2. Bärnighausen T, Bloom D; Cafiero E; O'Brien J. The full benefits of vaccination, with an application to HPV. Clinical Microbiology and Infection 2012
  3. Eyal N, Bärnighausen T. Conditioning scholarships on long, future service: a defense. In: Cohen G. (ed.), The globalization of health care. Oxford, UK: Oxford University Press, 2012.
  4. Hontelez J, Lurie M, Bärnighausen T, Bakker R, Baltussen R, Tanser F, Hallett TB, Newell ML, de Vlas SJ. Expanded access to antiretroviral therapy leads to elimination of HIV in South Africa, even without universal test and treat: a mathematical modelling study. PLoS Medicine
  5. Lesssells RJ, Cooke GS. Viral infection. In: Oxford Treatment and Diagnosis in Internal Medicine (eds Davey and Sprigings)
  6. Rochat TJ, Mokomane Z. and the Directorate of Adoptions and International Social Services, National Department of Social Development, South Africa. Public perceptions, beliefs and experiences of fostering and adoption: Results of a national qualitative study in South Africa Children and Society, CHSO-0080-11.R1
  7. The IeDEA and ART cohort collaborations (Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, Nash D, Gsponer T, Sungkanuparph S, McGowan C, May M, Cooper D, Chimbetete C, Wolff M, Collier A, McManus H, Davies MA, Costagliola D, Crabtree-Ramirez B, Chaiwarith R, Cescon A, Cornell M, Diero L, Phanuphak P, Sawadogo A, Ehmer J, Eholie SP, Li PCK, Fox MP, Ghandi NE, González E, Lee CKC, Hoffmann CJ, Kambugum A, Keiser O, Ditangco R , Prozesky H, Lampe F, Kumarasamy N, Kitahata M, Lugina E, Lyamuya R, Vonthanak S, Fink V, d’Arminio Monforte A, Luz PM, Chen YMA, Minga A, Casabona J, Mwango A, Choi JY, Newell ML, Bukusi EA, Ngonyani K, Merati TP, Otieno J, Bosco MB, Phiri S, Ng OT, Anastos K, Rockstroh J, Santos I, Oka S, Somi G, Stephan C, Teira R, Wabwire D, Wandeler G, Boulle A, Reiss P, Wood R, Chi BH, Williams C, Sterne JA, Egger M). Immunodeficiency at the start of combination antiretroviral therapy in low, middle and high income countries. JAIDS 

2013 ABSTRACTS

20th Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 Mar 2013, Georgia, Atlanta, USA.

  1. Fladseth K, Newell ML, McGrath N. More equitable gender norms are associated with higher levels of condom use at last sex among HIV men and women: rural KwaZulu-Natal, South Africa.
  2. Plazy M, Dray-Spira J, Orne-Gliemann, Dabis F, Newell ML. Retention in care up to ART initiation within a decentralized HIV programme in South Africa: the critical role of the 1st clinic visit. (Poster)
  3. McGrath N, Lessells R, Newell ML. Time to eligibility for antiretroviral therapy in adults with CD4 count >500 cells/µl in rural KwaZulu-Natal, South Africa.
  4. McGrath N, Eaton J, Newell ML. Trends in Contraceptive Use and Choice of Contraceptive Method in a Rural South African Population-based Cohort During the ART Era, 2005–2011 (Poster)
  5. Mutevedzi P, Lessells R, Newell ML. Cause-specific early mortality following initiation of antiretroviral therapy in rural South Africa: contribution of existing morbidities (Poster)
  6. Rosenberg N, Westreich D, Bärnighausen T, Miller W, Behets F, Maman S, Newell ML, Pettifor A. The effect of HIV counseling and testing on HIV acquisition among South African youth: A protective association. (Poster)

XXVII IUSSP International Population Conference, 26-31 Aug 2013, Busan, Republic of Korea.

  1. McGrath N, Eaton J, Hosegood V, Newell ML. Sexual behaviour trends by residency status in rural South Africa: Implications for treatment and prevention strategies. (ORAL)
  2. Nyirenda M, Chatterji S, Rochat T, Mutevedzi P, Kowal P, Newell ML. Prevalence and correlates of depression among older people infected and affected with HIV in rural South Africa. (ORAL)
  3. Nyirenda M, Evandrou M, Mutevedzi P, Hosegood V, Falkingham J, Newell ML. Care-giving and-receiving among older people in rural South Africa: implications for functional disability and emotional well-being. (POSTER)

6th SA AIDS Conference, 18-21 June 2013, ICC, Durban, South Africa.

  1. Benton L, Hill Z, Newell ML. Childbearing in the time of ART: Family planning in a decentralized HIV Treatment and care programme in rural KwaZulu-Natal. (POSTER)
  2. Chetty T, Carter R, Bland R, Newell ML. Weight changes over 24 months postpartum in the Vertical Transmission Study: Effect of breastfeeding and HIV status in rural SA? (POSTER)
  3. Chimbindi N, Newell ML, Bärnighausen T. Coping with the price of healthcare before and after HIV treatment initiation in rural South Africa. (ORAL)
  4. Coetzee B, Bland RM, Kagee A. Paediatric resistance to antiretroviral therapy: the role of the caregiver. (POSTER)
  5. Danaviah S, de Oliveira T, Pillay S, Bland R, Viljoen J, van de Perre P, Newell ML. Tracing the origin of transmitted HIV via breastfeeding in postnatal mother-to-child transmission. (ORAL)
  6. Fladseth K, Gafos M, Newell ML, McGrath N. More equitable gender norms are associated with higher levels of condom use at last sex among HIV men and women: rural KwaZulu-Natal, South Africa (POSTER)
  7. Imrie J, Larmarange J, Orne-Gliemann J, Lert F. Taking test and treat interventions to the next level – beginning to think what additional information needs to guide Public health and Operational decisions? (POSTER)
  8. Iwuji C, Orne-Gliemann J, Newell ML, Dabis F, for the ANRS 12249 TasP Study Group. Evaluating the community-based impact of treatment as prevention in rural KwaZulu-Natal. The ANRS 12249 TasP trial. (POSTER)
  9. Larmarange J, Imrie J, Orne-Gliemann J, Lert F, Newell ML, for the ANRS 12249 TasP Study Group. Socio-economic issues investigated in an HIV Treatment as Prevention (TasP) trial in rural KwaZulu-Natal: research questions, implementation and progress. (POSTER).
  10. Michel J, Stott K, de Oliveira T, Newell C, Newell ML. Utilizing research as an opportunity to strengthen the health system in rural KwaZulu-Natal. (POSTER)
  11. Michel J, Newell ML. Lack of progress towards the implementation of the National Core Standards: the experience of a co-assessor. (POSTER)
  12. Michel J, Herbst K. “Garbage in garbage out. Why is our data quality so poor?”: Perspectives of PHC Operational Managers in rural KwaZulu-Natal. (POSTER)
  13. Mossong J, Grapsa E, Tanser F, Bärnighausen T, Newell ML. Modelling HIV incidence and survival from sex- and age-specific seroprevalence after antiretroviral treatment roll-out in rural South Africa (POSTER)
  14. Mossong J, Herbst K, Newell ML. Sex- and age-specific trends in adult mortality in rural KwaZulu-Natal between 2000 and 2011. (ORAL)
  15. Mutevedzi T, Tanser F, Newell ML. Adolescents’ self-reported health status and morbidity in a rural area with high HIV burden. (POSTER)
  16. Mutevedzi P, Lessells R, Iwuji C, Newell ML. Substantial reduction in early mortality on antiretroviral therapy for adults in rural KwaZulu-Natal with expanded CD4 cell count eligibility criteria. (ORAL)
  17. Naidu KK, Newell ML. Validation of PIMA CD4 point of care testing in a primary healthcare clinic in rural KwaZulu-Natal. (POSTER).
  18. Ndirangu J, Rollins NC, Bland RM, Coutsoudis A, Coovadia HM, Newell ML. Exclusive breastfeeding and all-cause mortality in infants of HIV-infected and uninfected women in KwaZulu-Natal, South Africa. (ORAL)
  19. Zaidi J, Grapsa E, Tanser F, Newell ML, Bärnighausen T. HIV prevalence trends after scale-up of antiretroviral treatment in the Hlabisa district: A population-based study in rural South Africa. (ORAL)

7th IAS Conference on Pathogenesis, Treatment & Prevention, 30 Jun – 3 Jul 2013, Kulala Lumpur, Malaysia.

  1. Mutevedzi P, Lessells R, Newell ML. Incidence and causes of early morbidity following initiation of antiretroviral therapy in rural South Africa.
  2. Ndirangu J, Thorne C, Newell ML. Virological treatment failure in children in a decentralized HIV programme in rural South Africa: association with household and maternal factors. (Poster) A-581-0107-02194

Population Association of America (PAA) 2013, 11-13 Apr 2013, New Orleans, LA, USA.

  1. Bor J, Herbst A, Newell ML, Bärnighausen T. Large gains in adult life expectancy in rural KwaZulu-Natal: valuing the scale-up of HIV treatment.
  2. Vandormael A, Tanser F, Newell ML. Treatment-as-Prevention: The protective effects of ARV-initiated households on the hazard of HIV acquisition. 

2nd International HIV Social Sciences and Humanities Conference, 7-10 Jul 2013, Paris, France.

  1. Imrie J, Larmarange J, Orne-Gliemann J, Lert F, for the ANRS 12249 TasP Study Group. Issues emerging from universal test and treat (UTT) intervention trials. (submitted)
  2. Larmarange J, Imrie J, Orne-Gliemann J, Lert F, Newell ML, for the ANRS 12249 TasP Study Group. Addressing Social Science in a HIV Treatment as Prevention trial in South Africa. (submitted)

3rd International HIV Treatment as Prevention Workshop, 22-25 Apr 2013, Sheraton Wall Centre, Vancouver, BC.

  1. Iwuji C, Orne-Gliemann J, Newell ML, Dabis F, for the ANRS 12249 TasP Study Group. A cluster-randomised community-based trial of treatment as prevention in rural KwaZulu-Natal, South Africa: early findings. (Oral)

17th International Workshop on HIV Observational Databases (IWHOD), 11-13 April 2013, Cavtat, Croatia.

  1. Mutevedzi P, Lessells RJ, Newell ML. Hospitalization following initiation of antiretroviral therapy (ART) in rural South Africa: diagnosis and outcomes by tuberculosis (TB) disease status.
  2. Ndirangu J, Bland R, Thorne C, Newell ML. Hospitalization and mortality after ART initiation in children in a rural area in South Africa. (Poster)

8th International Conference on HIV Treatment and Prevention Adherence (IAPAC), 2-4 June 2013, The Eden Roc Renaissance, Miami, USA.

  1. Coetzee B, Bland RM, Kagee A. Barriers and facilitators to paediatric adherence to antiretroviral therapy in rural KwaZulu-Natal, South Africa. (POSTER)

9th Public Health Association of South Africa (PHASA) Conference in association with the African Public Health Association (AFPHA), 26-27 Sept 2013, ICC, Cape Town, South Africa.

  1. Michel J, Newell ML. Caught between a rock and a hard place: health care workers in the public sector.

17th Annual Rural Health Conference (RUDASA), 8-10 Aug 2013, St Lucia, KwaZulu-Natal, South Africa

  1. Chetty T, Newell ML. Prevention of mother-to-child transmission of HIV in the Hlabisa sub-district: how well are we doing? (submitted as a poster)
  2. Michel J, Newell ML. Challenges in primary health care: Perspectives from the coalface.
  3. Naidu KK, Newell ML. The project close-out experience of a PEPFAR funded HIV Treatment and Care Programme in rural KwaZulu-Natal (submitted as an oral)

17th International Conference on AIDS and STI’s in Africa (ICASA), 7-11 Dec 2013, Cape Town, South Africa

  1. Michel J, Newell ML. A health system overload: Can the current health system cope with the ongoing HIV treatment roll-out as well as the expanding epidemic on non-communicable diseases?
  2. McGrath N, Newell ML. Partnership Change And Sexual Behavior Among Attenders Of A Public HIV Treatment And Care Programme In Rural KwaZulu-Natal, South Africa
  1. Anand, S., Bärnighausen, T., 2012. Health workers at the core of the health system: framework and research issues. Health Policy 105, 185–191. doi:10.1016/j.healthpol.2011.10.012
  2. Bärnighausen, T., Bloom, D.E., Cafiero, E.T., O’Brien, J.C., 2012. Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus. Clin. Microbiol. Infect. 18 Suppl 5, 70–76. doi:10.1111/j.1469-0691.2012.03977.x
  3. Bärnighausen, T., Bloom, D.E., Humair, S., 2012. Economics of antiretroviral treatment vs. circumcision for HIV prevention. Proc. Natl. Acad. Sci. U.S.A. 109, 21271–21276. doi:10.1073/pnas.1209017110
  4. Bärnighausen, T., Bloom, D.E., Humair, S., 2012. Health systems and HIV treatment in sub-Saharan Africa: matching intervention and programme evaluation strategies. Sex Transm Infect 88, e2. doi:10.1136/sextrans-2011-050303
  5. Bärnighausen, T., Chaiyachati, K., Chimbindi, N., Haberer, J., Newell, M.-L., 2012. Antiretroviral therapy requires life-long adherence – Authors’ reply. Lancet Infect Dis 12. doi:10.1016/S1473-3099(12)70202-5
  6. Bärnighausen, T., Kyle, M., Salomon, J.A., Waning, B., 2012. Assessing the population health impact of market interventions to improve access to antiretroviral treatment. Health Policy Plan 27, 467–476. doi:10.1093/heapol/czr058
  7. Bärnighausen, T., Salomon, J.A., Sangrujee, N., 2012e. HIV treatment as prevention: issues in economic evaluation. PLoS Med. 9. doi:10.1371/journal.pmed.1001263
  8. Bärnighausen, T., Tanser, F., Dabis, F., Newell, M.-L., 2012. Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence. Curr Opin HIV AIDS 7, 140–150. doi:10.1097/COH.0b013e32834fc1df
  9. Barnighausen, T., Tanser, F., Malaza, A., Herbst, K., Newell, M.-L., 2012. HIV status and participation in HIV surveillance in the era of antiretroviral treatment: a study of linked population-based and clinical data in rural South Africa. Trop Med Int Health 17, e103–e110. doi:10.1111/j.1365-3156.2012.02928.x
  10. Barter, D.M., Agboola, S.O., Murray, M.B., Bärnighausen, T., 2012. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review. BMC Public Health 12. doi:10.1186/1471-2458-12-980
  11. Becquet, R., Marston, M., Dabis, F., Moulton, L.H., Gray, G., Coovadia, H.M., Essex, M., Ekouevi, D.K., Jackson, D., Coutsoudis, A., Kilewo, C., Leroy, V., Wiktor, S.Z., Nduati, R., Msellati, P., Zaba, B., Ghys, P.D., Newell, M.-L., UNAIDS Child Survival Group, 2012. Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis. PLoS ONE 7. doi:10.1371/journal.pone.0028510
  12. Bor, J., Tanser, F., Newell, M.-L., Bärnighausen, T., 2012. Economic spillover effects of HIV treatment on rural South African households.
  13. Bor, J., Tanser, F., Newell, M.-L., Bärnighausen, T., 2012. Nearly full employment recovery among South African HIV patients on antiretroviral therapy:evidence from a large population cohort. Health Aff (Millwood) 31, 1459–1469. doi:10.1377/hlthaff.2012.0407
  14. Byass, P., Chandramohan, D., Clark, S.J., D’Ambruoso, L., Fottrell, E., Graham, W.J., Herbst, A.J., Hodgson, A., Hounton, S., Kahn, K., Krishnan, A., Leitao, J., Odhiambo, F., Sankoh, O.A., Tollman, S.M., 2012. Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool. Glob Health Action 5, 1–8. doi:10.3402/gha.v5i0.19281
  15. Castro, H., Pillay, D., Sabin, C., Dunn, D.T., 2012. Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance. BMC Med Res Methodol 12, 30. doi:10.1186/1471-2288-12-30
  16. Chepngeno-Langat, G., Hosegood, V., 2012. Older people and sexuality: Double jeopardy of ageism and sexism in youth-dominated societies. Agenda 26, 93–99. doi:10.1080/10130950.2012.757864
  17. Chetty, T., Knight, S., Giddy, J., Crankshaw, T.L., Butler, L.M., Newell, M.-L., 2012. A retrospective study of Human Immunodeficiency Virus transmission, mortality and loss to follow-up among infants in the first 18 months of life in a prevention of mother-to-child transmission programme in an urban hospital in KwaZulu-Natal, South Africa. BMC Pediatr 12. doi:10.1186/1471-2431-12-146
  18. Chimbindi, N., Bärnighausen, T., Newell, M.-L., 2012. Almost universal coverage: HIV testing among TB patients in a rural public programme. Int. J. Tuberc. Lung Dis. 16. doi:10.5588/ijtld.11.0754
  19. Conradie, F., Wilson, D., Basson, A., de Oliveira, T., Hunt, G., Joel, D., Papathanosopoulos, M., Preiser, W., Klausner, J., Spencer, D., Stevens, W., Venter, F., van Vuuren, C., 2012. The 2012 southern African ARV drug resistance testing guidelines : guidelines. Southern African Journal of HIV Medicine 13, 162–167.
  20. Cornell, M., Schomaker, M., Garone, D.B., Giddy, J., Hoffmann, C.J., Lessells, R., Maskew, M., Prozesky, H., Wood, R., Johnson, L.F., Egger, M., Boulle, A., Myer, L., International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration, 2012. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. PLoS Med. 9. doi:10.1371/journal.pmed.1001304
  21. Crampin, A.C., Dube, A., Mboma, S., Price, A., Chihana, M., Jahn, A., Baschieri, A., Molesworth, A., Mwaiyeghele, E., Branson, K., Floyd, S., McGrath, N., Fine, P.E.M., French, N., Glynn, J.R., Zaba, B., 2012. Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol 41, 676–685. doi:10.1093/ije/dys088
  22. Dennis, A.M., Hué, S., Hurt, C.B., Napravnik, S., Sebastian, J., Pillay, D., Eron, J.J., 2012. Phylogenetic insights into regional HIV transmission. AIDS 26, 1813–1822. doi:10.1097/QAD.0b013e3283573244
  23. Dolling, D., Phillips, A.N., Delpech, V., Pillay, D., Cane, P.A., Crook, A.M., Shepherd, J., Fearnhill, E., Hill, T., Dunn, D., UK HIV Drug Resistance Database, UK Collaborative HIV Cohort (UK CHIC) Study, 2012. Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men. HIV Med. 13, 309–314. doi:10.1111/j.1468-1293.2011.00968.x
  24. Donegan, K.L., Walker, A.S., Dunn, D., Judd, A., Pillay, D., Menson, E., Lyall, H., Tudor-Williams, G., Gibb, D.M., Collaborative HIV Paediatric Study, UK HIV Drug Resistance Database, 2012. The prevalence of darunavir-associated mutations in HIV-1-infected children in the UK. Antivir. Ther. (Lond.) 17, 599–603. doi:10.3851/IMP2015
  25. Eaton, J.W., Johnson, L.F., Salomon, J.A., Bärnighausen, T., Bendavid, E., Bershteyn, A., Bloom, D.E., Cambiano, V., Fraser, C., Hontelez, J.A.C., Humair, S., Klein, D.J., Long, E.F., Phillips, A.N., Pretorius, C., Stover, J., Wenger, E.A., Williams, B.G., Hallett, T.B., 2012. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 9, 001245. doi:10.1371/journal.pmed.1001245
  26. Eaton, J.W., McGrath, N., Newell, M.-L., 2012. Unpacking the recommended indicator for concurrent sexual partnerships. AIDS 26, 1037–1039. doi:10.1097/QAD.0b013e328351f726
  27. Eyal, N., Bärnighausen, T., 2012. Precommitting to serve the underserved. Am J Bioeth 12, 23–34. doi:10.1080/15265161.2012.665134
  28. Floyd, S., Marston, M., Baisley, K., Wringe, A., Herbst, K., Chihana, M., Kasamba, I., Bärnighausen, T., Urassa, M., French, N., Todd, J., Zaba, B., 2012. The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level – a comparative analysis of data from four settings in Southern and East Africa. Tropical Medicine & International Health 17, e84–e93. doi:10.1111/j.1365-3156.2012.03032.x
  29. Gall, A., Ferns, B., Morris, C., Watson, S., Cotten, M., Robinson, M., Berry, N., Pillay, D., Kellam, P., 2012. Universal Amplification, Next-Generation Sequencing, and Assembly of HIV-1 Genomes. J Clin Microbiol 50, 3838–3844. doi:10.1128/JCM.01516-12
  30. Gilks, C.F., Walker, A.S., Dunn, D.T., Gibb, D.M., Kikaire, B., Reid, A., Musana, H., Mambule, I., Kasirye, R., Robertson, V., Ssali, F., Spyer, M., Pillay, D., Yirrell, D., Kaleebu, P., DART Virology Group and Trial Team, 2012. Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA). Antivir. Ther. (Lond.) 17, 1363–1373. doi:10.3851/IMP2253
  31. Giordano, K., Bärnighausen, T., McGrath, N., Snow, R., Harlow, S., Newell, M.-L., 2012. Factors associated with repeated refusal to participate in longitudinal population-based HIV surveillance in rural South Africa: an observational study, regression analyses. Journal of HIV/AIDS Surveillance and Epidemiology 4.
  32. Goedhals, D., Rossouw, I., Hallbauer, U., Mamabolo, M., de Oliveira, T., 2012. The tainted milk of human kindness. The Lancet 380. doi:10.1016/S0140-6736(12)60957-X
  33. Goldberg, A.B., Fox, A.M., Gore, R.J., Bärnighausen, T., 2012. Indicators of political commitment to respond to HIV. Sex Transm Infect 88. doi:10.1136/sextrans-2011-050221
  34. Gompels, M., Dunn, D.T., Phillips, A., Dooley, D., De Burgh Thomas, A., Anderson, J., Post, F., Pillay, D., Gazzard, B., Hill, T., Johnson, M., Gilson, R., Bansi, L., Easterbrook, P., Fisher, M., Walsh, J., Orkin, C., Ainsworth, J., Leen, C., Sabin, C., UK Collaborative HIV Cohort (UK CHIC) Study (Appendix), 2012. Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy? J. Infect. Dis. 205, 540–547. doi:10.1093/infdis/jir380
  35. Group, T.K.B.S., De Vincenzi, I., Newell, M.L., Read, J.S., Van de Perre, P., Luchters, S., Mofenson, L., Dioulasso, B., Meda, N., Fao, P., Ky-Zerbo, O., Gouem, C., Somda, P., Hien, H., Ouedraogo, P.E., Kania, D., Sanou, A., Kossiwavi, I.A., Sanogo, B., Ouedraogo, M., Siribie, I., Valéa, D., Ouedraogo, S., Somé, R., Rouet, F., Rollins, N., McFetridge, L., Naidu, K., Luchters, S., Reyners, M., Irungu, E., Katingima, C., Mwaura, M., Ouattara, G., Mepham, S., Viljoen, J., Bland, R., Mthethwa, L., 2012. Maternal HIV-1 Disease Progression 18-24 Months Post-Delivery According to Antiretroviral Prophylaxis Regimen (Triple-Antiretroviral Prophylaxis during Pregnancy and Breastfeeding Versus Zidovudine/Single-Dose Nevirapine Prophylaxis): The Kesho Bora Randomized Controlled Trial. Clin Infect Dis. doi:10.1093/cid/cis461
  36. Gupta, R.K., Jordan, M.R., Sultan, B.J., Hill, A., Davis, D.H., Gregson, J., Sawyer, A.W., Hamers, R.L., Ndembi, N., Pillay, D., Bertagnolio, S., 2012. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet 380, 1250–1258. doi:10.1016/S0140-6736(12)61038-1
  37. Hogan, D.R., Salomon, J.A., Canning, D., Hammitt, J.K., Zaslavsky, A.M., Bärnighausen, T., 2012. National HIV prevalence estimates for sub-Saharan Africa: controlling selection bias with Heckman-type selection models. Sex Transm Infect 88, i17–i23. doi:10.1136/sextrans-2012-050636
  38. Hontelez, J.A.C., de Vlas, S.J., Baltussen, R., Newell, M.-L., Bakker, R., Tanser, F., Lurie, M., Bärnighausen, T., 2012. The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS 26 Suppl 1, S19–30. doi:10.1097/QAD.0b013e3283558526
  39. Hosegood, V., Madhavan, S., 2012. Understanding Fatherhood and Father Involvement in South Africa: Insights from Surveys and Population Cohorts. Fathering: A Journal of Theory, Research, and Practice about Men as Fathers 10, 257–273. doi:10.3149/fth.1003.257
  40. Hué, S., Hassan, A.S., Nabwera, H., Sanders, E.J., Pillay, D., Berkley, J.A., Cane, P.A., 2012. HIV Type 1 in a Rural Coastal Town in Kenya Shows Multiple Introductions with Many Subtypes and Much Recombination. AIDS Res Hum Retroviruses 28, 220–224. doi:10.1089/aid.2011.0048
  41. Huntington, S.E., Bansi, L.K., Thorne, C., Anderson, J., Newell, M.-L., Taylor, G.P., Pillay, D., Hill, T., Tookey, P.A., Sabin, C.A., 2012. Using two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women. BMC Med Res Methodol 12, 110. doi:10.1186/1471-2288-12-110
  42. Johnson, L.F., Davies, M.-A., Moultrie, H., Sherman, G.G., Bland, R.M., Rehle, T.M., Dorrington, R.E., Newell, M.-L., 2012. The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis. Pediatr. Infect. Dis. J. 31, 474–480. doi:10.1097/INF.0b013e3182456ba2
  43. Johnson, L.F., Stinson, K., Newell, M.-L., Bland, R.M., Moultrie, H., Davies, M.-A., Rehle, T.M., Dorrington, R.E., Sherman, G.G., 2012. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J. Acquir. Immune Defic. Syndr. 59, 417–425. doi:10.1097/QAI.0b013e3182432f27
  44. Kassanjee, R., McWalter, T.A., Bärnighausen, T., Welte, A., 2012. A new general biomarker-based incidence estimator. Epidemiology 23, 721–728. doi:10.1097/EDE.0b013e3182576c07
  45. Le Doaré, K., Bland, R., Newell, M.-L., 2012. Neurodevelopment in children born to HIV-infected mothers by infection and treatment status. Pediatrics 130, e1326–1344. doi:10.1542/peds.2012-0405
  46. Lessells, R.J., Katzenstein, D.K., de Oliveira, T., 2012. Are subtype differences important in HIV drug resistance? Curr Opin Virol 2, 636–643. doi:10.1016/j.coviro.2012.08.006
  47. Maheswaran, H., Thulare, H., Stanistreet, D., Tanser, F., Newell, M.-L., 2012. Starting a home and mobile HIV testing service in a rural area of South Africa. J. Acquir. Immune Defic. Syndr. 59, e43–46. doi:10.1097/QAI.0b013e3182414ed7
  48. Malaza, A., Mossong, J., Bärnighausen, T., Newell, M.-L., 2012. Hypertension and obesity in adults living in a high HIV prevalence rural area in South Africa. PLoS ONE 7. doi:10.1371/journal.pone.0047761
  49. Maman, D., Glynn, J.R., Crampin, A.C., Kranzer, K., Saul, J., Jahn, A., Mwinuka, V., Ngwira, M.H., Mvula, H., Munthali, F., McGrath, N., 2012. Very early anthropometric changes after antiretroviral therapy predict subsequent survival, in karonga, Malawi. Open AIDS J 6, 36–44. doi:10.2174/1874613601206010036
  50. Manasa, J., Katzenstein, D., Cassol, S., Newell, M.-L., de Oliveira, T., Southern Africa Treatment And Resistance Network (SATuRN), 2012. Primary drug resistance in South Africa: data from 10 years of surveys. AIDS Res. Hum. Retroviruses 28, 558–565. doi:10.1089/AID.2011.0284
  51. Mbisa, J.L., Hué, S., Buckton, A.J., Myers, R.E., Duiculescu, D., Ene, L., Oprea, C., Tardei, G., Rugina, S., Mardarescu, M., Floch, C., Notheis, G., Zöhrer, B., Cane, P.A., Pillay, D., 2012. Phylodynamic and Phylogeographic Patterns of the HIV Type 1 Subtype F1 Parenteral Epidemic in Romania. AIDS Res Hum Retroviruses 28, 961–966. doi:10.1089/aid.2011.0390
  52. McGrath, N., Eaton, J.W., Tanser, F., Bärnighausen, T., Newell, M., 2012. Sexual behaviour trends by gender in rural South African population-based cohort during the era of scaled-up access to VCT and ART, 2005–2011.
  53. Mills, E.J., Bärnighausen, T., Negin, J., 2012. HIV and aging--preparing for the challenges ahead. N. Engl. J. Med. 366, 1270–1273. doi:10.1056/NEJMp1113643
  54. Mkwanazi, N.B., Rochat, T.J., Imrie, J., Bland, R.M., 2012. Disclosure of maternal HIV status to children: considerations for research and practice in sub-Saharan Africa. Future Virology 7, 1159–1182. doi:10.2217/fvl.12.109
  55. Murrell, B., de Oliveira, T., Seebregts, C., Kosakovsky Pond, S.L., Scheffler, K., 2012. Modeling HIV-1 Drug Resistance as Episodic Directional Selection. PLoS Comput Biol 8. doi:10.1371/journal.pcbi.1002507
  56. Ndirangu, J., Newell, M.-L., Bland, R.M., Thorne, C., 2012. Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. Hum. Reprod. 27, 1846–1856. doi:10.1093/humrep/des090
  57. Ndirangu, J., Newell, M.-L., Thorne, C., Bland, R., 2012. Treating HIV infected mothers reduces mortality in children under 5 years of age to levels seen in children of HIV uninfected mothers: evidence from rural South Africa. Antivir Ther 17, 81–90. doi:10.3851/IMP1991
  58. Ndirangu, J., Viljoen, J., Bland, R.M., Danaviah, S., Thorne, C., Van de Perre, P., Newell, M.-L., 2012. Cell-free (RNA) and cell-associated (DNA) HIV-1 and postnatal transmission through breastfeeding. PLoS ONE 7. doi:10.1371/journal.pone.0051493
  59. Ndlovu, B., Danaviah, S., Moodley, E., Ghebremichael, M., Bland, R., Viljoen, J., Newell, M.-L., Ndung’u, T., Carr, W., 2012. Use of dried blood spots for the determination of genetic variation of IL-10,Killer Immunoglobulin-like receptor and HLA Class 1 genes. Tissue Antigens 79, 114–122. doi:10.1111/j.1399-0039.2011.01807.x
  60. Negin, J., Bärnighausen, T., Lundgren, J.D., Mills, E.J., 2012. Aging with HIV in Africa: the challenges of living longer. AIDS 26, S1–S5. doi:10.1097/QAD.0b013e3283560f54
  61. Nyirenda, M., Chatterji, S., Falkingham, J., Mutevedzi, P., Hosegood, V., Evandrou, M., Kowal, P., Newell, M.-L., 2012. An investigation of factors associated with the health and well-being of HIV-infected or HIV-affected older people in rural South Africa. BMC Public Health 12. doi:10.1186/1471-2458-12-259
  62. Olgiati, A., Bärnighausen, T., Newell, M.-L., 2012. Do self-assessments of health predict future mortality in rural South Africa? The case of KwaZulu-Natal in the era of antiretroviral treatment. Trop. Med. Int. Health 17, 844–853. doi:10.1111/j.1365-3156.2012.03012.x
  63. Parsons, C.E., Young, K.S., Rochat, T.J., Kringelbach, M.L., Stein, A., 2012. Postnatal depression and its effects on child development: a review of evidence from low- and middle-income countries. Br. Med. Bull. 101, 57–79. doi:10.1093/bmb/ldr047
  64. Price, H., Bansi, L., Sabin, C.A., Bhagani, S., Burroughs, A., Chadwick, D., Dunn, D., Fisher, M., Main, J., Nelson, M., Pillay, D., Rodger, A., Taylor, C., Gilson, R., 2012. Hepatitis B Virus Infection in HIV-Positive Individuals in the UK Collaborative HIV Cohort (UK CHIC) Study. PLoS One 7. doi:10.1371/journal.pone.0049314
  65. Richter, L.M., Rochat, T.J., Hsiao, C., Zuma, T.H., 2012. Evaluation of a Brief Intervention to Improve the Nursing Care of Young Children in a High HIV and AIDS Setting. Nurs Res Pract 2012. doi:10.1155/2012/647182
  66. Robyn, P.J., Bärnighausen, T., Souares, A., Savadogo, G., Bicaba, B., Sié, A., Sauerborn, R., 2012. Health worker preferences for community-based health insurance payment mechanisms: a discrete choice experiment. BMC Health Serv Res 12. doi:10.1186/1472-6963-12-159
  67. Rockers, P.C., Feigl, A.B., Røttingen, J.-A., Fretheim, A., de Ferranti, D., Lavis, J.N., Melberg, H.O., Bärnighausen, T., 2012. Study-design selection criteria in systematic reviews of effectiveness of health systems interventions and reforms: A meta-review. Health Policy 104, 206–214. doi:10.1016/j.healthpol.2011.12.007
  68. Stott, K., Michel, J., Oliveira, T.D., 2012. Principles of HIV drug resistance for clinical management in South Africa. HIV Nursing Matters 3, 46–51.
  69. The HIV Modelling Consortium Treatment as Prevention Editorial Group, 2012. HIV Treatment as Prevention: Models, Data, and Questions--Towards Evidence-Based Decision-Making. PLoS Med 9. doi:10.1371/journal.pmed.1001259
  70. Tong, C.Y.W., Cane, P.A., Pillay, D., 2012. ARHAI: antiviral resistance. J. Antimicrob. Chemother. 67 Suppl 1, i65–68. doi:10.1093/jac/dks197
  71. UK Collaborative Group on HIV Drug Resistance, 2012. Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study. BMJ 345. doi:10.1136/bmj.e5253
  72. Van de Perre, P., Rubbo, P.-A., Viljoen, J., Nagot, N., Tylleskär, T., Lepage, P., Vendrell, J.-P., Tuaillon, E., 2012. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. Sci Transl Med 4. doi:10.1126/scitranslmed.3003327
  73. Von Knorring, N., Gafos, M., Ramokonupi, M., Jentsch, U., MDP Team, 2012. Quality control and performance of HIV rapid tests in a microbicide clinical trial in rural KwaZulu-Natal. PLoS ONE 7. doi:10.1371/journal.pone.0030728
  74. Von Wyl, V., Cambiano, V., Jordan, M.R., Bertagnolio, S., Miners, A., Pillay, D., Lundgren, J., Phillips, A.N., 2012. Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring. PLoS One 7. doi:10.1371/journal.pone.0042834
  75. World Health Organization, W., WHO ResNet, De Oliveira, T., 2012. WHO | WHO HIV drug resistance report 2012 [WWW Document]. WHO. URL http://www.who.int/hiv/pub/drugresistance/report2012/en/ (accessed 3.31.15).
  76. Zaba, B., Kasamba, I., Floyd, S., Isingo, R., Herbst, K., Bärnighausen, T., Gregson, S., Nyamukapa, C., Kayuni, N., Todd, J., Marston, M., Wringe, A., 2012. Using age-specific mortality of HIV infected persons to predict anti-retroviral treatment need: a comparative analysis of data from five African population-based cohort studies. Trop. Med. Int. Health 17, e3–14. doi:10.1111/j.1365-3156.2011.02943.x
  77. Zhou, J., Lurie, M.N., Bärnighausen, T., McGarvey, S.T., Newell, M.-L., Tanser, F., 2012. Determinants and spatial patterns of adult overweight and hypertension in a high HIV prevalence rural South African population. Health Place 18, 1300–1306. doi:10.1016/j.healthplace.2012.09.001


ABSTRACTS TO CONFERENCES 2012

19th Conference on Retroviruses and Opportunistic Infections CROI 2012, 5-8 Mar 2012, Washington State Convention Center, Seattle Washington, USA

Tanser F. Bärnighausen T, Grapsa E, Newell ML. Effect of ART coverage on rate of new HIV infections in a hyperendemic, rural population: South Africa

PASA 2012 Communities of the 2012 Population Association of America annual conference, San Francisco, 3-5 May, 2012

"Coming home to get treated? Anti-retroviral treatments and in-migration patterns in rural South Africa", to be presented in the session on HIV and STD in Migrant-sending. 

2012 International Microbicides Conference, Sydney, Australia, 15-18 April 2012

Ndlovu H, Mzimela M, Gafos M, and the MDP team.  Awareness and uptake of cervical cancer screening by HIV negative women aged 30 years and above enrolled in a microbicide trial in a predominantly rural area of KwaZulu-Natal, South Africa. (Poster)

Ndlovu HB, Gafos M, Mzimela MA, McGrath N, Nyirenda M, Pool R, Elford J, and the MDP team. A comparison of volunteers in a microbicide trial with the general population in KwaZulu-Natal, South Africa. (Oral)

Mzimela M, Gafos M, Ndlovu H, Pool R, Elford J, and the MDP team. Women’s reasons for enrolling in a microbicide clinical trial in a predominantly rural area of KwaZulu-Natal, South Africa. (Poster)

Gafos M, Mzimela M, Ndlovu H, Pool R, Elford J, and the MDP team. ‘The things we do for love’: Love medicines and microbicides in a predominantly rural area of KwaZulu-Natal, South Africa.(Oral)

Gafos M, Mzimela M, Ndlovu H, Pool R, Elford J, and the MDP team. ‘What have men got to do with it?’: The role of men in reproductive and sexual health in a predominantly rural area of KwaZulu-Natal, South Africa. (Oral Poster)

International HIV Treatment as Prevention (TasP) Workshop, 22-25 April 2012, Sheraton Wall centre, Vancouver.

Hontelez JAC, Lurie MN, Bärnighausen T, Baltussen R, Bakker R, Hallett T, Newell ML, de Vlas S. Treatment as prevention for HIV in South Africa: different  models show consistency in occurrence, but difference in timing of elimination and the overall impact of the intervention. (Oral)

Bärnighausen T, Tanser F, Bor J The economic benefits of ART: evidence from a complete population cohort in rural South Africa. Late breaker (Oral)

Bärnighausen T, Humair S, Bloom D. Is HIV treatment-as-prevention a “game-changer”? An economic evaluation of HIV combination prevention.

Royal College of Pediatrics and Child Health (RCPCH) Conference, 22-24 May 2012, Glasgow

Craig E, Reilly J, Bland R. How best to assess unhealthy weight status. (Oral)

American College of Sports Medicine (ASCM) Conference, 29 May – 2 Jun 2012, San Francisco, California

Craig E, Reilly J, Bland R. Comparison of accelerometer cut-points in physical activity assessment of rural South African children and adolescent. (Poster)

3rd South African TB Conference, 12-15 June 2012, ICC, Durban.

Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell ML, Godfrey-Faussett P. Operational feasibility and performance of the Xpert® MTB/RIF diagnostic system in a rural primary health care clinic: a preliminary analysis [oral presentation]

Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell ML, Godfrey-Faussett P. False negative rifampicin resistance result with the Xpert® MTB/RIF diagnostic system: case report and implications [oral presentation]

Lessells RJ, Bland RM, Newell ML, Herbst K. Persisting high burden of TB at a rural district hospital in KwaZulu-Natal [poster presentation]

Lessells RJ, Mutevedzi PC, Ndirangu J, Newell ML, Bland RM. Contribution of TB and drug-resistant TB to early mortality on antiretroviral therapy in rural KwaZulu-Natal: prospective cohort study [poster presentation]

Zihindula G, Sibisi T, Naidu KK, Lessells R. Lessons from the field: Three challenges to the integrated management of TB/HIV in Primary Health Care settings in rural KwaZulu-Natal South Africa [poster presentation]

Sibisi T, Zihindula G, Naidu KK, Lessells R. Managerial gap between the facility managers and TB focal nurses in primary health care settings (PHC) [poster presentation]

XIX International AIDS Conference, 22-27 Jul 2012, Washington DC, USA.

Rochat T, Bland R, Newell ML Intervening in intimate relationships: Models for managing partnership conflicts and maternal mental health in PMTCT clinical and community efforts. Oral presentation at Children and HIV: Closing the Gap ending vertical transmission through community action: Pre conference symposium AIDS 2012 hosted by the Teresa Group, CCABA and the Global Fund for Children

Manasa J, McGrath N, Lessells R, Skingsley A, Newell ML, de Oliveira T. High levels of drug resistance after failure of first-line antiretroviral therapy in rural South Africa: impact on standardised second-line regimens. (Ref# A-452-0081-14710) (upgraded to full Oral)

McGrath N, Eaton JW, Tanser F, Bärnighausen T, Newell ML. Sexual behaviour trends by gender in a rural South African population-based cohort during the era of scaled-up access to VCT and ART, 2005-2010. Ref # A-452-0176-14722 (Oral poster)

Knight L, Hosegood V, Timaeus I. Care and support by households and extended families in the era of HIV treatment: Responses to HIV and AIDS in rural South Africa. (Oral poster)

Bärnighausen T, Bloom D, Humair S. Is treatment-as-prevention a game-changer? Costs and effectiveness. (Oral)

Rosenberg N, Pettifor A, Bärnighausen T, Newell ML. Unmet Need for HIV Counseling and Testing Among South African Youth. (Poster)

Bor J, Bärnighausen T, Tanser F, Newell ML. Economic spillover effects of ART on rural South African households. (Oral poster)

Bor J, Tanser F, Newell ML, Bärnighausen T. Long-run effects of ART on employment in rural South Africa: evidence from a population cohort. (Poster)

Hontelez J, Lurie M, Bärnighausen T, Baltussen R, Tanser T, Bakker R, Hallett T, Newell ML, de Vlas S. Treatment as prevention for HIV in South Africa: different models show consistency in occurrence, but difference in timing of elimination and the overall impact of the intervention. (Oral).

Chimbindi N, Newell ML, Bärnighausen T. Time and money: the costs of utilizing HIV and TB treatment in rural KwaZulu-Natal. (Oral poster)

Hontelez J, Newell ML, Bland R, Munnelly K, Lessells R, Bärnighausen T. Human resources needs for universal access to antiretroviral therapy in South Africa. (Poster)

O’Farrell, Bloom D, Bärnighausen T. Strategies to facilitate timely and rigorous impact evaluation of large-scale HIV interventions. (Poster)

Danaviah S, de Oliveira T, Pillay S, Bland R, Viljoen J, van de Perre P, Newell ML. The origin of the quasi-species: Tracing the acquired virus in mother-to-child HIV transmission. (Poster)

Zaidi J, Grapsa E, Tanser F, Newell ML, Bärnighausen T. HIV prevalence trends after scale-up of antiretroviral treatment: a population-based study in a poor, rural community in KwaZulu-Natal. (Oral)

Bor J, Herbst A, Newell ML, Bärnighausen T. Dramatic increases in population life expectancy and the economic value of ART in rural South Africa. Late-breaker oral presentation

Bärnighausen T.Integrating Health Systems Toward Universal health Coverage. Oral panel presentation

Hontelez JAC, de Vlas S, Baltussen R, Bakker R, Tanser F, Lurie MN, Bärnighausen T. Ageing with HIV in sub-Saharan Africa. (Oral poster)

IAEN 2012 (International AIDS and Economics Network Conference), 20-21 July 2012 Washington DC, USA

Bärnighausen T, Bloom D, O’Brien J, Cafiero E. Economic evaluation of HIV vaccination: current practice and broadened perspectives. (Oral presentation)

Bärnighausen T, Bloom D, Humair S. Is treatment-as-prevention a game-changer? Costs and effectiveness.

Bor J, Tanser F, Newell ML, Bärnighausen T. Economic spillover effects of ART on rural South African households.

Bor J, Tanser F, Newell ML, Bärnighausen T. Long-run effects of ART on employment in rural South Africa: evidence from a population cohort.

Chimbindi N, Newell ML, Bärnighausen T. Time and money: the costs of utilizing HIV and TB treatment in rural KwaZulu-Natal.

O’Farrell, Bloom B, Bärnighausen T. Strategies to facilitate timely and rigorous impact evaluation of large-scale HIV interventions.

12th International Congress of Behavioural Medicine, 29 Aug – 1 Sep 2012, Budapest Hilton, Hungary.

Chimbindi N, Newell ML, Bärnighausen T. Borrowing money and selling assets to pay for healthcare before and after HIV treatment initiation in rural South Africa. Abstract # 771 (Oral)

College of Health Sciences Research Symposium, 14-15 Sept 2012, UKZN

Chimbindi N, Bärnighausen T, Newell ML. TB patients’ reported healthcare utilization barriers in a rural public programme. (Oral)

International Union against Sexually Transmitted Infections (IUSTI) World Congress 2012, 15-17 Oct, Melbourne Convention and Exhibition Centre. Melbourne, Australia.

Hoddinott G, Jones K, Newell M-L, Olivier S, Tanser F, Harrison A, Imrie J. Asking young people about sexual debut: reliability and validity of a single self-reported measure.  (Poster)

Imrie J, Hoddinott G, Olivier S, Fuller S, Jones K, Tanser F, Harrison A, Newell M-L. Medical male circumcision: prevalence, knowledge and intentions in young Zulu men in rural KwaZulu-Natal, South Africa. (Oral)

Imrie J, Hoddinott G, Olivier S, Fuller S, Newell M-L. Improving male participant retention in future HIV vaccine and biomedical intervention trials: can follow-up modality, biospecimen collection method, or form of participant reimbursement make a difference (Poster)

Imrie J, Olivier S, Hoddinott G, Tanser F, Harrison A, Newell M-L. Does having a peer-confidant influence young people in rural South Africa’s HIV-related knowledge, perceptions and reported sexual behaviour? – “Well, my friend says…” (Oral)

Orphans & Vulnerable Children in Africa (OVC) Conference, 30 Oct – 2 Nov 2012, Gallagher Convention Centre. Midrand.

Mkwanazi N, Rochat T, Bland R. Making clinics child-friendly for primary school-aged children in rural KwaZulu-Natal.  (Submitted)

Mabhena N, Mutevedzi P, Bland R. Clinical and Virological outcomes of adolescents in a rural HIV treatment programme in KZN, South Africa 

Rochat T, Mkwanazi N, Bland R. The effectiveness of a family-based disclosure intervention for HIV-positive mothers and HIV-negative school-aged children in rural KZN, South Africa

Hoddinott G, Newell ML, Tanser F, Harrison A, Imrie J. Who adolescents in rural KwaZulu-Natal, South Africa live with – implications for family-based sexual and reproductive health interventions. (Poster)

Skhosana N, Naidu KK. The role of a social worker in delivering psychosocial services to OVC in a high HIV prevalence primary healthcare setting in rural KwaZulu-Natal. (Oral) 

43rd Union World Conference on Lung health, 13-17 Nov 2012, Kula Lumpur, Malaysia.

Lessells RJ, Cooke GS, Nicol MP, McGrath N, Newell ML, Godfrey-Faussett P. Positioning of the Xpert® MTB/RIF diagnostic system in a rural health system in KwaZulu-Natal, South Africa: preliminary findings from a cluster randomized trial (poster discussion)

Lessells RJ, Cooke GS, Nicol MP, McGrath N, de Oliveira T, Newell ML, Godfrey-Faussett P. The potential utility of Xpert® MTB/RIF for real-time surveillance of drug resistance in rural KwaZulu-Natal, South Africa (poster discussion]

24th Nutritional Congress Africa 2012. 1-4 Oct 2012, Bloemfontein, South Africa.

Herbst C, Labadarios D. Comparison of micronutrient-intake of lactating mothers from the Hlabisa district in KwaZulu-Natal using two different dietary intake methods. (poster presentation) 

Joint Public Health Association of South Africa (PHASA) and the Rural Doctors Association of South Africa (RuDASA) Conference, 5-7 Sept, Bloemfontein, South Africa.

Naidu KK, Lessells RJ, Seebregts C, van Vuuren C, Rossouw T, McGrath N, Newell ML, de Oliveira T. Primary health care implementation of an antiretroviral treatment failure clinic model in rural KwaZulu-Natal. (Oral)

Michel J, Matlakala MC, Naidu K, Newell ML. The big six derailing adherence in ART in rural KZN, South Africa. 

Michel J, Matlakala MC, Naidu K, Newell ML. The challenges experienced by non governmental organisations with regards to the roll-out of anti retroviral drugs in KwaZulu-Natal.

SA HIV Clinicians Society Conference 2012, 25-28 Nov 2012, ICC, Cape Town, South Africa.

Stott KE, Naidu KK, Lessells RJ, Bland RM, Newell ML, de Oliveira T, Primary healthcare antiretroviral treatment failure management in rural KwaZulu-Natal: Experiences from a medical officer in the field.(Poster)

Naidu KK Mori R, Newell ML A systematic review of the effect of interrupted PMTCT antiretroviral interventions on maternal disease progression and survival. (Oral)

Iwuji C, Okesola N, Dabis F, Newell ML for the ANRS 12249 TasP group. Initial challenges in the implementation of an antiretroviral treatment as prevention trial in a rural setting of KwaZulu-Natal, South Africa (Poster)

1st IAGG Africa Region Conference on Gerontology and Geriatrics, 17-20 Oct 2012, Cape Town. South Africa.

Nyirenda M, Mugisha J, Scholten F, Seeley J, Mutevedzi P, Kowal P, Newell ML. Health, wellbeing and functional disability among older people infected or affected by HIV/AIDS in Uganda and South Africa

  1. Ajoge, H.O., Gordon, M.L., de Oliveira, T., Green, T.N., Ibrahim, S., Shittu, O.S., Olonitola, S.O., Ahmad, A.A., Ndung’u, T., 2011. Genetic Characteristics, Coreceptor Usage Potential and Evolution of Nigerian HIV-1 Subtype G and CRF02_AG Isolates. PLoS One 6. doi:10.1371/journal.pone.0017865
  2. Barber, T.J., Geretti, A.M., Anderson, J., Schwenk, A., Phillips, A.N., Bansi, L., Gilson, R., Hill, T., Walsh, J., Fisher, M., Johnson, M., Post, F., Easterbrook, P., Gazzard, B., Palfreeman, A., Orkin, C., Leen, C., Gompels, M., Dunn, D., Delpech, V., Pillay, D., Sabin, C.A., UK CHIC Study Steering Committee, 2011. Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study. Antivir. Ther. (Lond.) 16, 805–814. doi:10.3851/IMP1818
  3. Bärnighausen, T., Bloom, D., 2011. The global health workforce, in: The Oxford Handbook of Health Economics. Oxford University Press, pp. 486–519.
  4. Bärnighausen, T., Bloom, D.E., Canning, D., Friedman, A., Levine, O.S., O’Brien, J., Privor-Dumm, L., Walker, D., 2011. Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine. Vaccine 29, 2371–2380. doi:10.1016/j.vaccine.2010.11.090
  5. Bärnighausen, T., Bloom, D.E., Humair, S., 2011. Going horizontal--shifts in funding of global health interventions. N. Engl. J. Med. 364, 2181–2183. doi:10.1056/NEJMp1014255
  6. Bärnighausen, T., Bor, J., Wandira-Kazibwe, S., Canning, D., 2011. Correcting HIV prevalence estimates for survey nonparticipation using Heckman-type selection models. Epidemiology 22, 27–35. doi:10.1097/EDE.0b013e3181ffa201
  7. Barnighausen, T., Bor, J., Wandira-Kazibwe, S., Canning, D., 2011. Interviewer identity as exclusion restriction in epidemiology. Epidemiology 22. doi:10.1097/EDE.0b013e3182117615
  8. Bärnighausen, T., Chaiyachati, K., Chimbindi, N., Peoples, A., Haberer, J., Newell, M.-L., 2011. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 11, 942–951. doi:10.1016/S1473-3099(11)70181-5
  9. Bland, R.M., 2011. Management of HIV-infected children in Africa: progress and challenges. Arch. Dis. Child. 96, 911–915. doi:10.1136/adc.2010.193789
  10. Bor, J., Bärnighausen, T., Newell, C., Tanser, F., Newell, M.-L., 2011. Social exposure to an antiretroviral treatment programme in rural KwaZulu-Natal. Trop. Med. Int. Health 16, 988–994. doi:10.1111/j.1365-3156.2011.02795.x
  11. Buckton, A.J., Harris, R.J., Pillay, D., Cane, P.A., 2011. HIV type-1 drug resistance in treatment-naive patients monitored using minority species assays: a systematic review and meta-analysis. Antivir. Ther. (Lond.) 16, 9–16. doi:10.3851/IMP1687
  12. Buckton, A.J., Prabhu, D., Motamed, C., Harris, R.J., Hill, C., Murphy, G., Parry, J.V., Johnson, J.A., Lowndes, C.M., Gill, N., Pillay, D., Cane, P.A., 2011. Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance. HIV Med. 12, 250–254. doi:10.1111/j.1468-1293.2010.00882.x
  13. Burns, F.M., Evans, A.R., Mercer, C.H., Parutis, V., Gerry, C.J., Mole, R.C.M., French, R.S., Imrie, J., Hart, G.J., 2011. Sexual and HIV risk behaviour in central and eastern European migrants in London. Sex Transm Infect 87, 318–324. doi:10.1136/sti.2010.047209
  14. haiyachati, K., Hirschhorn, L.R., Tanser, F., Newell, M.-L., Bärnighausen, T., 2011. Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa. AIDS Patient Care STDS 25, 163–170. doi:10.1089/apc.2010.0257
  15. Cliffe, S., Townsend, C.L., Cortina-Borja, M., Newell, M.-L., 2011. Fertility intentions of HIV-infected women in the United Kingdom. AIDS Care 23, 1093–1101. doi:10.1080/09540121.2011.554515
  16. Cooke, G., Beaton, R.K., Lessells, R., John, L., Ashworth, S., Kon, O., Williams, O.M., Supply, P., Moodley, P., Pym, A., 2011. International Spread of MDR TB from Tugela Ferry, South Africa. Emerging Infectious Diseases 17. doi:10.3201/eid1711.110291
  17. Cozzi-Lepri, A., Prosperi, M.C.F., Kjær, J., Dunn, D., Paredes, R., Sabin, C.A., Lundgren, J.D., Phillips, A.N., Pillay, D., 2011. Can Linear Regression Modeling Help Clinicians in the Interpretation of Genotypic Resistance Data? An Application to Derive a Lopinavir-Score. PLoS One 6. doi:10.1371/journal.pone.0025665
  18. Dunn, D.T., Goodall, R.L., Munderi, P., Kityo, C., Ranopa, M., Bacheler, L., Van Houtte, M., Gilks, C., Kaleebu, P., Pillay, D., 2011. Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring. Antimicrob Agents Chemother 55, 4575–4580. doi:10.1128/AAC.00580-11
  19. Evans, A.R., Hart, G.J., Mole, R., Mercer, C.H., Parutis, V., Gerry, C.J., Imrie, J., Burns, F.M., 2011. Central and east European migrant men who have sex with men: an exploration of sexual risk in the U.K. Sex Transm Infect 87, 325–330. doi:10.1136/sti.2010.046409
  20. Evans, A.R., Hart, G.J., Mole, R., Mercer, C.H., Parutis, V., Gerry, C.J., Imrie, J., Burns, F.M., 2011. Central and East European migrant men who have sex with men in London: a comparison of recruitment methods. BMC Med Res Methodol 11. doi:10.1186/1471-2288-11-69
  21. Fox, A.M., Goldberg, A.B., Gore, R.J., Bärnighausen, T., 2011. Conceptual and methodological challenges to measuring political commitment to respond to HIV. J Int AIDS Soc 14 Suppl 2. doi:10.1186/1758-2652-14-S2-S5
  22. Gafos, M., Mzimela, M., Ndlovu, H., Mhlongo, N., Hoogland, Y., Mutemwa, R., 2011. “One teabag is better than four”: Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South Africa. PLoS ONE 6. doi:10.1371/journal.pone.0014577
  23. Garrib, A., Herbst, A.J., Hosegood, V., Newell, M.-L., 2011. Injury mortality in rural South Africa 2000-2007: rates and associated factors. Trop. Med. Int. Health 16, 439–446. doi:10.1111/j.1365-3156.2011.02730.x
  24. Garvey, L., Winston, A., Walsh, J., Post, F., Porter, K., Gazzard, B., Fisher, M., Leen, C., Pillay, D., Hill, T., Johnson, M., Gilson, R., Anderson, J., Easterbrook, P., Bansi, L., Orkin, C., Ainsworth, J., Palfreeman, A., Gompels, M., Phillips, A.N., Sabin, C.A., 2011. Antiretroviral therapy CNS penetration and HIV-1–associated CNS disease. Neurology 76, 693–700. doi:10.1212/WNL.0b013e31820d8b0b
  25. Granich, R., Gupta, S., Suthar, A.B., Smyth, C., Hoos, D., Vitoria, M., Simao, M., Hankins, C., Schwartlander, B., Ridzon, R., Bazin, B., Williams, B., Lo, Y.-R., McClure, C., Montaner, J., Hirnschall, G., ART in Prevention of HIV and TB Research Writing Group, 2011. Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr. HIV Res. 9, 446–469. doi:10.2174/157016211798038597
  26. Gray, E.R., Garson, J.A., Breuer, J., Edwards, S., Kellam, P., Pillay, D., Towers, G.J., 2011. No Evidence of XMRV or Related Retroviruses in a London HIV-1-Positive Patient Cohort. PLoS One 6. doi:10.1371/journal.pone.0018096
  27. Herbst, A.J., Mafojane, T., Newell, M.-L., 2011. Verbal autopsy-based cause-specific mortality trends in rural KwaZulu-Natal, South Africa, 2000-2009. Popul Health Metr 9. doi:10.1186/1478-7954-9-47
  28. Hontelez, J.A.C., de Vlas, S.J., Tanser, F., Bakker, R., Bärnighausen, T., Newell, M.-L., Baltussen, R., Lurie, M.N., 2011. The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS ONE 6. doi:10.1371/journal.pone.0021919
  29. Hontelez, J.A.C., Lurie, M.N., Newell, M.-L., Bakker, R., Tanser, F., Bärnighausen, T., Baltussen, R., de Vlas, S.J., 2011. Ageing with HIV in South Africa. AIDS 25, 1665–1667. doi:10.1097/QAD.0b013e32834982ea
  30. Hontelez, J.A.C., Nagelkerke, N., Bärnighausen, T., Bakker, R., Tanser, F., Newell, M.-L., Lurie, M.N., Baltussen, R., de Vlas, S.J., 2011. The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model. Vaccine 29, 6100–6106. doi:10.1016/j.vaccine.2011.06.059
  31. Houlihan, C.F., Bland, R.M., Mutevedzi, P.C., Lessells, R.J., Ndirangu, J., Thulare, H., Newell, M.-L., 2011. Cohort profile: Hlabisa HIV treatment and care programme. Int J Epidemiol 40, 318–326. doi:10.1093/ije/dyp402
  32. Huntington, S.E., Bansi, L.K., Thorne, C., Anderson, J., Newell, M.-L., Taylor, G.P., Pillay, D., Hill, T., Tookey, P.A., Sabin, C.A., UK Collaborative HIV Cohort (UK CHIC) Study and the National Study of HIV in Pregnancy and Childhood (NSHPC), 2011. Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception. AIDS 25, 1647–1655. doi:10.1097/QAD.0b013e32834982af
  33. Imrie, J., Tanser, F., 2011. Targeting strategies and behavior change to combat the HIV epidemic in southern Africa. Future Virology 6, 793–800. doi:10.2217/fvl.11.54
  34. Iwuji, C., Churchill, D., Gilleece, Y., Kingdon, E., Wright, D., Lucas, S., Fisher, M., 2011. Nephrotic Syndrome in Leishmaniasis: Infectious Diseases in Clinical Practice 19, 139–141. doi:10.1097/IPC.0b013e3181f7438e
  35. Iwuji, C.C., Mayanja, B.N., Weiss, H.A., Atuhumuza, E., Hughes, P., Maher, D., Grosskurth, H., 2011. Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in Uganda. HIV Med. 12, 553–561. doi:10.1111/j.1468-1293.2011.00923.x
  36. Kesho Bora Study Group, de Vincenzi, I., 2011. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infect Dis 11, 171–180. doi:10.1016/S1473-3099(10)70288-7
  37. Lalor, M.K., Floyd, S., Gorak-Stolinska, P., Ben-Smith, A., Weir, R.E., Smith, S.G., Newport, M.J., Blitz, R., Mvula, H., Branson, K., McGrath, N., Crampin, A.C., Fine, P.E., Dockrell, H.M., 2011. BCG Vaccination Induces Different Cytokine Profiles Following Infant BCG Vaccination in the UK and Malawi. J Infect Dis 204, 1075–1085. doi:10.1093/infdis/jir515
  38. Lessells, R.J., Cooke, G.S., Newell, M.-L., Godfrey-Faussett, P., 2011. Evaluation of Tuberculosis Diagnostics: Establishing an Evidence Base Around the Public Health Impact. J Infect Dis. 204, S1187–S1195. doi:10.1093/infdis/jir412
  39. Lessells, R.J., Mutevedzi, P.C., Cooke, G.S., Newell, M.-L., 2011. Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J. Acquir. Immune Defic. Syndr. 56, e79–86. doi:10.1097/QAI.0b013e3182075ae2
  40. Lessells, R.J., Mutevedzi, P.C., Heller, T., Newell, M.-L., 2011b. Poor long-term outcomes for cryptococcal meningitis in rural South Africa. S. Afr. Med. J. 101, 251–252.
  41. Marston, M., Becquet, R., Zaba, B., Moulton, L.H., Gray, G., Coovadia, H., Essex, M., Ekouevi, D.K., Jackson, D., Coutsoudis, A., Kilewo, C., Leroy, V., Wiktor, S., Nduati, R., Msellati, P., Dabis, F., Newell, M.-L., Ghys, P.D., 2011. Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol 40, 385–396. doi:10.1093/ije/dyq255
  42. Mbisa, J.L., Gupta, R.K., Kabamba, D., Mulenga, V., Kalumbi, M., Chintu, C., Parry, C.M., Gibb, D.M., Walker, S.A., Cane, P.A., Pillay, D., 2011. The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains. Retrovirology 8, 31. doi:10.1186/1742-4690-8-31
  43. McCormick, A.L., Parry, C.M., Crombe, A., Goodall, R.L., Gupta, R.K., Kaleebu, P., Kityo, C., Chirara, M., Towers, G.J., Pillay, D., 2011. Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1. Antimicrob Agents Chemother 55, 1806–1809. doi:10.1128/AAC.01197-10
  44. McGrath, N., Richter, L., Newell, M.-L., 2011. Design and methods of a longitudinal study investigating the impact of antiretroviral treatment on the partnerships and sexual behaviour of HIV-infected individuals in rural KwaZulu-Natal, South Africa. BMC Public Health 11. doi:10.1186/1471-2458-11-121
  45. Mepham, S.O., Bland, R.M., Newell, M.-L., 2011. Prevention of mother-to-child transmission of HIV in resource-rich and -poor settings. BJOG 118, 202–218. doi:10.1111/j.1471-0528.2010.02733.x
  46. Mepham, S., Zondi, Z., Mbuyazi, A., Mkhwanazi, N., Newell, M.L., 2011. Challenges in PMTCT antiretroviral adherence in northern KwaZulu-Natal, South Africa. AIDS Care 23, 741–747. doi:10.1080/09540121.2010.516341
  47. Mutevedzi, P.C., Lessells, R.J., Rodger, A.J., Newell, M.-L., 2011. Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults. PLoS ONE 6. doi:10.1371/journal.pone.0021795
  48. Mutevedzi, P.C., Newell, M.-L., 2011. A missing piece in the puzzle: HIV in mature adults in sub-Saharan Africa. Future Virol 6, 755–767. doi:10.2217/fvl.11.43
  49. Ndirangu, J., Bland, R., Bärnighausen, T., Newell, M.-L., 2011. Validating child vaccination status in a demographic surveillance system using data from a clinical cohort study: evidence from rural South Africa. BMC Public Health 11, 372–378. doi:10.1186/1471-2458-11-372
  50. Neveu, D., Viljoen, J., Bland, R.M., Nagot, N., Danaviah, S., Coutsoudis, A., Rollins, N.C., Coovadia, H.M., Van de Perre, P., Newell, M.-L., 2011. Cumulative exposure to cell-free HIV in breast milk, rather than feeding pattern per se, identifies postnatally infected infants. Clin. Infect. Dis. 52, 819–825. doi:10.1093/cid/ciq203
  51. Newell, M.-L., Nagot, N., Neveu, D., Coovadia, H., van der Perre, P., 2011. Reply to Filteau. Clin Infect Dis 53, 209–210. doi:10.1093/cid/cir328
  52. Newell, M.L., Thorne, C., Bland, R.M., 2011. Children with HIV infection, in: HIV/AIDS in the Post-HAART Era. People’s Medical Publishing House, Shelton, pp. 595–612.
  53. Ott, M.Q., Bärnighausen, T., Tanser, F., Lurie, M.N., Newell, M.-L., 2011. Age-gaps in sexual partnerships: seeing beyond “sugar daddies.” AIDS 25, 861–863. doi:10.1097/QAD.0b013e32834344c9
  54. Parry, C.M., Kolli, M., Myers, R.E., Cane, P.A., Schiffer, C., Pillay, D., 2011. Three Residues in HIV-1 Matrix Contribute to Protease Inhibitor Susceptibility and Replication Capacity. Antimicrob Agents Chemother 55, 1106–1113. doi:10.1128/AAC.01228-10
  55. Phillips, A.N., Pillay, D., Garnett, G., Bennett, D., Vitoria, M., Cambiano, V., Lundgren, J., 2011. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. AIDS 25, 843–850. doi:10.1097/QAD.0b013e328344037a
  56. Rochat, T.J., Bland, R., Coovadia, H., Stein, A., Newell, M.-L., 2011. Towards a family-centered approach to HIV treatment and care for HIV-exposed children, their mothers and their families in poorly resourced settings. Future Virol 6, 687–696. doi:10.2217/fvl.11.45
  57. Rochat, T.J., Tomlinson, M., Bärnighausen, T., Newell, M.-L., Stein, A., 2011. The prevalence and clinical presentation of antenatal depression in rural South Africa. J Affect Disord 135, 362–373. doi:10.1016/j.jad.2011.08.011
  58. Rochat, T., Mitchell, C., 2011. Young children and HIV in sub-Saharan Africa: implications for practice and intervention, in: International Perspectives on Children and Mental Health. pp. 45–74.
  59. Rotheram-Borus, M.-J., Richter, L., Van Rooyen, H., van Heerden, A., Tomlinson, M., Stein, A., Rochat, T., de Kadt, J., Mtungwa, N., Mkhize, L., Ndlovu, L., Ntombela, L., Comulada, W.S., Desmond, K.A., Greco, E., 2011. Project Masihambisane: a cluster randomised controlled trial with peer mentors to improve outcomes for pregnant mothers living with HIV. Trials 12. doi:10.1186/1745-6215-12-2
  60. Rouet, F., Liégeois, F., Mouinga-Ondémé, A., Kania, D., Viljoen, J., Wambua, S., Ngo-Giang-Huong, N., Ménan, H., Peeters, M., Nerrienet, E., 2011. Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1. Expert Opin Med Diagn 5, 183–202. doi:10.1517/17530059.2011.566860
  61. Sweat, M., Morin, S., Celentano, D., Mulawa, M., Singh, B., Mbwambo, J., Kawichai, S., Chingono, A., Khumalo-Sakutukwa, G., Gray, G., Richter, L., Kulich, M., Sadowski, A., Coates, T., Project Accept study team, 2011. Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis 11, 525–532. doi:10.1016/S1473-3099(11)70060-3
  62. Tanser, F., Bärnighausen, T., Hund, L., Garnett, G.P., McGrath, N., Newell, M.-L., 2011. Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study. Lancet 378, 247–255. doi:10.1016/S0140-6736(11)60779-4
  63. Tanser, F., Bärnighausen, T., Hund, L., Garnett, G.P., McGrath, N., Newell, M.-L., 2011. Role of concurrency in generalised HIV epidemics – Authors’ reply. The Lancet 378, 1845–1846. doi:10.1016/S0140-6736(11)61806-0
  64. Taylor, G.P., Anderson, J., Clayden, P., Gazzard, B.G., Fortin, J., Kennedy, J., Lazarus, L., Newell, M.-L., Osoro, B., Sellers, S., Tookey, P.A., Tudor-Williams, G., Williams, A., de Ruiter, A., BHIVA/CHIVA Guidelines Writing Group, 2011. British HIV Association and Children’s HIV Association position statement on infant feeding in the UK 2011. HIV Med. 12, 389–393. doi:10.1111/j.1468-1293.2011.00918.x
  65. The Kesho Bora Study Group, 2011. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: The Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges. Contemporary Clinical Trials 32, 74–85. doi:10.1016/j.cct.2010.09.008
  66. Tshabalala, M., Manasa, J., Zijenah, L.S., Rusakaniko, S., Kadzirange, G., Mucheche, M., Kassaye, S., Johnston, E., Katzenstein, D., 2011. Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe. PLoS ONE 6. doi:10.1371/journal.pone.0021241
  67. Watts, D.H., Huang, S., Culnane, M., Kaiser, K.A., Scheuerle, A., Mofenson, L., Stanley, K., Newell, M.-L., Mandelbrot, L., Delfraissy, J.-F., Cunningham, C.K., 2011. Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication. J Perinat Med 39, 163–170. doi:10.1515/JPM.2010.139
  68. Wittkop, L., Günthard, H.F., de Wolf, F., Dunn, D., Cozzi-Lepri, A., de Luca, A., Kücherer, C., Obel, N., von Wyl, V., Masquelier, B., Stephan, C., Torti, C., Antinori, A., García, F., Judd, A., Porter, K., Thiébaut, R., Castro, H., van Sighem, A.I., Colin, C., Kjaer, J., Lundgren, J.D., Paredes, R., Pozniak, A., Clotet, B., Phillips, A., Pillay, D., Chêne, G., EuroCoord-CHAIN study group, 2011. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Lancet Infect Dis 11, 363–371. doi:10.1016/S1473-3099(11)70032-9
  1. Abecasis, A.B., Wang, Y., Libin, P., Imbrechts, S., de Oliveira, T., Camacho, R.J., Vandamme, A.-M., 2010. Comparative performance of the REGA subtyping tool version 2 versus version 1. Infect. Genet. Evol. 10, 380–385. doi:10.1016/j.meegid.2009.09.020
  2. Armstrong-James, D., Stebbing, J., Scourfield, A., Smit, E., Ferns, B., Pillay, D., Nelson, M., 2010. Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc. Antiviral Res. 86, 224–226. doi:10.1016/j.antiviral.2010.02.324
  3. Bärnighausen, T., 2010. The ethics of using data generated in the barbaric human experiments of the Japanese units for biological warfare in occupied China, 1932- 1945., in: Japanese Wartime Medical Atrocities: Comparative Enquiries in Science, History and Ethics. Routledge, New York.
  4. Bärnighausen, T., 2010. The role of the health system in HIV treatment-as-prevention: AIDS 24, 2741–2742. doi:10.1097/QAD.0b013e3283408735
  5. Bärnighausen, T., Bloom, D.E., Humair, S., 2010a. Universal antiretroviral treatment: the challenge of human resources. Bull. World Health Organ. 88, 951–952. doi:10.2471/BLT.09.073890
  6. Bärnighausen, T., McWalter, T.A., Rosner, Z., Newell, M.-L., Welte, A., 2010. HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis. Epidemiology 21, 685–697. doi:10.1097/EDE.0b013e3181e9e978
  7. Bärnighausen, T., Tanser, F., Hallett, T., Newell, M.-L., 2010. Short communication: Prioritizing communities for HIV prevention in sub-Saharan Africa. AIDS Res. Hum. Retroviruses 26, 401–405. doi:10.1089/aid.2009.0236
  8. Becquet, R., Bland, R., Ekouevi, D.K., Dabis, F., Newell, M.-L., 2010. Universal antiretroviral therapy among pregnant and postpartum HIV-infected women would improve maternal health and decrease postnatal HIV transmission. AIDS 24, 1239–1241. doi:10.1097/QAD.0b013e328338b791
  9. Bland, R., Coovadia, H., Coutsoudis, A., Rollins, N., Newell, M., 2010. Cohort profile: Mamanengane or the Africa Centre vertical transmission study. Int J Epidemiol 39, 351–360. doi:10.1093/ije/dyp165
  10. Bland, R.M., 2010. Body mass index, immune recovery and survival: an important but understudied relationship. AIDS 24, 2125–2126. doi:10.1097/QAD.0b013e32833cfd76
  11. Bunders, M., Pembrey, L., Kuijpers, T., Newell, M.-L., 2010. Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children. AIDS Res. Hum. Retroviruses 26, 967–975. doi:10.1089/aid.2009.0241
  12. Camlin, C.S., Hosegood, V., Newell, M.-L., McGrath, N., Barnighausen, T., Snow, R.C., 2010. Gender, Migration and HIV in Rural KwaZulu-Natal, South Africa. PLoS One 5. doi:10.1371/journal.pone.0011539
  13. Campbell-Hall, V., Petersen, I., Bhana, A., Mjadu, S., Hosegood, V., Flisher, A.J., MHaPP Research Programme Consortium, 2010. Collaboration between traditional practitioners and primary health care staff in South Africa: developing a workable partnership for community mental health services. Transcult Psychiatry 47, 610–628. doi:10.1177/1363461510383459
  14. Chilton, D.N., Castro, H., Lattimore, S., Harrison, L.J., Fearnhill, E., Delpech, V., Rice, B., Pillay, D., Dunn, D.T., UK Collaborative Group on HIV Drug Resistance, 2010. HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom. Antivir. Ther. (Lond.) 15, 985–991. doi:10.3851/IMP1658
  15. Chimbindi, N.Z., McGrath, N., Herbst, K., San Tint, K., Newell, M.-L., 2010. Socio-Demographic Determinants of Condom Use Among Sexually Active Young Adults in Rural KwaZulu-Natal, South Africa. Open AIDS J 4, 88–95. doi:10.2174/1874613601004010088
  16. Cooke, G.S., Main, J., Thursz, M.R., 2010. Treatment for hepatitis B. BMJ 340, b5429. doi:10.1136/bmj.b5429
  17. Cooke, G.S., Tanser, F.C., Bärnighausen, T.W., Newell, M.-L., 2010. Population uptake of antiretroviral treatment through primary care in rural South Africa. BMC Public Health 10. doi:10.1186/1471-2458-10-585
  18. Cousins, T., 2010. Report on reflective practice: internal process relection on participation rates in HIV surveilllance in the DSA. Africa Centre for Health and Population Studies.
  19. Coutsoudis, A., England, K., Rollins, N., Coovadia, H., Newell, M.-L., Bland, R., 2010. Women’s morbidity and mortality in the first 2 years after delivery according to HIV status. AIDS 24, 2859–2866. doi:10.1097/QAD.0b013e32834041b7
  20. Cunningham, S.A., Elo, I.T., Herbst, K., Hosegood, V., 2010. Prenatal development in rural South Africa: relationship between birth weight and access to fathers and grandparents. Popul Stud (Camb) 64, 229–246. doi:10.1080/00324728.2010.510201
  21. Dabis, F., Newell, M.-L., Hirschel, B., 2010. HIV drugs for treatment, and for prevention. Lancet 375, 2056–2057. doi:10.1016/S0140-6736(10)60838-0
  22. DART Trial Team, 2010. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet 375, 123–131. doi:10.1016/S0140-6736(09)62067-5
  23. De Oliveira, T., Pillay, D., Gifford, R.J., UK Collaborative Group on HIV Drug Resistance, 2010. The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. PLoS ONE 5. doi:10.1371/journal.pone.0009311
  24. De Oliveira, T., Shafer, R.W., Seebregts, C., 2010. Public database for HIV drug resistance in southern Africa. Nature 464. doi:10.1038/464673c
  25. Desmond, C., Hosegood, V., 2010. Men, families and HIV/AIDS, in: Men in Families and Family Policy in a Changing World. United Nations Department of Economic and Social Affairs, New York, pp. 163–201.
  26. European Collaborative Study, 2010. Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception. Antiviral Therapy 15, 41–49. doi:10.3851/IMP1489
  27. Fitzgerald, M., Collumbien, M., Hosegood, V., 2010. “No one can ask me ‘Why do you take that stuff?’”: men’s experiences of antiretroviral treatment in South Africa. AIDS Care 22, 355–360. doi:10.1080/09540120903111536
  28. Fletcher, A.J., Hué, S., Schaller, T., Pillay, D., Towers, G.J., 2010. Hare TRIM5α Restricts Divergent Retroviruses and Exhibits Significant Sequence Variation from Closely Related Lagomorpha TRIM5 Genes. J Virol 84, 12463–12468. doi:10.1128/JVI.01514-10
  29. Gafos, M., Mzimela, M., Sukazi, S., Pool, R., Montgomery, C., Elford, J., 2010. Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use. Cult Health Sex 12, 929–942. doi:10.1080/13691058.2010.507876
  30. Gilson, R.J.C., Man, S.-L., Copas, A., Rider, A., Forsyth, S., Hill, T., Bansi, L., Porter, K., Gazzard, B., Orkin, C., Pillay, D., Schwenk, A., Johnson, M., Easterbook, P., Walsh, J., Fisher, M., Leen, C., Anderson, J., Sabin, C.A., UK Collaborative HIV Cohort Study Group, 2010. Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study. HIV Med. 11, 152–160. doi:10.1111/j.1468-1293.2009.00755.x
  31. Gupta, R.K., Ford, D., Mulenga, V., Walker, A.S., Kabamba, D., Kalumbi, M., Grant, P.R., Ferrier, A., Pillay, D., Gibb, D.M., Chintu, C., 2010. Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine. Pediatr. Infect. Dis. J. 29, e57–62. doi:10.1097/INF.0b013e3181e47609
  32. GUPTA, R.K., KOHLI, A., McCORMICK, A.L., TOWERS, G.J., PILLAY, D., PARRY, C.M., 2010. Full length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays. AIDS 24, 1651–1655.
  33. Harrison, A., Newell, M.-L., Imrie, J., Hoddinott, G., 2010. HIV prevention for South African youth: which interventions work? A systematic review of current evidence. BMC Public Health 10. doi:10.1186/1471-2458-10-102
  34. Harrison, L., Castro, H., Cane, P., Pillay, D., Booth, C., Phillips, A., Geretti, A.M., Dunn, D., UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort Study (UK CHIC), 2010. The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. AIDS 24, 1917–1922. doi:10.1097/QAD.0b013e32833c1d93
  35. Heller, T., Goblirsch, S., Wallrauch, C., Lessells, R., Brunetti, E., 2010. Abdominal tuberculosis: sonographic diagnosis and treatment response in HIV-positive adults in rural South Africa. Int. J. Infect. Dis. 14 Suppl 3, e108–112. doi:10.1016/j.ijid.2009.11.030
  36. Heller, T., Lessells, R.J., Wallrauch, C., Brunetti, E., 2010. Tuberculosis pericarditis with cardiac tamponade: management in the resource-limited setting. Am. J. Trop. Med. Hyg. 83, 1311–1314. doi:10.4269/ajtmh.2010.10-0271
  37. Heller, T., Lessells, R.J., Wallrauch, C.G., Bärnighausen, T., Cooke, G.S., Mhlongo, L., Master, I., Newell, M.L., 2010. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa. Int. J. Tuberc. Lung Dis. 14, 420–426.
  38. Heller, T., Wallrauch, C., Lessells, R.J., 2010. Reply to Sharma et Al and Saukkonen et Al. Clin. Infect. Dis. 51, 255. doi:10.1086/653682
  39. Heller, T., Wallrauch, C., Lessells, R.J., Goblirsch, S., Brunetti, E., 2010. Short Course for Focused Assessment with Sonography for Human Immunodeficiency Virus/Tuberculosis: Preliminary Results in a Rural Setting in South Africa with High Prevalence of Human Immunodeficiency Virus and Tuberculosis. Am J Trop Med Hyg 82, 512–515. doi:10.4269/ajtmh.2010.09-0561
  40. Hosegood, V., Madhavan, S., 2010. Data availability on men’s involvement in families in sub-Saharan Africa to inform family-centred programmes for children affected by HIV and AIDS. J Int AIDS Soc 13 Suppl 2. doi:10.1186/1758-2652-13-S2-S5
  41. Houlihan, C.F., Mutevedzi, P.C., Lessells, R.J., Cooke, G.S., Tanser, F.C., Newell, M.-L., 2010. The tuberculosis challenge in a rural South African HIV programme. BMC Infect. Dis. 10. doi:10.1186/1471-2334-10-23
  42. Huang, K.-H.G., Bonsall, D., Katzourakis, A., Thomson, E.C., Fidler, S.J., Main, J., Muir, D., Weber, J.N., Frater, A.J., Phillips, R.E., Pybus, O.G., Goulder, P.J.R., McClure, M.O., Cooke, G.S., Klenerman, P., 2010. B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection. Nat Commun 1. doi:10.1038/ncomms1100
  43. Hué, S., Gray, E.R., Gall, A., Katzourakis, A., Tan, C.P., Houldcroft, C.J., McLaren, S., Pillay, D., Futreal, A., Garson, J.A., Pybus, O.G., Kellam, P., Towers, G.J., 2010. Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 7, 111. doi:10.1186/1742-4690-7-111
  44. Jahn, A., Floyd, S., Crampin, A.C., Mvula, H., Mwinuka, V., Mwaiyeghele, E., McGrath, N., Zaba, B., Fine, P.E.M., Glynn, J.R., 2010. Declining child mortality in northern Malawi despite high rates of infection with HIV. Bull. World Health Organ. 88, 746–753. doi:10.2471/BLT.09.075085
  45. Jahn, A., Floyd, S., McGrath, N., Crampin, A.C., Kachiwanda, L., Mwinuka, V., Zaba, B., Fine, P.E.M., Glynn, J.R., 2010. Child mortality in rural Malawi: HIV closes the survival gap between the socio-economic strata. PLoS ONE 5. doi:10.1371/journal.pone.0011320
  46. Janssen, N., Ndirangu, J., Newell, M.-L., Bland, R.M., 2010. Successful paediatric HIV treatment in rural primary care in Africa. Arch. Dis. Child. 95, 414–421. doi:10.1136/adc.2009.169367
  47. Jin, F., Jansson, J., Law, M., Prestage, G.P., Zablotska, I., Imrie, J.C.G., Kippax, S.C., Kaldor, J.M., Grulich, A.E., Wilson, D.P., 2010. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 24, 907–913. doi:10.1097/QAD.0b013e3283372d90
  48. Johnson, L., Newell, M.L., Davies, M.-A., Stinson, K., Moultrie, H., Bland, R., Sherman, G., Rehle, T.M., Dorrington, R.E., 2010. A model of paediatric HIV in South Africa.
  49. Lewycka, S., Mwansambo, C., Kazembe, P., Phiri, T., Mganga, A., Rosato, M., Chapota, H., Malamba, F., Vergnano, S., Newell, M.-L., Osrin, D., Costello, A., 2010. A cluster randomised controlled trial of the community effectiveness of two interventions in rural Malawi to improve health care and to reduce maternal, newborn and infant mortality. Trials 11. doi:10.1186/1745-6215-11-88
  50. Lightowler, J.V.J., Cooke, G.S., Mutevedzi, P., Lessells, R.J., Newell, M.-L., Dedicoat, M., 2010. Treatment of Cryptococcal Meningitis in KwaZulu-Natal, South Africa. PLoS One 5. doi:10.1371/journal.pone.0008630
  51. Lyagoba, F., Dunn, D.T., Pillay, D., Kityo, C., Robertson, V., Tugume, S., Hakim, J., Munderi, P., Chirara, M., Ndembi, N., Goodall, R.L., Yirrell, D.L., Burke, A., Gilks, C.F., Kaleebu, P., DART Virology and Trial Team, 2010. Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring. J. Acquir. Immune Defic. Syndr. 55, 277–283. doi:10.1097/QAI.0b013e3181ea0df8
  52. Maher, D., Biraro, S., Hosegood, V., Isingo, R., Lutalo, T., Mushati, P., Ngwira, B., Nyirenda, M., Todd, J., Zaba, B., Collaborators in ALPHA Network, 2010. Translating global health research aims into action: the example of the ALPHA network. Trop. Med. Int. Health 15, 321–328. doi:10.1111/j.1365-3156.2009.02456.x
  53. Marks, A.J., Pillay, D., McLean, A.R., 2010. The effect of intrinsic stochasticity on transmitted HIV drug resistance patterns. J. Theor. Biol. 262, 1–13. doi:10.1016/j.jtbi.2009.09.017
  54. McCormack, S., Ramjee, G., Kamali, A., Rees, H., Crook, A.M., Gafos, M., Jentsch, U., Pool, R., Chisembele, M., Kapiga, S., Mutemwa, R., Vallely, A., Palanee, T., Sookrajh, Y., Lacey, C.J., Darbyshire, J., Grosskurth, H., Profy, A., Nunn, A., Hayes, R., Weber, J., 2010. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet 376, 1329–1337. doi:10.1016/S0140-6736(10)61086-0
  55. McCormick, A.L., Goodall, R.L., Joyce, A., Ndembi, N., Chirara, M., Katundu, P., Walker, S., Yirrell, D., Gilks, C.F., Pillay, D., DART Virology Group and Trial Team, 2010. Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting. J. Acquir. Immune Defic. Syndr. 54, 215–216. doi:10.1097/QAI.0b013e3181cc1058
  56. McGrath, N., Glynn, J.R., Saul, J., Kranzer, K., Jahn, A., Mwaungulu, F., Ngwira, M.H.C., Mvula, H., Munthali, F., Mwinuka, V., Mwaungulu, L., Fine, P.E.M., Crampin, A.C., 2010. What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi. BMC Public Health 10. doi:10.1186/1471-2458-10-601
  57. McGrath, N., Hosegood, V., Chirowodza, A., Joseph, P., Darbes, L., Boettiger, M., van Rooyen, H., 2010. Recruiting heterosexual couples from the general population for studies in rural South Africa--challenges and lessons (Project Accept, HPTN 043). S. Afr. Med. J. 100, 658,–660.
  58. Montgomery, C.M., Gafos, M., Lees, S., Morar, N.S., Mweemba, O., Ssali, A., Stadler, J., Pool, R., team,  the M., 2010. Re-framing microbicide acceptability: findings from the MDP301 trial. Culture, Health & Sexuality 12, 649–662. doi:10.1080/13691051003736261
  59. Mutevedzi, P.C., Lessells, R.J., Heller, T., Bärnighausen, T., Cooke, G.S., Newell, M.-L., 2010. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull. World Health Organ. 88, 593–600. doi:10.2471/BLT.09.069419
  60. Ndembi, N., Ndembi, N., Goodall, R.L., Dunn, D.T., McCormick, A., Burke, A., Lyagoba, F., Munderi, P., Katundu, P., Kityo, C., Robertson, V., Yirrell, D.L., Walker, A.S., Gibb, D.M., Gilks, C.F., Kaleebu, P., Pillay, D., Development of Antiretroviral Treatment in Africa Virology Group and Trial Team, 2010. Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir. J. Infect. Dis. 201, 106–113. doi:10.1086/648590
  61. Ndirangu, J., Newell, M.-L., Tanser, F., Herbst, A.J., Bland, R., 2010. Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact? AIDS 24, 593–602. doi:10.1097/QAD.0b013e328335cff5
  62. Nyirenda, M., McGrath, N., Newell, M.-L., 2010. Gender differentials in the impact of parental death: Adolescent’s sexual behaviour and risk of HIV infection in rural South Africa. Vulnerable Child Youth Stud 5, 284–296. doi:10.1080/17450128.2010.507804
  63. Nyirenda, M., Newell, M.-L., 2010. Orphanhood by socio-economic charecteristics and the risk of HIV infection in rural KwaZulu-Natal., The State of the population in KwaZulu-Natal.
  64. Nyirenda, M., Zaba, B., Bärnighausen, T., Hosegood, V., Newell, M.-L., 2010. Adjusting HIV prevalence for survey non-response using mortality rates: an application of the method using surveillance data from Rural South Africa. PLoS ONE 5. doi:10.1371/journal.pone.0012370
  65. Patel, D., Bland, R., Coovadia, H., Rollins, N., Coutsoudis, A., Newell, M.-L., 2010. Breastfeeding, HIV status and weights in South African children: a comparison of HIV-exposed and unexposed children. AIDS 24, 437–445. doi:10.1097/QAD.0b013e3283345f91
  66. Pluess, B., Tanser, F.C., Lengeler, C., Sharp, B.L., 2010. Indoor residual spraying for preventing malaria, in: The Cochrane Collaboration (Ed.), Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK.
  67. Pool, R., Montgomery, C.M., Morar, N.S., Mweemba, O., Ssali, A., Gafos, M., Lees, S., Stadler, J., Crook, A., Nunn, A., Hayes, R., McCormack, S., 2010. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS ONE 5. doi:10.1371/journal.pone.0011600
  68. Pool, R., Montgomery, C.M., Morar, N.S., Mweemba, O., Ssali, A., Gafos, M., Lees, S., Stadler, J., Nunn, A., Crook, A., Hayes, R., McCormack, S., 2010. Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model. PLoS ONE 5. doi:10.1371/journal.pone.0011632
  69. Price, H., Asboe, D., Pozniak, A., Gazzard, B., Fearnhill, E., Pillay, D., Dunn, D., UK Collaborative Group on HIV Drug Resistance, UK Collaborative HIV Cohort Study, 2010. Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data. Antivir. Ther. (Lond.) 15, 203–211. doi:10.3851/IMP1511
  70. Richens, J., Copas, A., Sadiq, S.T., Kingori, P., McCarthy, O., Jones, V., Hay, P., Miles, K., Gilson, R., Imrie, J., Pakianathan, M., 2010. A randomised controlled trial of computer-assisted interviewing in sexual health clinics. Sex Transm Infect 86, 310–314. doi:10.1136/sti.2010.043422
  71. Rouet, F., Foulongne, V., Viljoen, J., Steegen, K., Becquart, P., Valéa, D., Danaviah, S., Segondy, M., Verhofstede, C., Van de Perre, P., WHO/ANRS 1289 Kesho Bora Study Group, 2010. Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study. J. Virol. Methods 163, 253–257. doi:10.1016/j.jviromet.2009.10.005
  72. Serwaa-Bonsu, A., Herbst, A.J., Reniers, G., Ijaa, W., Clark, B., Kabudula, C., Sankoh, O., 2010. First experiences in the implementation of biometric technology to link data from Health and Demographic Surveillance Systems with health facility data. Glob Health Action 3. doi:10.3402/gha.v3i0.2120
  73. Stöhr, W., Back, D., Dunn, D., Sabin, C., Winston, A., Gilson, R., Pillay, D., Hill, T., Ainsworth, J., Gazzard, B., Leen, C., Bansi, L., Fisher, M., Orkin, C., Anderson, J., Johnson, M., Easterbrook, P., Gibbons, S., Khoo, S., 2010. Factors influencing lopinavir and atazanavir plasma concentration. J Antimicrob Chemother 65, 129–137. doi:10.1093/jac/dkp408
  74. Thursz, M., Cooke, G.S., Hall, A.J., 2010. Hepatitis B treatment in resource poor settings: time for action. Trop. Med. Int. Health 15, 2–4. doi:10.1111/j.1365-3156.2009.02410.x
  75. Townsend, C.L., Tookey, P.A., Newell, M.-L., Cortina-Borja, M., 2010. Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission. Antivir. Ther. (Lond.) 15, 775–783. doi:10.3851/IMP1613
  76. Townsend, C., Schulte, J., Thorne, C., Dominguez, K.I., Tookey, P.A., Cortina-Borja, M., Peckham, C.S., Bohannon, B., Newell, M.-L., Pediatric Spectrum of HIV Disease Consortium,  the E.C.S. and the N.S. of H. in P. and C., 2010. Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe. BJOG 117, 1399–1410. doi:10.1111/j.1471-0528.2010.02689.x
  77. Turner, J., Bansi, L., Gilson, R., Gazzard, B., Walsh, J., Pillay, D., Orkin, C., Phillips, A., Easterbrook, P., Johnson, M., Porter, K., Schwenk, A., Hill, T., Leen, C., Anderson, J., Fisher, M., Sabin, C., UK Collaborative HIV Cohort (UK CHIC) Study, 2010. The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes. J. Viral Hepat. 17, 569–577. doi:10.1111/j.1365-2893.2009.01215.x
  78. UNAIDS Reference Group on Estimat, 2010. HIV: consensus indicators are needed for concurrency. The Lancet 375, 621–622. doi:10.1016/S0140-6736(09)62040-7
  79. Viljoen, J., Gampini, S., Danaviah, S., Valéa, D., Pillay, S., Kania, D., Méda, N., Newell, M.-L., Van de Perre, P., Rouet, F., World Health Organization/ANRS 1289 Kesho Bora Study Group, 2010. Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso. J. Acquir. Immune Defic. Syndr. 55, 290–298. doi:10.1097/QAI.0b013e3181edaaf5
  80. Wallrauch, C., Bärnighausen, T., Newell, M.L., 2010. HIV prevalence and incidence in people 50 years and older in rural South Africa. S. Afr. Med. J. 100, 812–814.
  81. Wallrauch, C., Heller, T., Lessells, R., Kekana, M., Barnighausen, T., Newell, M.-L., 2010. High uptake of HIV testing for tuberculosis patients in an integrated primary health care HIV/TB programme in rural KwaZulu-Natal. S. Afr. Med. J. 100, 146–147.
  82. Waning, B., Diedrichsen, E., Jambert, E., Bärnighausen, T., Li, Y., Pouw, M., Moon, S., 2010. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. BMC Pediatr 10, 74. doi:10.1186/1471-2431-10-74
  83. Waning, B., Kyle, M., Diedrichsen, E., Soucy, L., Hochstadt, J., Bärnighausen, T., Moon, S., 2010b. Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. Global Health 6. doi:10.1186/1744-8603-6-9

HIV dynamics and impact of ART roll-out programme

Bärnighausen, T., Bloom, D.E., 2009. “Conditional scholarships” for HIV/AIDS health workers: educating and retaining the workforce to provide antiretroviral treatment in sub-Saharan Africa. Soc Sci Med 68, 544–551. doi:10.1016/j.socscimed.2008.11.009

Bärnighausen, T., Tanser, F., Newell, M.-L., 2009. Lack of a decline in HIV incidence in a rural community with high HIV prevalence in South Africa, 2003-2007. AIDS Res. Hum. Retroviruses 25, 405–409. doi:10.1089/aid.2008.0211

Bärnighausen, T., Tanser, F., 2009. Rethinking the role of the local community in HIV epidemic spread in sub-Saharan Africa: a proximate-determinants approach. HIV Ther 3, 435–445. doi:10.2217/hiv.09.33

Becquet, R., Bland, R., Leroy, V., Rollins, N.C., Ekouevi, D.K., Coutsoudis, A., Dabis, F., Coovadia, H.M., Salamon, R., Newell, M.-L., 2009. Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohorts. PLoS ONE 4. doi:10.1371/journal.pone.0007397

Dalai, S.C., de Oliveira, T., Harkins, G.W., Kassaye, S.G., Lint, J., Manasa, J., Johnston, E., Katzenstein, D., 2009. Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe . AIDS 23, 2523–2532. doi:10.1097/QAD.0b013e3283320ef3

Hallett, T.B., Ghys, P., Bärnighausen, T., Yan, P., Garnett, G.P., 2009. > Errors in “BED”-derived estimates of HIV incidence will vary by place, time and age . PLoS ONE 4. doi:10.1371/journal.pone.0005720

Herbst, A.J., Cooke, G.S., Bärnighausen, T., KanyKany, A., Tanser, F., Newell, M.-L., 2009. > Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa . Bull. World Health Organ. 87, 754–762. doi:10.1590/S0042-96862009001000011

Huang, K.-H.G., Goedhals, D., Fryer, H., van Vuuren, C., Katzourakis, A., De Oliveira, T., Brown, H., Cassol, S., Seebregts, C., McLean, A., Klenerman, P., Phillips, R., Frater, J., Bloemfontein-Oxford Collaborative Group, 2009. > Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa . Antivir. Ther. (Lond.) 14, 975–984. doi:10.3851/IMP1416

Monteiro, J.P., Alcantara, L.C.J., de Oliveira, T., Oliveira, A.M., Melo, M.A.G., Brites, C., Galvão-Castro, B., 2009. Genetic variability of human immunodeficiency virus-1 in Bahia state, Northeast, Brazil: high diversity of HIV genotypes . J. Med. Virol. 81, 391–399. doi:10.1002/jmv.21414

Ndirangu, J., Bärnighausen, T., Tanser, F., Tint, K., Newell, M.-L., 2009. Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa*. Trop. Med. Int. Health 14, 1383–1393. doi:10.1111/j.1365-3156.2009.02382.x

Tanser, F., Bärnighausen, T., Cooke, G.S., Newell, M.-L., 2009. Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic . Int J Epidemiol 38, 1008–1016. doi:10.1093/ije/dyp148

Walter, B.L., Armitage, A.E., Graham, S.C., de Oliveira, T., Skinhøj, P., Jones, E.Y., Stuart, D.I., McMichael, A.J., Chesebro, B., Iversen, A.K., 2009. > Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility . AIDS 23, 1047–1057. doi:10.1097/QAD.0b013e32832a1806

Welaga, P., Hosegood, V., Weiner, R., Hill, C., Herbst, K., Newell, M.-L., 2009. Coming home to die? The association between migration and mortality in rural South Africa . BMC Public Health 9. doi:10.1186/1471-2458-9-193

Welte, A., McWalter, T.A., Bärnighausen, T., 2009. A Simplified Formula for Inferring HIV Incidence from Cross-Sectional Surveys Using a Test for Recent Infection. AIDS Res. Hum. Retroviruses 25, 125–126. doi:10.1089/aid.2008.0150

Welte, A., McWalter, T.A., Bärnighausen, T., 2009. Reply to “Should biomarker estimates of HIV incidence be adjusted?.” AIDS 23, 2062–2063; author reply 2066–2068. doi:10.1097/QAD.0b013e32832eff59

Building interventions and understanding behaviour

Franey, C., Knott, D., Barnighausen, T., Dedicoat, M., Adam, A., Lessells, R.J., Newell, M.-L., Cooke, G.S., 2009. Renal impairment in a rural African antiretroviral programme . BMC Infect. Dis. 9. doi:10.1186/1471-2334-9-143

Hosegood, V., 2009. The demographic impact of HIV and AIDS across the family and household life-cycle: implications for efforts to strengthen families in sub-Saharan Africa . AIDS Care 21 Suppl 1, 13–21. doi:10.1080/09540120902923063

Hosegood, V., McGrath, N., Moultrie, T.A., 2009. Dispensing with marriage: Marital and partnership trends in rural KwaZulu-Natal, South Africa 2000-2006 . Demographic Research 20, 279–312. doi:10.4054/DemRes.2009.20.13

Maheswaran, H., Bland, R.M., 2009. Preventing mother-to-child transmission of HIV in resource-limited settings . Future Virology 4, 165–175. doi:10.2217/17460794.4.2.165

Marston, M., Slaymaker, E., Cremin, I., Floyd, S., McGrath, N., Kasamba, I., Lutalo, T., Nyirenda, M., Ndyanabo, A., Mupambireyi, Z., Zaba, B., 2009. > Trends in marriage and time spent single in sub-Saharan Africa: a comparative analysis of six population-based cohort studies and nine Demographic and Health Surveys. Sex Transm Infect 85 Suppl 1, i64–71. doi:10.1136/sti.2008.034249

McGrath, N., Nyirenda, M., Hosegood, V., Newell, M.-L., 2009. Age at first sex in rural South Africa. Sex Transm Infect 85 Suppl 1, i49–55. doi:10.1136/sti.2008.033324

Mepham, S., Bland, R.M., Newell, M.L., 2009. Challenges for the management of HIV-infected pregnant women in resource constrained settings, in: Infectious Pregnancy Complications. Nova Publishers.

Richter, L., Chandan, U., Rochat, T., 2009. Improving hospital care for young children in the context of HIV/AIDS and poverty . J Child Health Care 13, 198–211. doi:10.1177/1367493509336680

Rollins, N.C., Becquet, R., Bland, R.M., Coutsoudis, A., Coovadia, H.M., Newell, M.-L., 2009. > Preventing postnatal mother-to-child transmission of HIV: context matters . AIDS 23. doi:10.1097/QAD.0b013e328327727b

Todd, J., Cremin, I., McGrath, N., Bwanika, J.-B., Wringe, A., Marston, M., Kasamba, I., Mushati, P., Lutalo, T., Hosegood, V., Zaba, B., 2009. Reported number of sexual partners: comparison of data from four African longitudinal studies . Sex Transm Infect 85 Suppl 1, i72–80. doi:10.1136/sti.2008.033985

Wringe, A., Cremin, I., Todd, J., McGrath, N., Kasamba, I., Herbst, K., Mushore, P., Zaba, B., Slaymaker, E., 2009. Comparative assessment of the quality of age-at-event reporting in three HIV cohort studies in sub-Saharan Africa . Sex Transm Infect 85 Suppl 1, i56–63. doi:10.1136/sti.2008.033423

Evaluation and Implementation

Cooke, G.S., Little, K.E., Bland, R.M., Thulare, H., Newell, M.L., 2009. > Need for timely paediatric HIV treatment within primary health care in rural South Africa . PLoS ONE. doi:10.1371/journal.pone.0007101

Petersen, I., Bhana, A., Campbell-Hall, V., Mjadu, S., Lund, C., Kleintjies, S., Hosegood, V., Flisher, A.J., Mental Health and Poverty Research Programme Consortium, 2009. Planning for district mental health services in South Africa: a situational analysis of a rural district site . Health Policy Plan 24, 140–150. doi:10.1093/heapol/czn049

Other

Alcantara, L.C.J., Cassol, S., Libin, P., Deforche, K., Pybus, O.G., Van Ranst, M., Galvão-Castro, B., Vandamme, A.-M., de Oliveira, T., 2009. A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences . Nucleic Acids Res. 37, W634–642. doi:10.1093/nar/gkp455

Ardington, C., Case, A., Hosegood, V., 2009. Labor supply responses to large social transfers: Longitudinal evidence from South Africa. Am Econ J Appl Econ 1, 22–48. doi:10.1257/app.1.1.22

Bansi, L., Sabin, C., Gilson, R., Gazzard, B., Leen, C., Anderson, J., Dunn, D., Hill, T., Fisher, M., Ainsworth, J., Pillay, D., Johnson, M., Walsh, J., Orkin, C., Easterbrook, P., Gompels, M., Phillips, A., UK Collaborative HIV Cohort Study, 2009. Virological response to initial antiretroviral regimens containing abacavir or tenofovir. J. Infect. Dis. 200, 710–714. doi:10.1086/605024

Bärnighausen, T., Bloom, D.E., 2009. Changing research perspectives on the global health workforce. National Bureau of Economic Research.

Bärnighausen, T., Bloom, D.E., 2009. Designing financial-incentive programmes for return of medical service in underserved areas: seven management functions . Hum Resour Health 7. doi:10.1186/1478-4491-7-52

Bärnighausen, T., Bloom, D.E., 2009. Financial incentives for return of service in underserved areas: a systematic review. BMC Health Serv Res 9. doi:10.1186/1472-6963-9-86

Bärnighausen, T., Bloom, D.E., Humair, S., 2009. A Mathematical Model for Estimating the Number of Health Workers Required for Universal Antiretroviral Treatment. National Bureau of Economic Research.

Barnighausen, T., Wallrauch, C., Lessells, R.J., Tanser, F., 2009. The HIV Epidemic and HIV treatment, State of the population in KwaZulu-Natal. UKZN and UNDP, Durban.

Belshaw, R., de Oliveira, T., Markowitz, S., Rambaut, A., 2009. The RNA Virus Database . Nucleic Acids Res 37, D431–D435. doi:10.1093/nar/gkn729

Bennett, D.E., Camacho, R.J., Otelea, D., Kuritzkes, D.R., Fleury, H., Kiuchi, M., Heneine, W., Kantor, R., Jordan, M.R., Schapiro, J.M., Vandamme, A.-M., Sandstrom, P., Boucher, C.A.B., van de Vijver, D., Rhee, S.-Y., Liu, T.F., Pillay, D., Shafer, R.W., 2009. Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update. PLoS ONE 4. doi:10.1371/journal.pone.0004724

Bevilacqua, E., Fabris, A., Floreano, P., Pembrey, L., Newell, M.-L., Tovo, P.-A., Amoroso, A., EPHN collaborators, 2009. Genetic factors in mother-to-child transmission of HCV infection . Virology 390, 64–70. doi:10.1016/j.virol.2009.05.007

Bower, M., Fisher, M., Hill, T., Reeves, I., Walsh, J., Orkin, C., Phillips, A.N., Bansi, L., Gilson, R., Easterbrook, P., Johnson, M., Gazzard, B., Leen, C., Pillay, D., Schwenk, A., Anderson, J., Porter, K., Gompels, M., Sabin, C.A., 2009. > CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK . Haematologica 94, 875–880. doi:10.3324/haematol.2008.002691

Brown, A.E., Gifford, R.J., Clewley, J.P., Kucherer, C., Masquelier, B., Porter, K., Balotta, C., Back, N.K.T., Jorgensen, L.B., de Mendoza, C., Bhaskaran, K., Gill, O.N., Johnson, A.M., Pillay, D., Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) Collaboration, 2009. > Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions . J. Infect. Dis. 199, 427–431. doi:10.1086/596049

Brown, A.E., Murphy, G., Rinck, G., Clewley, J.P., Hill, C., Parry, J.V., Johnson, A.M., Pillay, D., Gill, O.N., 2009. Implications for HIV testing policy derived from combining data on voluntary confidential testing with viral sequences and serological analyses . Sex Transm Infect 85, 4–9. doi:10.1136/sti.2008.031831

Coovadia, H., Bland, R.M., Walls, T., 2009. Two commentaries on “Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.” Evidence-Based Child Health: A Cochrane Review Journal 4, 1449–1451. doi:10.1002/ebch.437

England, K., Thorne, C., Pembrey, L., Newell, M.-L., 2009. Policies and practices for the clinical management of HIV/HCV coinfected children in Europe: an epidemiological survey . Eur. J. Pediatr. 168, 915–917. doi:10.1007/s00431-008-0855-2

Ferns, R.B., Kirk, S., Bennett, J., Cook, P.M., Williams, I., Edwards, S., Pillay, D., 2009. The dynamics of appearance and disappearance of HIV-1 integrase mutations during and after withdrawal of raltegravir therapy. AIDS 23, 2159–2164. doi:10.1097/QAD.0b013e32832ec4ae

Geretti, A.M., Harrison, L., Green, H., Sabin, C., Hill, T., Fearnhill, E., Pillay, D., Dunn, D., UK Collaborative Group on HIV Drug Resistance, 2009. > Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy . Clin. Infect. Dis. 48, 1296–1305. doi:10.1086/598502

Gifford, R.J., Liu, T.F., Rhee, S.-Y., Kiuchi, M., Hue, S., Pillay, D., Shafer, R.W., 2009. > The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance . Bioinformatics 25, 1197–1198. doi:10.1093/bioinformatics/btp134

Gupta, R.K., Hill, A., Sawyer, A.W., Cozzi-Lepri, A., von Wyl, V., Yerly, S., Lima, V.D., Günthard, H.F., Gilks, C., Pillay, D., 2009. Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis . Lancet Infect Dis 9, 409–417. doi:10.1016/S1473-3099(09)70136-7

Gupta, R.K., Hué, S., Schaller, T., Verschoor, E., Pillay, D., Towers, G.J., 2009. > Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion. PLoS Pathog 5. doi:10.1371/journal.ppat.1000443

Gupta, R.K., Mlcochova, P., Pelchen-Matthews, A., Petit, S.J., Mattiuzzo, G., Pillay, D., Takeuchi, Y., Marsh, M., Towers, G.J., 2009. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration . Proc Natl Acad Sci U S A 106, 20889–20894. doi:10.1073/pnas.0907075106

Hernán, M.A., McAdams, M., McGrath, N., Lanoy, E., Costagliola, D., 2009. > Observation plans in longitudinal studies with time-varying treatments. Stat Methods Med Res 18, 27–52. doi:10.1177/0962280208092345

Hué, S., Gifford, R.J., Dunn, D., Fernhill, E., Pillay, D., 2009. > Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve Individuals. J Virol 83, 2645–2654. doi:10.1128/JVI.01556-08

Imrie, J., Macdonald, N., 2009. HIV testing in men who have sex with men: are we ready to take the next HIV testing test? Sex Transm Infect 85, 487–488. doi:10.1136/sti.2009.036632

Kandathil, A.J., Kannangai, R., Abraham, O.C., Rupali, P., Pulimood, S.A., Verghese, V.P., Grant, P., Pillay, D., Sridharan, G., 2009. The frequency of HIV-I drug resistance mutations among treatment-naive individuals at a tertiary care centre in south India . Int J STD AIDS 20, 522–526. doi:10.1258/ijsa.2008.008403

Kandathil, A.J., Kannangai, R., Verghese, V.P., Pulimood, S.A., Rupali, P., Sridharan, G., Grant, P., Pillay, D., Abraham, O.C., 2009. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India. Indian J Med Microbiol 27, 231–236. doi:10.4103/0255-0857.53205

Kitua, A.Y., Corrah, T., Herbst, K., Nyirenda, T., Agwale, S., Makanga, M., Mgone, C.S., 2009. Strengthening capacity, collaboration and quality of clinical research in Africa: EDCTP Networks of Excellence. Tanzan J Health Res 11, 51–54.

Lalor, M.K., Ben-Smith, A., Gorak-Stolinska, P., Weir, R.E., Floyd, S., Blitz, R., Mvula, H., Newport, M.J., Branson, K., McGrath, N., Crampin, A.C., Fine, P.E.M., Dockrell, H.M., 2009. Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. J. Infect. Dis. 199, 795–800.

Lamers, S.L., Salemi, M., Galligan, D.C., de Oliveira, T., Fogel, G.B., Granier, S.C., Zhao, L., Brown, J.N., Morris, A., Masliah, E., McGrath, M.S., 2009. > Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology . PLoS ONE 4. doi:10.1371/journal.pone.0005065

Martinez de Tejada, B., Newell, M.-L., 2009. The clinical content of preconception care: infectious diseases in preconception care. Am. J. Obstet. Gynecol. 201, e13;–author reply e14. doi:10.1016/j.ajog.2009.04.040

Mepham, S.O., Squire, S.B., Chisuwo, L., Kandulu, J., Bates, I., 2009. > Utilisation of laboratory services by health workers in a district hospital in Malawi. J. Clin. Pathol. 62, 935–938. doi:10.1136/jcp.2009.069062

Newell, M.-L., Bland, R.M., 2009. Antiretroviral treatment in HIV-infected African infants . Therapy 61, 11–13. doi:10.2217/14750708.6.1.11

Parry, C.M., Kohli, A., Boinett, C.J., Towers, G.J., McCormick, A.L., Pillay, D., 2009. > Gag Determinants of Fitness and Drug Susceptibility in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1 . J Virol 83, 9094–9101. doi:10.1128/JVI.02356-08

Richter, L.M., Sherr, L., Adato, M., Belsey, M., Chandan, U., Desmond, C., Drimie, S., Haour-Knipe, M., Hosegood, V., Kimou, J., Madhavan, S., Mathambo, V., Wakhweya, A., 2009. Strengthening families to support children affected by HIV and AIDS . AIDS Care 21 Suppl 1, 3–12. doi:10.1080/09540120902923121

Tanser, F., Gething, P., Atkinson, P., 2009. Location-allocation Planning, in: Lecturer, T.B., McLaffertyessor, S., Moonessor, G. (Eds.), A Companion to Health and Medical Geography. Wiley-Blackwell, pp. 540–566.

Wilkinson, E., Engelbrecht, S., 2009. Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa . Infect. Genet. Evol. 9, 840–846. doi:10.1016/j.meegid.2009.05.001

Abstracts to conferences in 2009

SA AIDS Conference

Ndirangu J, Bärnighausen T, Tint KS, Tanser F, Newell ML. Is maternal HIV status associated with childhood vaccination uptake? Data from rural KwaZulu Natal, South Africa. Oral presentation @ 4th SA AIDS Conference, ICC Durban

Mutevedzi P, Lessells R, Houlihan C, Cooke GS, Newell ML. Evolution of baseline characteristics in a large decentralised ART programme in rural KwaZulu Natal. Poster presentation @ 4th SA AIDS Conference, ICC Durban

Nyirenda M, Hosegood V, Wallrauch C, Newell ML. Older people and HIV: ageing in a rural South African community severely affected by HIV.  4th SA AIDS Conference, ICC Durban

Nyirenda M, McGrath N, Newell ML. Death of the same sex parent: the vulnerability of adolescents in rural South Africa to HIV infection. 4th SA AIDS Conference, ICC Durban

Hoddinott G, Imrie J, Harrison A, Newell ML. Secondary schools rural South Africa – what is their place in HIV prevention? Poster presentation @ 4th SA AIDS Conference, ICC Durban

Lessells R, Cooke GS, Newell ML. Characteristics of individuals attending a pilot pre-ART clinic in Hlabisa sub-district. Poster presentation @ 4th SA AIDS Conference, ICC Durban

Lessells R, Cooke GS, Newell ML. HIV and hepatitis B virus (HBV) co-infection in rural KwaZulu Natal: baseline characteristics and outcomes in first year of antiretroviral therapy (ART). Oral presentation @ 4th SA AIDS Conference, ICC Durban

Rosner Z, Bärnighausen T, Welte A, McWalter T, Newell ML. Use of the cBED enzyme immunoassay for HIV incidence estimates: a systematic review. 4th SA AIDS Conference, ICC Durban

Kany Kany AL, Copelyn JT. Breast enlargements in male patients on antiretroviral treatment in rural South Africa. Oral presentation @ 4th SA AIDS Conference, ICC Durban

Houlihan C, Mutevedzi P, Cooke GS, Newell ML. The challenge posed by TB to a rural HIV programme with a high prevalence of both TB and HIV. Oral presentation @ 4th SA AIDS Conference, ICC Durban

Houlihan C, Maheswaran H, Thulare H, Heller T, Newell ML. Pilot study of Provider Initiated Testing and Counselling (PITC) in a rural primary health care clinic. Poster presentation @ 4th SA AIDS Conference, ICC Durban

Janssen J, Ndirangu J, Newell ML, Bland RM. Clinical and virological outcomes of children receiving antiretroviral treatment in a decentralized programme in rural KwaZulu-Natal. Oral presentation @ 4th SA AIDS Conference, ICC Durban

Knight L, Hosegood V, Timaues I. The role of Disability Grants in mitigating the impact of HIV and AIDS-related illness and death in South Africa. Oral presentation @ 4th SA AIDS Conference, ICC Durban  

Wallrauch C, Heller T, Kekane D, Bärnighausen T, Lessells R, Newell C, Newell ML. Practical TB/HIV integration: Experience from Hlabisa sub-district in northern KwaZulu-Natal. Oral presentation @ 4th SA AIDS Conference, ICC Durban  

Copelyn J, Seigel A, Buckley M, Wallrauch C, Heller T. Meningitis in HIV patients in a rural setting – case load, diagnostic parameters and predictors of in-hospital mortality. Oral presentation @ 4th SA AIDS Conference, ICC Durban  

Heller T, Seigel A, Copelyn J, Buckley M, Wallrauch C. Evaluation of a course on Focused Assessment with Sonography for HIV/TB (FASH) in a rural African setting with high HIV prevalence. Oral presentation 2 4th SA AIDS Conference, ICC Durban  

Heller T, Seigel A, Copelyn J, Buckley M, Wallrauch C. Abdominal Tuberculosis: Sonographic diagnosis and treatment response in HIV-positive adults. Oral presentation @ 4th SA AIDS Conference, ICC Durban  

Von Knorring N, Ndlovu H, Mhlongo N, Gafos M. Uptake of HIV management referrals among women screened out of a microbicide clinical trial in the Umkhanyakude District of KwaZulu Natal.  4th SA AIDS Conference, ICC Durban  

Mzimela M, Ndlovu H, Gafos M. Changing patterns of condom use in HIV prevention trials. 4th SA AIDS Conference, ICC Durban  

Labuschagne E, Buthelezi MB. Facilitating an effective Home Based Care program in a resource-limited rural setting. Poster presentation @ 4th SA AIDS Conference, ICC Durban  

Fitzgerald M, Collumbien M, Hosegood V. “No one can ask me ‘why do you take that stuff?’“: men’s experiences of antiretroviral treatment in South Africa. 4th SA AIDS Conference, ICC Durban  

Riddick A, Janssen N, Dedicoat M. Changing adult medical admission patterns at a rural South African Hospital.  Oral presentation @ 4th SA AIDS Conference, ICC Durban  

Lightowler J, Cooke G, Mutevedzi P, Dedicoat M. A Year’s experience of cryptococcal meningitis in northern KwaZulu Natal: a prospective cohort study. 4th SA AIDS Conference, ICC Durban

De Oliveira T, Iversen A, Rambaut A, MacLaughlin S, Harkins G, Cassol S. Tracking the origin, History and Expansion of HIV-1 Subtype C. Oral presentation @ 4th SA AIDS Conference, ICC Durban  

IAS Conference

Lessells R, Mutevedzi P, Thulare H, Cooke GS, Newell ML. Monitoring HIV-positive individuals prior to eligibility for antiretroviral therapy: do current strategies promote retention in HIV care in rural KwaZulu Natal? 19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

Lessells R, Mutevedzi P, Cooke GS, Newell ML. Relationship between HIV clinical staging and CD4 count in rural KwaZulu Natal: implications for changing the antiretroviral therapy eligibility criteria. 19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

Mutevedzi P, Lessells RJ, Houlihan C, Cooke GS, Newell ML. Rapid scale-up of a decentralized ART programme delivered through primary health care clinics in rural KwaZulu-Natal: What is the impact on outcomes? 19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

Ndirangu J, Bland R, Newell ML. Weight and weight gain in HIV-infected children receiving Antiretroviral Therapy in rural KwaZulu-Natal. 19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

Mepham S, Bland R, Ndirangu J, Newell ML. HIV incidence and associated socio-economic factors in a prospective cohort of pregnant women in rural, northern KwaZulu-Natal, South Africa.  19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

Ndirangu J, Bland R, Newell ML. A decline in early life mortality in a high HIV prevalence rural area of South Africa: associated with implementation of PMTCT and/or ART programmes? 19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

McGrath N, Wallrauch, Bärnighausen T, Tanser F, Newell ML. Concurrent relationships in rural South Africa: Longitudinal data on prevalence and risk factors.  19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

Wallrauch C, Bärnighausen T, Mbizana C, Mthiya N, Johnson A, Newell ML. Home delivery of HIV test results: frequently demanded in a population based HIV surveillance in northern KwaZulu Natal. 19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

Houlihan C, Mutevedzi P, Lessells R, Bärnighausen T, Newell ML. Long term virological and immunological outcomes after stavudine-related lactic acidosis in rural KwaZulu-Natal. 19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

Bärnighausen T. The case for integration of HIV care and prevention: evidence from population-based surveys in rural KwaZulu-Natal. 19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

style='mso-spacerun:yes'> Chersich M, Hilber MA, Shmidlin K, Egger M, Francis S, Beaten J, Brown J, Delany-Moretlwe S, Hayes R, Kaul R, Luchters S, McGrath N, Myer L, Rees H, Temmerman M, Van der Straten A, Van de Wijgert J, Watson-Jones D, Zwahlen M, Low N. Association between intravaginal practices and HIV acquisition in women: individual patient data meta-analysis of cohort studies in sub-Saharan Africa. 19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

Mc Laughlin S, Harkins G, Pybus O, de Oliviera T.  Molecular epidemiology and migration characteristics of global HIV 1 subtype C epidemics.  19-22 July, 5th IAS2009 Conference at ICC, Cape Town  

Bland RM, Ndirangu J, Newell ML. Improving identification and treatment of HIV-infected infants and children: successes in a rural South African setting. Poster presentation @ 1st International Workshop on HIV Pediatrics, 17-18 July 2009, Cape Town (Pre-IAS)  

Ndirangu J, Newell ML, Tanser F, Herbst K, Bland R. Decline in early life mortality in high HIV prevalence rural area of HIV prevention or treatment? Poster presentation @ 1st International Workshop on HIV Pediatrics, 17-18 July 2009, Cape Town (Pre-IAS)  

Ndirangu J, Bland R, Newell ML. Weight gain in HIV-infected children receiving Antiretroviral Therapy in rural KwaZulu-Natal: does age at initiation count? Poster presentation @ 1st International Workshop on HIV Pediatrics, 17-18 July 2009, Cape Town (Pre-IAS)  

Kassanjee R, Welte A, Mc Walter TA, Viljoen J, Bärnighausen T, Newell ML. Calibration of BED assay for use in incidence estimation. E-Poster @ 5th IAS2009 Conference at ICC, Cape Town, 19-22 July 2009 Kesho Bora Study Group. Triple-antiretroviral prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-1: the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya and South Africa.  Late breaker Abstract to IAS2009, 19-22 July, Cape Town  

Bärnighausen T, Kahn J. Economic evaluation and financing of HIV interventions and programmes. Session co-chair at 5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009), 19-22 July, Cape Town, South Africa  

Other Conferences

Bärnighausen T, Bangre O, Tanser F, Cooke G, Newell ML. HIV incidence time trend and characteristics of recent seroconverters in a rural community with high HIV prevalence in South Africa. Oral presentation @ 16th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 Feb 2009; Montreal, Canada  

Bärnighausen T, Wallrauch C, Welte A, McWalter T, Mbizana N, Viljoen J, Graham N, Tanser F, Puren A, Newell ML. Comparison of HIV Incidence and Risk Factors for Recent Infection Based on Longitudinal Follow-up versus Cross-sectional cBED Assay Testing: A Study in Rural South Africa. Poster presentation @ 16th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 Feb 2009; Montreal, Canada  

Camlin C, Hosegood V, Snow RC, McGrath N, Bärnighausen T, Newell ML. HIV on the move: Sex differences in patterns of migration and HIV infection in KwaZulu Natal, South Africa. Population Association of America 2009 Annual Meeting (PASA), 30 Apr – 2 May 2009; Detroit, USA  

Gifford R, Pillay D, Fearnhill E, Delpech V, de Oliveira T for the UK Drug Resistance. HIV-1 subtype C transmission in the UK.  Oral presentation @ 4th International Workshop on HIV Transmission, 17-18 July 2009; Cape Town  

Nyirenda M, Bärnighausen T, Newell ML. A simplified approach for estimating prevalence from mortality by HIV sero-status [in rural South Africa. 26th IUSSP 2009 International Population Conference, Morocco  

style='mso-spacerun:yes'> McGrath N, Hosegood V, Isingo R, Lopman B, Kasamba I, Marston M, Todd J. Older people’s sexual behaviour and HIV risk in four high prevalence sub-Saharan African populations. IUSSP XXVI International Population Conference, 27 Sep-2 Oct 2009; Marrakech  

Slaymaker E, Hosegood V, McGrath N, Todd J. Age at second sex: a determinant of HIV transmission. Oral presentation IUSSP XXVI International Population Conference, 27 Sep-2 Oct 2009; Marrakech   Hosegood V, Bland R, McGrath N, Newell ML. Young children and fathers: patterns and determinants of social and residential arrangements in rural South Africa. Oral presentation @ IUSSP XXVI International Population Conference, 27 Sep-2 Oct 2009; Marrakech  

Knight LC. The role of social fluidity and mobility in household responses to HIV and AIDS in rural South Africa. IUSSP XXVI International Population Conference, 27 Sep-2 Oct 2009; Marrakech   Garbero A, Woolard I, Hosegood V. Who is falling behind? Is AIDS illness and death contributing to increased ‘income’ mobility in Kwa-Zulu Natal, South Africa.  Population Association of America (PAA 2009)  

Garbero A, Timaeus IM. Incorporating uncertainty in poverty dynamics: an assessment of the economic impact of AIDS mortality in the presence of measurement error and missing data.  Population Association of America Annual Meeting, 30 April – 2 May 2009; Detroit, USA   Bärnighausen T. Value of vaccination. Oral presentation @ 4th Regional Pneumoccocal Symposium. 2-3 March 2009; Johannesburg, South Africa   Finucane M, Bärnighausen T, Newell ML, Hirschhorn L. Predictors of discordant responses to adherence self-report measures. Poster presentation@  4th International Conference on HIV treatment adherence, 5-7 April 2009; Miami, USA  

Kamau A, Seebregts CJ, Katzenstein D, Kantor R, Cassol S, Morris L, Hoffman C, de Oliviera T. The curse of dimensionality, itemset mining: an approach to overcome the “curse” of dimensionality and identify co and co-occurrence of drug resistance mutations among HIV-1-infected patients with virologic failure therapy in South Africa. XVIII International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications, 9-13 June 2009; Fort Myers, Florida  http://www.informedhorizons.com/resistance2009/  

Kantor R, Delong A, Ledwaba J, Kamau A, Seebregts C, de Oliviera T, Hogan J, Martinson N, McIntyre J, Morris L, Katzenstein D for the South African Treatment and Resistance Network (SATuRN). XVIII International HIV Drug Resistance Workshop: Basic principles and Clinical Implications, 9-13 June 2009; Fort Myers, Florida  http://www.informedhorizons.com/resistance2009/  

Yeji F, Hirschhorn L, Klipstein-Grobusch K, Bärnighausen T. Predictors of mental health status in patients in a public-sector antiretroviral treatment programme in rural South Africa. INDEPTH AGM 2009           

Mepham S, Gaillard P, Zonde Z, Newell ML.  Challenges in PMTCT Antiretroviral Adherence in northern KwaZulu-Natal, South Africa. Fifth EDCTP Forum, 12-14 Oct 2009; Arusha  

Bärnighausen T. Measuring health workforce inequalities: methods and applications.  Discussant at 57th Session of the International Statistical Institute (ISI), 16-22 Aug 2009; Durban, South Africa  

Tanser F, Bärnighausen T, McGrath N, Garnett G, Newell ML. Levels of partnership concurrency and risk of HIV acquisition in a high-prevalence, rural South African population. 2nd Conference on Infectious Disease Dynamics, 2-4 Dec 2009; Athens, Greece  

Ndlovu B, Danaviah S, Moodley E, Viljoen J, Ndung’u T, Carrington M, Carr W. On use of dried blood spots for the determination of killer immunoglobulin-like receptor gene repertoires.  Annual Conference of the SAIS (South African Immunological Society), 9-11 Dec 2009  

Von Knorring N, Gafos M, Hoogland Y, Mutevedzi P, Jentsch J. Quality control and performance of HIV rapid testing in a microbicide clinical trial in rural KwaZulu-Natal. 11IUSTI World Congress, 9-11 Nov 2009; Cape Town, South Africa  

Imrie J, Hoddinott G, Harrison A, Newell ML. Developing a third generation HIV prevention intervention for rural youth in KwaZulu-Natal, South Africa – Feasibility and Acceptability IUSTI World Congress, 9-11 Nov 2009; Cape Town, South Africa  

Imrie J, Hart GJ, Newell ML. Implementing ‘combination HIV prevention’ in the real world – what are the issues? 19th International Society for Sexually Transmitted Diseases Research, 29 Jun – 1 Jul 2009; London, UK  

Chimbindi N, Tint KS, McGrath N, Herbst AJ, Newell ML. Determinants of condom use among young adults aged 15-24 years in Africa Centre Demographic Surveillance Area in Kwa-Zulu Natal, South Africa. Poster presentation  @ PASA Conference, 8-10 Jul 2009; University of Western Cape, South Africa  

Chevenet F, Arigon AM, Lahvaslaiho H, Gascuel O, de Oliveira T.  Development of a bioinformatics application for the identification and characterization of HIV-1 transmission chains.  Poster presentation @ 4th International Workshop on HIV Transmission, 1-18 Jul 2009; Cape Town, South Africa  

Yeji F, Hirschhorn L, Klipstein-Grobusch K, Bärnighausen T. Does social support affect depression in patients on antiretroviral treatment program in rural KwaZulu-Natal, South Africa? 5th PHASA conference, Dec 2009; WITS, Johannesburg, South Africa  

Stanley A, Hosegood V, Timaeus IM. I have chosen to be in love with someone who understands me: disclosure, support and condom use in relationships where both partners take ART. AIDS Impact Conference, 22-25 Sep 2009; Gabarone  

Rochat T, Tomlinson M, Newell ML, Stein A. Depression among pregnant women testing for HIV in rural South Africa, Implications for VTC and PMTCT. Session 17: HIV Testing and Risk Management. AIDS IMPACT. The 9th International Conference in Gaborone, Botswana at the Grand Palm Hotel, 22nd - 25th September 2009  

Rochat T, Coovadia H, Stein A, Bland R, Sherr L, Newell ML. Paediatric ART in Southern Africa where to from here? Lessons from 2007-2009 Priorities for 2011. Session 37: Paediatric ART Workshop, AIDS IMPACT, The 9th International Conference in Gaborone, Botswana at the Grand Palm Hotel, 22nd - 25th September 2009z

Armitage, A.E., Katzourakis, A., de Oliveira, T., Welch, J.J., Belshaw, R., Bishop, K.N., Kramer, B., McMichael, A.J., Rambaut, A., Iversen, A.K.N., 2008. Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) Sequences. J Virol 82, 8743–8761. doi:10.1128/JVI.00584-08

Bansi, L.K., Benzie, A.A., Phillips, A.N., Portsmouth, S., Hill, T., Leen, C., Schwenk, A., Johnson, M., Anderson, J., Gilson, R., Easterbrook, P., Gazzard, B., Fisher, M., Orkin, C., Porter, K., Pillay, D., Taylor, G.P., Walsh, J.C., Sabin, C.A., UK Collaborative HIV Cohort (UK CHIC) Study, 2008. Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression? AIDS 22, 349–356. doi:10.1097/QAD.0b013e3282f4709a

Bärnighausen, T., 2008. Deadly science: the Japanese biological warfare experiments on human beings in China, in: Questionable Medicine: Immoral Research in Germany, Japan and USA in the 20th Century. Campus Publishing, Frankfurt.

Bärnighausen, T., 2008. Reasons for loss to follow-up in antiretroviral treatment programs in South Africa. Future HIV Therapy 2, 141–145. doi:10.2217/17469600.2.2.141

Bärnighausen, T., Bloom, D., 2008. Designing financial-incentive programmes for return of medical service in underserved areas of sub-Saharan Africa (PGDA Working Paper). Program on the Global Demography of Aging.

Bärnighausen, T., Bloom, D.E., Canning, D., O’Brien, J., 2008. Accounting for the full benefits of childhood vaccination in South Africa. S. Afr. Med. J. 98, 842,–844–846.

Bärnighausen, T., Bloom, D.E., Humair, S., 2008. Estimating health worker need to provide antiretroviral treatment in the developing world (PGDA Working Paper No. 3808). Program on the Global Demography of Aging.

Bärnighausen, T., Bloom, D., O’Brien, J., 2008. The economic case for expanding vaccination coverage of children. Johns Hopkins Bloomberg School of Public Health.

Bärnighausen, T., Tanser, F., Gqwede, Z., Mbizana, C., Herbst, K., Newell, M.-L., 2008. High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS 22, 139–144. doi:10.1097/QAD.0b013e3282f2ef43

Bärnighausen, T., Wallrauch, C., Welte, A., McWalter, T.A., Mbizana, N., Viljoen, J., Graham, N., Tanser, F., Puren, A., Newell, M.-L., 2008. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS ONE 3. doi:10.1371/journal.pone.0003640

Bärnighausen, T., Welz, T., Hosegood, V., Bätzing-Feigenbaum, J., Tanser, F., Herbst, K., Hill, C., Newell, M.-L., 2008. Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population with very high HIV prevalence in South Africa. J Hum Hypertens 22, 236–239. doi:10.1038/sj.jhh.1002308

Bland, R.M., Little, K.E., Coovadia, H.M., Coutsoudis, A., Rollins, N.C., Newell, M.-L., 2008. Intervention to promote exclusive breast-feeding for the first 6 months of life in a high HIV prevalence area. AIDS 22, 883–891. doi:10.1097/QAD.0b013e3282f768de

Bland, R.M., Newell, M.-L., 2008. Prolonged breastfeeding and HIV transmission. Prev Med 47, 34–35. doi:10.1016/j.ypmed.2008.03.007

Buckton, A.J., Bissett, S.L., Myers, R.E., Beddows, S., Edwards, S., Cane, P.A., Pillay, D., 2008. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance. J. Antimicrob. Chemother. 62, 1191–1198. doi:10.1093/jac/dkn412

Camlin, C.S., 2008. HIV on the move: sex differences in patterns of migration and HIV in South Africa (PhD Thesis). University of Michigan, USA.

Case, A., Garrib, A., Menendez, A., Olgiati, A., 2008. Paying the Piper: The High Cost of Funerals in South Africa (SSRN Scholarly Paper No. ID 1294131). Social Science Research Network, Rochester, NY.

Cooke, G.S., Campbell, S.J., Bennett, S., Lienhardt, C., McAdam, K.P.W.J., Sirugo, G., Sow, O., Gustafson, P., Mwangulu, F., van Helden, P., Fine, P., Hoal, E.G., Hill, A.V.S., 2008. Mapping of a Novel Susceptibility Locus Suggests a Role for MC3R and CTSZ in Human Tuberculosis. Am J Respir Crit Care Med 178, 203–207. doi:10.1164/rccm.200710-1554OC

Coovadia, H., Bland, R., 2008. From Alma-Ata to Agincourt: primary health care in AIDS. Lancet 372, 866–868. doi:10.1016/S0140-6736(08)61373-2

Danaviah, S., 2008. A molecular study of spinal TB in HIV-infected patients. (PhD Thesis). University of KwaZulu-Natal, Durban.

De Paoli, M.M., Mkwanazi, N.B., Richter, L.M., Rollins, N., 2008. Early cessation of breastfeeding to prevent postnatal transmission of HIV: a recommendation in need of guidance. Acta Paediatr. 97, 1663–1668. doi:10.1111/j.1651-2227.2008.00956.x

Desmond, C., Bland, R.M., Boyce, G., Coovadia, H.M., Coutsoudis, A., Rollins, N., Newell, M.-L., 2008. Scaling-up exclusive breastfeeding support programmes: the example of KwaZulu-Natal. PLoS ONE 3. doi:10.1371/journal.pone.0002454

Dunn, D., Geretti, A.M., Green, H., Fearnhill, E., Pozniak, A., Churchill, D., Pillay, D., Sabin, C., Phillips, A., UK Collaborative Group on HIV Drug Resistance, UK Collaborative HIV Cohort Study, 2008. Population trends in the prevalence and patterns of protease resistance related to exposure to unboosted and boosted protease inhibitors. Antivir. Ther. (Lond.) 13, 771–777.

Garrib, A., Stoops, N., McKenzie, A., Dlamini, L., Govender, T., Rohde, J., Herbst, K., 2008. An evaluation of the District Health Information System in rural South Africa. S. Afr. Med. J. 98, 549–552.

Green, H., Tilston, P., Fearnhill, E., Pillay, D., Dunn, D.T., UK Collaborative Group on HIV Drug Resistance, 2008. The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the United Kingdom. J. Acquir. Immune Defic. Syndr. 49, 196–204. doi:10.1097/QAI.0b013e318185725f

Grover, D., Copas, A., Green, H., Edwards, S.G., Dunn, D.T., Sabin, C., Phillips, A., Allen, E., Pillay, D., UK Collaborative Group on HIV Drug Resistance and UK Collaborative HIV Cohort Study (UK CHIC), 2008. What is the risk of mortality following diagnosis of multidrug-resistant HIV-1? J. Antimicrob. Chemother. 61, 705–713. doi:10.1093/jac/dkm522

Hill, C., Hosegood, V., Newell, M.-L., 2008. Children’s care and living arrangements in a high HIV prevalence area in rural South Africa. Vulnerable Children and Youth Studies 3, 65–77. doi:10.1080/17450120701602091

Iwuji, C.C., Reeves, I., Nambiar, K., Richardson, D., 2008. Diagnostic utility of urethral smears in predicting urethral chlamydia in HIV-infected men. Int J STD AIDS 19, 741–743. doi:10.1258/ijsa.2008.008118

Jahn, A., Floyd, S., Crampin, A.C., Mwaungulu, F., Mvula, H., Munthali, F., McGrath, N., Mwafilaso, J., Mwinuka, V., Mangongo, B., Fine, P.E.M., Zaba, B., Glynn, J.R., 2008. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 371, 1603–1611. doi:10.1016/S0140-6736(08)60693-5

Jahn, A., Floyd, S., Mwinuka, V., Mwafilaso, J., Mwagomba, D., Mkisi, R.E., Katsulukuta, A., Khunga, A., Crampin, A.C., Branson, K., McGrath, N., Fine, P.E.M., 2008. Ascertainment of childhood vaccination histories in northern Malawi. Trop. Med. Int. Health 13, 129–138. doi:10.1111/j.1365-3156.2007.01982.x

KIDS-ART-LINC Collaboration, 2008. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J. Acquir. Immune Defic. Syndr. 49, 523–531. doi:10.1097/QAI.0b013e31818aadce

Kranzer, K., McGrath, N., Saul, J., Crampin, A.C., Jahn, A., Malema, S., Mulawa, D., Fine, P.E.M., Zaba, B., Glynn, J.R., 2008. Individual, household and community factors associated with HIV test refusal in rural Malawi. Trop. Med. Int. Health 13, 1341–1350. doi:10.1111/j.1365-3156.2008.02148.x

Landes, M., Newell, M.-L., Barlow, P., Fiore, S., Malyuta, R., Martinelli, P., Posokhova, S., Savasi, V., Semenenko, I., Stelmah, A., Tibaldi, C., Thorne, C., 2008. Hepatitis B or hepatitis C coinfection in HIV-infected pregnant women in Europe. HIV Med. 9, 526–534. doi:10.1111/j.1468-1293.2008.00599.x

Lessells, R.J., Cooke, G.S., 2008. Effect of the HIV epidemic on liver cancer in Africa. Lancet 371. doi:10.1016/S0140-6736(08)60652-2

Lessells, R.J., Main, J., Cooke, G.S., 2008. HIV and hepatitis B co-infection in Africa. Lancet Infect Dis 8, 210–211. doi:10.1016/S1473-3099(08)70047-1

Little, K.E., Bland, R.M., Newell, M.L., 2008. Vertically acquired paediatric HIV infection: the challenges of providing comprehensive packages of care in resource-limited settings. Trop. Med. Int. Health 13, 1098–1110. doi:10.1111/j.1365-3156.2008.02130.x

Margerison, E.S., Maguire, M., Pillay, D., Cane, P., Elston, R.C., 2008. The HIV-1 protease substitution K55R: a protease-inhibitor-associated substitution involved in restoring viral replication. J. Antimicrob. Chemother. 61, 786–791. doi:10.1093/jac/dkm545

Mihailidis, C., Dunn, D., Pillay, D., Pozniak, A., 2008. Effect of isolated V118I mutation in reverse transcriptase on response to first-line antiretroviral therapy. AIDS 22, 427–430. doi:10.1097/QAD.0b013e3282f3744f

Mkwanazi, N.B., Patel, D., Newell, M.-L., Rollins, N.C., Coutsoudis, A., Coovadia, H.M., Bland, R.M., 2008. Rapid testing may not improve uptake of HIV testing and same day results in a rural South African community: a cohort study of 12,000 women. PLoS ONE 3. doi:10.1371/journal.pone.0003501

Moultrie, T.A., Hosegood, V., McGrath, N., Hill, C., Herbst, K., Newell, M.-L., 2008. Refining the criteria for stalled fertility declines: an application to rural KwaZulu-Natal, South Africa, 1990-2005. Stud Fam Plann 39, 39–48.

Mpontshane, N., Van den Broeck, J., Chhagan, M., Luabeya, K.K.A., Johnson, A., Bennish, M.L., 2008. HIV infection is associated with decreased dietary diversity in South African children. J. Nutr. 138, 1705–1711.

Mullineux, J., Firmstone, V., Matthews, P., Ireson, R., 2008. Innovative sexual health education for general practice: an evaluation of the Sexual Health in Practice (SHIP) scheme. Education for Primary Care 19, 397–407.

Myers, R.E., Pillay, D., 2008. Analysis of Natural Sequence Variation and Covariation in Human Immunodeficiency Virus Type 1 Integrase. J Virol 82, 9228–9235. doi:10.1128/JVI.01535-07

Ndinda, C., Chimbwete, C., McGrath, N., Pool, R., 2008. Perceptions of anal sex in rural South Africa. Cult Health Sex 10, 205–212. doi:10.1080/13691050600988416

Ngubane, N., Patel, D., Newell, M.L., Coovadia, H.M., Rollins, N., Coutsoudis, A., Bland, R.M., 2008. Messages about dual contraception in areas of high HIV prevalence are not heeded. S. Afr. Med. J. 98, 209–212.

Orne-Gliemann, J., Becquet, R., Ekouevi, D.K., Leroy, V., Perez, F., Dabis, F., 2008. Children and HIV/AIDS: from research to policy and action in resource-limited settings. AIDS 22, 797–805. doi:10.1097/QAD.0b013e3282f4f45a

Pembrey, L., Newell, M.-L., Tovo, P.-A., European Paediatric Hepatitis C Virus Network, 2008. Age-related lymphocyte and neutrophil levels in children of hepatitis C-infected women. Pediatr. Infect. Dis. J. 27, 800–807. doi:10.1097/INF.0b013e31816ffc0e

Phillips, A.N., Pillay, D., Miners, A.H., Bennett, D.E., Gilks, C.F., Lundgren, J.D., 2008. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. Lancet 371, 1443–1451. doi:10.1016/S0140-6736(08)60624-8

Prost, M.-A., Jahn, A., Floyd, S., Mvula, H., Mwaiyeghele, E., Mwinuka, V., Mhango, T., Crampin, A.C., McGrath, N., Fine, P.E.M., Glynn, J.R., 2008. Implication of new WHO growth standards on identification of risk factors and estimated prevalence of malnutrition in rural Malawian infants. PLoS ONE 3. doi:10.1371/journal.pone.0002684

Rodger, A.J., Cooke, G.S., Ord, R., Sutherland, C.J., Pasvol, G., 2008. Cluster of falciparum malaria cases in UK airport. Emerging Infect. Dis. 14, 1284–1286. doi:10.3201/eid1408.080031

Rollins, N.C., Becquet, R., Bland, R.M., Coutsoudis, A., Coovadia, H.M., Newell, M.-L., 2008. Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmes. AIDS 22, 2349–2357. doi:10.1097/QAD.0b013e328312c740

Rosengarten, M., Michael, M., Mykhalovskiy, E., Imrie, J., 2008. The challenges of technological innovation in HIV. Lancet 372, 357–358. doi:10.1016/S0140-6736(08)61140-X

Rouet, F., Ménan, H., Viljoen, J., Ngo-Giang-Huong, N., Mandaliya, K., Valéa, D., Lien, T.X., Danaviah, S., Rousset, D., Ganon, A., Nerrienet, E., 2008. In-house HIV-1 RNA real-time RT-PCR assays: principle, available tests and usefulness in developing countries. Expert Rev. Mol. Diagn. 8, 635–650. doi:10.1586/14737159.8.5.635

Salemi, M., de Oliveira, T., Ciccozzi, M., Rezza, G., Goodenow, M.M., 2008. High-Resolution Molecular Epidemiology and Evolutionary History of HIV-1 Subtypes in Albania. PLoS ONE 3. doi:10.1371/journal.pone.0001390

Salemi, M., Goodenow, M.M., Montieri, S., de Oliveira, T., Santoro, M.M., Beshkov, D., Alexiev, I., Elenkov, I., Elenkov, I., Yakimova, T., Varleva, T., Rezza, G., Ciccozzi, M., 2008. The HIV Type 1 Epidemic in Bulgaria Involves Multiple Subtypes and Is Sustained by Continuous Viral Inflow from West and East European Countries. AIDS Res Hum Retroviruses 24, 771–779. doi:10.1089/aid.2007.0181

Sherr, L., Varrall, R., Mueller, J., JLICA Workgroup 1 Members, Richter, L., Wakhweya, A., Adato, M., Belsey, M., Chandan, U., Drimie, S., Haour-Knipe Victoria Hosegood, M., Kimou, J., Madhavan, S., Mathambo, V., Desmond, C., 2008. A systematic review on the meaning of the concept “AIDS Orphan”: confusion over definitions and implications for care. AIDS Care 20, 527–536. doi:10.1080/09540120701867248

Stöhr, W., Back, D., Dunn, D., Sabin, C., Winston, A., Gilson, R., Pillay, D., Hill, T., Ainsworth, J., Pozniak, A., Leen, C., Bansi, L., Fisher, M., Orkin, C., Anderson, J., Johnson, M., Easterbrook, P., Gibbons, S., Khoo, S., Liverpool TDM Database, UK CHIC Study, 2008. Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication. Antivir. Ther. (Lond.) 13, 675–685.

Subramanian, L., McGrath, N., Ndlovu, H., Gafos, M., 2008. Family planning methods among women in a vaginal microbicide feasibility study in rural KwaZulu-Natal, South Africa. Afr J Reprod Health 12, 45–63.

Tanser, F., Hosegood, V., Bärnighausen, T., Herbst, K., Nyirenda, M., Muhwava, W., Newell, C., Viljoen, J., Mutevedzi, T., Newell, M.-L., 2008. Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol 37, 956–962. doi:10.1093/ije/dym211

Thorne, C., Malyuta, R., Semenenko, I., Pilipenko, T., Stelmah, A., Posokhova, S., Newell, M.-L., 2008. Mother-to-child transmission risk is increased among HIV-infected pregnant women in Ukraine with serological test results positive for syphilis. Clin. Infect. Dis. 47, 1114–1115. doi:10.1086/592124

Wallrauch, C., Bäärnighausen, T., Heller, T., Houlihan, C., Newell, M.-L., 2008. The white and the three-letter plague: integration of TB and HIV care in sub-Saharan Africa. Future HIV Therapy 2, 437–451. doi:10.2217/17469600.2.5.437

Welz, T., Herbst, K., 2008. Anonymous HIV testing with participant-controlled access to results using handheld computers: a new model of HIV testing used in a household survey in rural South Africa. Sex Transm Dis 35, 372–376. doi:10.1097/OLQ.0b013e31815fd3fc

White, R.G., Moodley, P., McGrath, N., Hosegood, V., Zaba, B., Herbst, K., Newell, M., Sturm, W.A., Hayes, R.J., 2008. Low effectiveness of syndromic treatment services for curable sexually transmitted infections in rural South Africa. Sex Transm Infect 84, 528–534. doi:10.1136/sti.2008.032011

Wickstrom, A., 2008. Love in the time of the virus. Linkoping University, Linkoping.

Abecasis, A.B., Lemey, P., Vidal, N., de Oliveira, T., Peeters, M., Camacho, R., Shapiro, B., Rambaut, A., Vandamme, A.-M., 2007. Recombination Confounds the Early Evolutionary History of Human Immunodeficiency Virus Type 1: Subtype G Is a Circulating Recombinant Form. J Virol 81, 8543–8551. doi:10.1128/JVI.00463-07

Abraham, A.M., Kavitha, S., Joseph, P., George, R., Pillay, D., Malathi, J., Jesudason, M.V., Sridharan, G., 2007. Aciclovir resistance among Indian strains of Herpes simplex virus as determined using a dye uptake assay. Indian J Med Microbiol 25, 260–262. doi:10.4103/0255-0857.34771

Anand, S., Barnighausen, T., 2007. Authors’ reply: health workers and vaccination coverage in developing countries. The Lancet 370, 479–480.

Anand, S., Bärnighausen, T., 2007. Health workers and vaccination coverage in developing countries: an econometric analysis. Lancet 369, 1277–1285. doi:10.1016/S0140-6736(07)60599-6

Arrivé, E., Newell, M.-L., Ekouevi, D.K., Chaix, M.-L., Thiebaut, R., Masquelier, B., Leroy, V., Perre, P.V. de, Rouzioux, C., Dabis, F., Ghent Group on HIV in Women and Children, 2007. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol 36, 1009–1021. doi:10.1093/ije/dym104

Bärnighausen, T., 2007. Access to antiretroviral treatment in the developing world: a framework, review and health systems research agenda. Therapy 4, 753–766.

Bärnighausen, T., Bloom, D.E., Humair, S., 2007. Human resources for treating HIV/AIDS: needs, capacities, and gaps. AIDS Patient Care STDS 21, 799–812. doi:10.1089/apc.2007.0193

Bärnighausen, T., Hosegood, V., Timaeus, I.M., Newell, M.-L., 2007. The socioeconomic determinants of HIV incidence: evidence from a longitudinal, population-based study in rural South Africa. AIDS 21 Suppl 7, S29–38. doi:10.1097/01.aids.0000300533.59483.95

Bärnighausen, T., Liu, Y., Zhang, X., Sauerborn, R., 2007. Willingness to pay for social health insurance among informal sector workers in Wuhan, China: a contingent valuation study. BMC Health Serv Res 7. doi:10.1186/1472-6963-7-114

Becquet, R., 2007. Antiretroviral therapy among HIV-infected breastfeeding mothers: a promising strategy to prevent HIV postnatal transmission in Africa. Future HIV Therapy 1, 17–21. doi:10.2217/17469600.1.1.17

Becquet, R., Newell, M.-L., 2007. Prevention of postnatal HIV infection: infant feeding and antiretroviral interventions. Curr Opin HIV AIDS 2, 361–366. doi:10.1097/COH.0b013e3282cecef4

Bland, R.M., 2007. Exclusive breastfeeding - what is its place in HIV prevalent areas? Continuing Medical Education 25.

Bland, R.M., Becquet, R., Rollins, N.C., Coutsoudis, A., Coovadia, H.M., Newell, M.L., 2007a. Breast health problems are rare in both HIV-infected and HIV-uninfected women who receive counseling and support for breast-feeding in South Africa. Clin. Infect. Dis. 45, 1502–1510. doi:10.1086/523320

Bland, R.M., Rollins, N.C., Coovadia, H.M., Coutsoudis, A., Newell, M.L., 2007. Infant feeding counselling for HIV-infected and uninfected women: appropriateness of choice and practice. Bull. World Health Organ. 85, 289–296. doi:10.1590/S0042-9686200700004000014

Bossert, T.J., World Health Organization., 2007. Assessing financing, education, management and policy context for strategic planning of human resources for health. World Health Organization, Geneva.

Ciccozzi, M., Montieri, S., Salemi, M., De Oliveira, T., Dorrucci, M., Sinicco, A., De Luca, A., Giuliani, M., Balotta, C., Rezza, G., 2007. An outbreak of HIV-1 subtype G among Italian injecting drug users. AIDS 21, 1213–1215. doi:10.1097/QAD.0b013e32813aee1a

Colizzi, V., de Oliveira, T., Roberts, R.J., 2007. Libya should stop denying scientific evidence on HIV. Nature 448, 992. doi:10.1038/448992a

Cooke, G.S., 2007. Evolution of adult antiretroviral therapy for programmatic delivery in Africa and the potential role for new therapeutic approaches. Therapy 4, 767–774. doi:10.2217/14750708.4.6.767

Coovadia, H.M., Bland, R.M., 2007. Preserving breastfeeding practice through the HIV pandemic. Trop. Med. Int. Health 12, 1116–1133. doi:10.1111/j.1365-3156.2007.01895.x

Coovadia, H.M., Rollins, N.C., Bland, R.M., Little, K., Coutsoudis, A., Bennish, M.L., Newell, M.-L., 2007. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 369, 1107–1116. doi:10.1016/S0140-6736(07)60283-9

Danaviah, S., Govender, S., Cassol, S., 2007. Histopathology and genotyping in infectious spondylitis of HIV- and HIV+ patients. Clin. Orthop. Relat. Res. 460, 50–55. doi:10.1097/BLO.0b013e31806a9147

Danaviah, S., Govender, S., Gordon, M.L., Cassol, S., 2007. Atypical mycobacterial spondylitis in HIV-negative patients identified by genotyping. Journal of Bone and Joint Surgery-British Volume- 89.

Deforche, K., Camacho, R., Grossman, Z., Silander, T., Soares, M.A., Moreau, Y., Shafer, R.W., Van Laethem, K., Carvalho, A.P., Wynhoven, B., Cane, P., Snoeck, J., Clarke, J., Sirivichayakul, S., Ariyoshi, K., Holguin, A., Rudich, H., Rodrigues, R., Bouzas, M.B., Cahn, P., Brigido, L.F., Soriano, V., Sugiura, W., Phanuphak, P., Morris, L., Weber, J., Pillay, D., Tanuri, A., Harrigan, P.R., Shapiro, J.M., Katzenstein, D.A., Kantor, R., Vandamme, A.-M., 2007. Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors. Infect. Genet. Evol. 7, 382–390. doi:10.1016/j.meegid.2006.09.004

Edwards, S.G., Grover, D., Scott, C., Tedder, R.S., Pillay, D., Copas, A., Miller, R.F., 2007. Cytomegalovirus viral load testing of blood using quantitative polymerase chain reaction in acutely unwell HIV-1-positive patients lacks diagnostic utility. Int J STD AIDS 18, 321–323. doi:10.1258/095646207780749600

Gifford, R.J., de Oliveira, T., Rambaut, A., Pybus, O.G., Dunn, D., Vandamme, A.-M., Kellam, P., Pillay, D., 2007. Phylogenetic Surveillance of Viral Genetic Diversity and the Evolving Molecular Epidemiology of Human Immunodeficiency Virus Type 1. J Virol 81, 13050–13056. doi:10.1128/JVI.00889-07

Govender, S., Ramnarain, A., Danaviah, S., 2007. Cervical spine tuberculosis in children. Clin. Orthop. Relat. Res. 460, 78–85. doi:10.1097/BLO.0b013e31806a915f

Green, H., Gibb, D.M., Walker, A.S., Pillay, D., Butler, K., Candeias, F., Castelli-Gattinara, G., Compagnucci, A., Della Negra, M., de Rossi, A., Feiterna-Sperling, C., Giaquinto, C., Harper, L., Levy, J., Saidi, Y., Wintergerst, U., Paediatric European Network for the Treatment of AIDS (PENTA), 2007. Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children. AIDS 21, 947–955. doi:10.1097/QAD.0b013e3280e087e7

Hosegood, V., Floyd, S., Marston, M., Hill, C., McGrath, N., Isingo, R., Crampin, A., Zaba, B., 2007. The effects of high HIV prevalence on orphanhood and living arrangements of children in Malawi, Tanzania, and South Africa. Popul Stud (Camb) 61, 327–336. doi:10.1080/00324720701524292

Hosegood, V., Preston-Whyte, E., Busza, J., Moitse, S., Timaeus, I.M., 2007. Revealing the full extent of households’ experiences of HIV and AIDS in rural South Africa. Soc Sci Med 65, 1249–1259. doi:10.1016/j.socscimed.2007.05.002

Jahn, A., Branson, K., Crampin, A.C., Fine, P.E., Glynn, J.R., McGrath, N., Mwafilaso, J., Mwaiyeghele, E., Mwinuka, V., Zaba, B., 2007. Evaluation of a village-informant driven demographic surveillance system in Karonga, Northern Malawi. Demographic Research 16, 219–248.

Karlsson, A.C., Iversen, A.K.N., Chapman, J.M., de Oliveira, T., Spotts, G., McMichael, A.J., Davenport, M.P., Hecht, F.M., Nixon, D.F., 2007. Sequential Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape. PLoS ONE 2. doi:10.1371/journal.pone.0000225

Lebon, A., Bland, R.M., Rollins, N.C., Coutsoudis, A., Coovadia, H., Newell, M.-L., 2007. Short communication: CD4 counts of HIV-infected pregnant women and their infected children--implications for PMTCT and treatment programmes. Trop. Med. Int. Health 12, 1472–1474. doi:10.1111/j.1365-3156.2007.01954.x

Lee, K.J., Shingadia, D., Pillay, D., Walker, A.S., Riordan, A., Menson, E., Duong, T., Tudor-Williams, G., Gibb, D.M., Collaborative HIV Paediatric Study Steering Committee, 2007. Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean? Antivir. Ther. (Lond.) 12, 949–956.

Luabeya, K.-K.A., Mpontshane, N., Mackay, M., Ward, H., Elson, I., Chhagan, M., Tomkins, A., den Broeck, J.V., Bennish, M.L., 2007. Zinc or Multiple Micronutrient Supplementation to Reduce Diarrhea and Respiratory Disease in South African Children: A Randomized Controlled Trial. PLoS ONE 2. doi:10.1371/journal.pone.0000541

Ma, C.-M., Hon, C.-C., Lam, T.-Y., Li, V.Y.-Y., Wong, C.K.-W., de Oliveira, T., Leung, F.C.-C., 2007. Evidence for recombination in natural populations of porcine circovirus type 2 in Hong Kong and mainland China. J. Gen. Virol. 88, 1733–1737. doi:10.1099/vir.0.82629-0

Manasa, J., Musabaike, H., Masimirembwa, C., Burke, E., Luthy, R., Mudzori, J., 2007. Evaluation of the Partec Flow Cytometer against the BD FACSCalibur System for Monitoring Immune Responses of Human Immunodeficiency Virus-Infected Patients in Zimbabwe. Clin Vaccine Immunol 14, 293–298. doi:10.1128/CVI.00416-06

McGrath, N., Kranzer, K., Saul, J., Crampin, A.C., Malema, S., Kachiwanda, L., Zaba, B., Jahn, A., Fine, P.E., Glynn, J.R., 2007. Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi. AIDS 21 Suppl 6, S105–113. doi:10.1097/01.aids.0000299417.69432.65

Mota-Miranda, A.C., de Oliveira, T., Moreau, D.R., Bomfim, C., Galvão-Castro, B., Alcantara, L.C., 2007. Mapping the molecular characteristics of Brazilian human T-cell lymphotropic virus type 1 Env (gp46) and Pol amino acid sequences for vaccine design. Mem. Inst. Oswaldo Cruz 102, 741–749. doi:10.159/S0074-02762007005000089

Moultrie, T.A., McGrath, N., 2007. Teenage fertility rates falling in South Africa. S. Afr. Med. J. 97, 442–443.

Ndinda, C., Chimbwete, C., McGrath, N., Pool, R., Mdp Group,  null, 2007. Community attitudes towards individuals living with HIV in rural KwaZulu-Natal, South Africa. AIDS Care 19, 92–101. doi:10.1080/09540120600888378

Newell, M.-L., Bärnighausen, T., 2007. Male circumcision to cut HIV risk in the general population. Lancet 369, 617–619. doi:10.1016/S0140-6736(07)60288-8

Nyirenda, M., Hosegood, V., Bärnighausen, T., Newell, M.-L., 2007. Mortality levels and trends by HIV serostatus in rural South Africa. AIDS 21 Suppl 6, S73–79. doi:10.1097/01.aids.0000299413.82893.2b

Papathakis, P.C., Rollins, N.C., Chantry, C.J., Bennish, M.L., Brown, K.H., 2007. Micronutrient status during lactation in HIV-infected and HIV-uninfected South African women during the first 6 mo after delivery. Am. J. Clin. Nutr. 85, 182–192.

Phillips, A.N., Gazzard, B., Gilson, R., Easterbrook, P., Johnson, M., Walsh, J., Leen, C., Fisher, M., Orkin, C., Anderson, J., Pillay, D., Delpech, V., Sabin, C., Schwenk, A., Dunn, D., Gompels, M., Hill, T., Porter, K., Babiker, A., UK Collaborative HIV Cohort Study, 2007a. Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count. AIDS 21, 1717–1721. doi:10.1097/QAD.0b013e32827038bf

Phillips, A.N., Leen, C., Wilson, A., Anderson, J., Dunn, D., Schwenk, A., Orkin, C., Hill, T., Fisher, M., Walsh, J., Pillay, D., Bansi, L., Gazzard, B., Easterbrook, P., Gilson, R., Johnson, M., Sabin, C.A., UK Collaborative HIV Cohort (CHIC) Study, 2007. Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study. Lancet 370, 1923–1928. doi:10.1016/S0140-6736(07)61815-7

Phillips, A.N., Sabin, C., Pillay, D., Lundgren, J.D., 2007. HIV in the UK 1980-2006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy. HIV Med. 8, 536–546. doi:10.1111/j.1468-1293.2007.00507.x

Queiroz, A.T.L. de, Mota-Miranda, A.C.A., Oliveira, T. de, Moreau, D.R., Urpia, C. de C., Carvalho, C.M., Galvão-Castro, B., Alcantara, L.C.J., 2007. Re-mapping the molecular features of the human immunodeficiency virus type 1 and human T-cell lymphotropic virus type 1 Brazilian sequences using a bioinformatics unit established in Salvador, Bahia, Brazil, to give support to the viral epidemiology studies. Memórias do Instituto Oswaldo Cruz 102, 133–139. doi:10.1590/S0074-02762007005000005

Rice, B.D., Bätzing-Feigenbaum, J., Hosegood, V., Tanser, F., Hill, C., Barnighausen, T., Herbst, K., Welz, T., Newell, M.-L., 2007. Population and antenatal-based HIV prevalence estimates in a high contracepting female population in rural South Africa. BMC Public Health 7. doi:10.1186/1471-2458-7-160

Rollins, N.C., 2007. Infant feeding and HIV. BMJ 334, 487–488. doi:10.1136/bmj.39135.411563.80

Rollins, N.C., Coovadia, H.M., Bland, R.M., Coutsoudis, A., Bennish, M.L., Patel, D., Newell, M.-L., 2007. Pregnancy outcomes in HIV-infected and uninfected women in rural and urban South Africa. J. Acquir. Immune Defic. Syndr. 44, 321–328. doi:10.1097/QAI.0b013e31802ea4b0

Rollins, N.C., van den Broeck, J., Kindra, G., Pent, M., Kasambira, T., Bennish, M.L., 2007. The effect of nutritional support on weight gain of HIV-infected children with prolonged diarrhoea. Acta Paediatr. 96, 62–68. doi:10.1111/j.1651-2227.2006.00013.x

Shafer, R.W., Rhee, S.-Y., Pillay, D., Miller, V., Sandstrom, P., Schapiro, J.M., Kuritzkes, D.R., Bennett, D., 2007. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS 21, 215–223. doi:10.1097/QAD.0b013e328011e691

Van den Broeck, J., Mackay, M., Mpontshane, N., Kany Kany Luabeya, A., Chhagan, M., Bennish, M.L., 2007. Maintaining data integrity in a rural clinical trial. Clin Trials 4, 572–582. doi:10.1177/1740774507084106

Welz, T., Hosegood, V., Jaffar, S., Bätzing-Feigenbaum, J., Herbst, K., Newell, M.-L., 2007. Continued very high prevalence of HIV infection in rural KwaZulu-Natal, South Africa: a population-based longitudinal study. AIDS 21, 1467–1472. doi:10.1097/QAD.0b013e3280ef6af2

White, R.G., Vynnycky, E., Glynn, J.R., Crampin, A.C., Jahn, A., Mwaungulu, F., Mwanyongo, O., Jabu, H., Phiri, H., McGrath, N., Zaba, B., Fine, P.E.M., 2007. HIV epidemic trend and antiretroviral treatment need in Karonga District, Malawi. Epidemiol. Infect. 135, 922–932. doi:10.1017/S0950268806007680

Zaba, B., Marston, M., Crampin, A.C., Isingo, R., Biraro, S., Bärnighausen, T., Lopman, B., Lutalo, T., Glynn, J.R., Todd, J., 2007. Age-specific mortality patterns in HIV-infected individuals: a comparative analysis of African community study data. AIDS 21 Suppl 6, S87–96. doi:10.1097/01.aids.0000299415.67646.26

Adjuik, M., Smith, T., Clark, S., Todd, J., Garrib, A., Kinfu, Y., Kahn, K., Mola, M., Ashraf, A., Masanja, H., Adazu, K., Adazu, U., Sacarlal, J., Alam, N., Marra, A., Gbangou, A., Mwageni, E., Binka, F., 2006. Cause-specific mortality rates in sub-Saharan Africa and Bangladesh. Bull. World Health Organ. 84, 181–188. doi:10.1590/S0042-96862006000300012

Alcantara, L.C.J., de Oliveira, T., Gordon, M., Pybus, O., Mascarenhas, R.E., Seixas, M.O., Gonçalves, M., Hlela, C., Cassol, S., Galvão-Castro, B., 2006. Tracing the origin of Brazilian HTLV-1 as determined by analysis of host and viral genes. AIDS 20, 780–782. doi:10.1097/01.aids.0000216383.14808.13

Alkharsah, K.R., Dedicoat, M., DeLuca, D.S., Schulz, T.F., Blasczyk, R., 2006. Identification of two new HLA-A variants, HLA-A*2911 and HLA-A*6827. Tissue Antigens 67, 170–172. doi:10.1111/j.1399-0039.2006.00505.x

Bezemer, D., de Ronde, A., Prins, M., Porter, K., Gifford, R., Pillay, D., Masquelier, B., Fleury, H., Dabis, F., Back, N., Jurriaans, S., van der Hoek, L., CASCADE collaboration, 2006. Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load. Antivir. Ther. (Lond.) 11, 173–178.

Case, A., Ardington, C., 2006. The impact of parental death on school outcomes: longitudinal evidence from South Africa. Demography 43, 401–420.

Choge, I., Cilliers, T., Walker, P., Taylor, N., Phoswa, M., Meyers, T., Viljoen, J., Violari, A., Gray, G., Moore, P.L., Papathanosopoulos, M., Morris, L., 2006. Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression. AIDS Res. Hum. Retroviruses 22, 458–465. doi:10.1089/aid.2006.22.458

Danaviah, S., Govender, S., Gordon, M., Cassol, S., 2006. A report of three unusual opportunistic bacterial infections of the spine. South African Orthopaedic Journal 5, 12–16.

Dedicoat, M., Livesley, N., 2006. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings). Cochrane Database Syst Rev. doi:10.1002/14651858.CD005420.pub2

De Oliveira, T., Pybus, O.G., Rambaut, A., Salemi, M., Cassol, S., Ciccozzi, M., Rezza, G., Gattinara, G.C., D’Arrigo, R., Amicosante, M., Perrin, L., Colizzi, V., Perno, C.F., Benghazi Study Group, 2006. Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature 444, 836–837.

Garrib, A., Jaffar, S., Knight, S., Bradshaw, D., Bennish, M.L., 2006. Rates and causes of child mortality in an area of high HIV prevalence in rural South Africa. Trop. Med. Int. Health 11, 1841–1848. doi:10.1111/j.1365-3156.2006.01738.x

Gifford, R., de Oliveira, T., Rambaut, A., Myers, R.E., Gale, C.V., Dunn, D., Shafer, R., Vandamme, A.-M., Kellam, P., Pillay, D., UK Collaborative Group on HIV Drug Resistance, 2006. Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity. AIDS 20, 1521–1529. doi:10.1097/01.aids.0000237368.64488.ae

Govender, L., Rochat, T., Richter, L., Rollins, N., 2006. Pediatric Nursing in the Context of the HIV/AIDS Epidemic in Resource-poor Settings—Balancing the “Art and the Science.” Holistic nursing practice 20, 247–254.

Green, H., Gibb, D.M., Compagnucci, A., Giacomet, V., de Rossi, A., Harper, L., Saïdi, Y., Castelli-Gattinara, G., Pillay, D., Babiker, A.G., Aboulker, J.-P., Lyall, H., Bacheler, L.T., Walker, A.S., Debré, M., Rosso, R., Burger, D.M., Della Negra, M., Dunn, D.T., Giaquinto, C., Paediatric European Network for the Treatment of AIDS, 2006. A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial. Antivir. Ther. (Lond.) 11, 857–867.

Hosegood, V., Timaeus, I.M., 2006. HIV/AIDS and Older People in South Africa.

Montgomery, C.M., Hosegood, V., Busza, J., Timaeus, I.M., 2006. Men’s involvement in the South African family: engendering change in the AIDS era. Soc Sci Med 62, 2411–2419. doi:10.1016/j.socscimed.2005.10.026

Papathakis, P.C., Van Loan, M.D., Rollins, N.C., Chantry, C.J., Bennish, M.L., Brown, K.H., 2006. Body composition changes during lactation in HIV-infected and HIV-uninfected South African women. J. Acquir. Immune Defic. Syndr. 43, 467–474. doi:10.1097/01.qai.0000243094.42276.92

Pillay, D., Bhaskaran, K., Jurriaans, S., Prins, M., Masquelier, B., Dabis, F., Gifford, R., Nielsen, C., Pedersen, C., Balotta, C., Rezza, G., Ortiz, M., de Mendoza, C., Kücherer, C., Poggensee, G., Gill, J., Porter, K., CASCADE Virology Collaboration, 2006. The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS 20, 21–28.

Rochat, T.J., Richter, L.M., Doll, H.A., Buthelezi, N.P., Tomkins, A., Stein, A., 2006. Depression among pregnant rural South African women undergoing HIV testing. JAMA 295, 1376–1378. doi:10.1001/jama.295.12.1376

Snoeck, J., Kantor, R., Shafer, R.W., Van Laethem, K., Deforche, K., Carvalho, A.P., Wynhoven, B., Soares, M.A., Cane, P., Clarke, J., Pillay, C., Sirivichayakul, S., Ariyoshi, K., Holguin, A., Rudich, H., Rodrigues, R., Bouzas, M.B., Brun-Vézinet, F., Reid, C., Cahn, P., Brigido, L.F., Grossman, Z., Soriano, V., Sugiura, W., Phanuphak, P., Morris, L., Weber, J., Pillay, D., Tanuri, A., Harrigan, R.P., Camacho, R., Schapiro, J.M., Katzenstein, D., Vandamme, A.-M., 2006. Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent. Antimicrob Agents Chemother 50, 694–701. doi:10.1128/AAC.50.2.694-701.2006

Tanser, F., 2006. Geographical Information Systems (GIS) Innovations For Primary Health Care in Developing Countries. Innovations: Technology, Governance, Globalization 1, 106–122. doi:10.1162/itgg.2006.1.2.106

Tanser, F., 2006. Methodology for optimising location of new primary health care facilities in rural communities: a case study in KwaZulu-Natal, South Africa. J Epidemiol Community Health 60, 846–850. doi:10.1136/jech.2005.043265

Tanser, F., Gijsbertsen, B., Herbst, K., 2006. Modelling and understanding primary health care accessibility and utilization in rural South Africa: an exploration using a geographical information system. Soc Sci Med 63, 691–705. doi:10.1016/j.socscimed.2006.01.015

Welaga, P., 2006. The impact of migration on adult mortality in rural South Africa: do people migrate into rural area to die? (Doctoral Dissertation). University of the Witswatersrand, Johannesburg.

Adhikari, M., Jeena, P., Pillay, T., Moodley, A., Kieliela, P., Cassol, S., 2005. The HIV-1 exposed neonate: outcome of intensive care management in the first week of life. Indian Pediatr 42, 1215–1219.

Benzler, J., Clark, S.J., 2005. Toward a Unified Timestamp with explicit precision. Demogr Res 12, 107–140. doi:10.4054/DemRes.2005.12.6

Case, A., Hosegood, V., Lund, F., 2005. The reach and impact of Child Support Grants: evidence from KwaZulu-Natal. Development Southern Africa 22, 467–482. doi:10.1080/03768350500322925

Cassol, E., Page, T., Mosam, A., Friedland, G., Jack, C., Lalloo, U., Kopetka, J., Patterson, B., Esterhuizen, T., Coovadia, H.M., 2005. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8. J. Infect. Dis. 191, 324–332. doi:10.1086/427337

Chilton, D., Dervisevic, S., Pillay, D., Rider, A., Copas, A., Miller, R.F., Edwards, S.G., 2005. Determinants of HIV drug resistance mutations in plasma virus after treatment interruption. AIDS 19, 2174–2175.

Dedicoat, M., Newton, R., 2005. Treatment of Kaposi’s sarcoma in resource-poor settings. Trop Doct 35.

De Oliveira, T., Deforche, K., Cassol, S., Salminen, M., Paraskevis, D., Seebregts, C., Snoeck, J., van Rensburg, E.J., Wensing, A.M.J., van de Vijver, D.A., Boucher, C.A., Camacho, R., Vandamme, A.-M., 2005. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 21, 3797–3800. doi:10.1093/bioinformatics/bti607

Doherty, R.S., de Oliveira, T., Seebregts, C., Danaviah, S., Gordon, M., Cassol, S., 2005. BioAfrica’s HIV-1 Proteomics Resource: Combining protein data with bioinformatics tools. Retrovirology 2. doi:10.1186/1742-4690-2-18

Dunn, D.T., Green, H., Loveday, C., Rinehart, A., Pillay, D., Fisher, M., McCormack, S., Babiker, A.G., Darbyshire, J.H., Evaluation of Resistance Assays (ERA) Trial Investigators, 2005. A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators. J. Acquir. Immune Defic. Syndr. 38, 553–559.

Evaluation of Resistance Assays (ERA) Trial Investigators, 2005. A randomized controlled trial of the clinical utility of genotypic resistance testing in patients with limited prior exposure to antiretroviral drugs. HIV Clin Trials 6, 183–186. doi:10.1310/hct.2005.6.4.001

Floyd, S., Marston, M., Hosegood, V., Scholten, F., Zaba, B., 2005. HIV and orphanhood: report on collaborative study prepared for UNICEF.

Ford, K., Hosegood, V., 2005. AIDS mortality and the mobility of children in KwaZulu Natal, South Africa. Demography 42, 757–768.

Fraser, H.S.F., Biondich, P., Moodley, D., Choi, S., Mamlin, B.W., Szolovits, P., 2005. Implementing electronic medical record systems in developing countries. Inform Prim Care 13, 83–95.

Grimwade, K., Sturm, A.W., Nunn, A.J., Mbatha, D., Zungu, D., Gilks, C.F., 2005. Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa. AIDS 19, 163–168.

Hosegood, V., Benzler, J., Solarsh, G.C., 2005. Population mobility and household dynamics in rural South Africa: implications for demographic and health research. Southern African Journal of Demography 10, 43–68.

Hosegood, V., Timæus, I.M., 2005. The impact of adult mortality on the living arrangements of older people in rural South Africa. Ageing and Society 25, 431–444. doi:10.1017/S0144686X0500365X

Hué, S., Pillay, D., Clewley, J.P., Pybus, O.G., 2005. Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc Natl Acad Sci U S A 102, 4425–4429. doi:10.1073/pnas.0407534102

Jaffar, S., Govender, T., Garrib, A., Welz, T., Grosskurth, H., Smith, P.G., Whittle, H., Bennish, M.L., 2005. Antiretroviral treatment in resource-poor settings: public health research priorities. Trop. Med. Int. Health 10, 295–299. doi:10.1111/j.1365-3156.2005.01390.x

Jaspan, H.B., Gray, G.E., Robinson, A.K.L., Coovadia, H.M., Bekker, L.-G., 2005. Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa. S. Afr. Med. J. 95, 685–687.

Kantor, R., Katzenstein, D.A., Efron, B., Carvalho, A.P., Wynhoven, B., Cane, P., Clarke, J., Sirivichayakul, S., Soares, M.A., Snoeck, J., Pillay, C., Rudich, H., Rodrigues, R., Holguin, A., Ariyoshi, K., Bouzas, M.B., Cahn, P., Sugiura, W., Soriano, V., Brigido, L.F., Grossman, Z., Morris, L., Vandamme, A.-M., Tanuri, A., Phanuphak, P., Weber, J.N., Pillay, D., Harrigan, P.R., Camacho, R., Schapiro, J.M., Shafer, R.W., 2005. Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration. PLoS Medicine 2, e112. doi:10.1371/journal.pmed.0020112

Markham, W.A., Bullock, A.D., Matthews, P., Firmstone, V.R., Kelly, S., Field, S.J., 2005. Sexual health care training needs of general practitioner trainers: a regional survey. J Fam Plann Reprod Health Care 31, 213–218. doi:10.1783/1471189054484086

Masquelier, B., Bhaskaran, K., Pillay, D., Gifford, R., Balestre, E., Jørgensen, L.B., Pedersen, C., van der Hoek, L., Prins, M., Balotta, C., Longo, B., Kücherer, C., Poggensee, G., Ortiz, M., de Mendoza, C., Gill, J., Fleury, H., Porter, K., CASCADE Collaboration, 2005. Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003. J. Acquir. Immune Defic. Syndr. 40, 505–511.

Mosam, A., Cassol, E., Page, T., Bodasing, U., Cassol, S., Dawood, H., Friedland, G.H., Scadden, D.T., Aboobaker, J., Jordaan, J.P., Lalloo, U.G., Esterhuizen, T.M., Coovadia, H.M., 2005. Generic antiretroviral efficacy in AIDS-associated Kaposi’s sarcoma in sub-Saharan Africa. AIDS 19, 441–443.

Mosam, A., Goga, Y., Thejpal, R., Cassol, E., Page, T., Cassol, S., Aboobaker, J., Coovadia, H.M., 2005. Lymphadenopathy, pneumonia, and HIV--a common trio, an uncommon outcome. Lancet 365. doi:10.1016/S0140-6736(05)17747-2

Ndinda, C., 2005. Sweat Equity: Women’s Participation in Subsidised Housing in South Africa. Africa Insight 34, 58–64. doi:10.4314/ai.v34i2.22403

Pao, D., Fisher, M., Hué, S., Dean, G., Murphy, G., Cane, P.A., Sabin, C.A., Pillay, D., 2005. Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS 19, 85–90.

Papathakis, P.C., Rollins, N.C., Brown, K.H., Bennish, M.L., Van Loan, M.D., 2005. Comparison of isotope dilution with bioimpedance spectroscopy and anthropometry for assessment of body composition in asymptomatic HIV-infected and HIV-uninfected breastfeeding mothers. Am. J. Clin. Nutr. 82, 538–546.

Phillips, A.N., Dunn, D., Sabin, C., Pozniak, A., Matthias, R., Geretti, A.M., Clarke, J., Churchill, D., Williams, I., Hill, T., Green, H., Porter, K., Scullard, G., Johnson, M., Easterbrook, P., Gilson, R., Fisher, M., Loveday, C., Gazzard, B., Pillay, D., UK Collaborative Group on HIV Drug Resistance, UK CHIC Study Group, 2005. Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS 19, 487–494.

Pillay, D., Green, H., Matthias, R., Dunn, D., Phillips, A., Sabin, C., Evans, B., UK Collaborative Group on HIV Drug Resistance, 2005. Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom. J. Infect. Dis. 192, 967–973. doi:10.1086/432763

Sadiq, S., Taylor, S., Copas, A., Bennett, J., Kaye, S., Drake, S., Kirk, S., Pillay, D., Weller, I., 2005. The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy. Sex Transm Infect 81, 120–123. doi:10.1136/sti.2004.010249

Saha, D., Khan, W.A., Karim, M.M., Chowdhury, H.R., Salam, M.A., Bennish, M.L., 2005. Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. Lancet 366, 1085–1093. doi:10.1016/S0140-6736(05)67290-X

Salemi, M., de Oliveira, T., Soares, M.A., Pybus, O., Dumans, A.T., Vandamme, A.-M., Tanuri, A., Cassol, S., Fitch, W.M., 2005. Different epidemic potentials of the HIV-1B and C subtypes. J. Mol. Evol. 60, 598–605. doi:10.1007/s00239-004-0206-5

Salemi, M., Lamers, S.L., Yu, S., De Oliveira, T., Fitch, W.M., McGrath, M.S., 2005. Phylodynamic Analysis of Human Immunodeficiency Virus Type 1 in Distinct Brain Compartments Provides a Model for the Neuropathogenesis of AIDS. J Virol 79, 11343–11352. doi:10.1128/JVI.79.17.11343-11352.2005

Scott, B.E., Weiss, H.A., Viljoen, J.I., 2005. The acceptability of male circumcision as an HIV intervention among a rural Zulu population, Kwazulu-Natal, South Africa. AIDS Care 17, 304–313. doi:10.1080/09540120412331299744

Shah, S., Rollins, N.C., Bland, R., Child Health Group, 2005. Breastfeeding knowledge among health workers in rural South Africa. J. Trop. Pediatr. 51, 33–38. doi:10.1093/tropej/fmh071

Stein, A., Krebs, G., Richter, L., Tomkins, A., Rochat, T., Bennish, M.L., 2005. Babies of a pandemic. Arch. Dis. Child. 90, 116–118. doi:10.1136/adc.2004.049361

Tanser, F., Sharp, B., 2005. Global climate change and malaria. Lancet Infect Dis 5, 256–258. doi:10.1016/S1473-3099(05)70091-8

Tayloe, D., 2005. Therapeutic response of HIV-1 subtype C in African patients. J. Infect. Dis. 192, 187; author reply 187–188. doi:10.1086/430624

Thairu, L.N., Pelto, G.H., Rollins, N.C., Bland, R.M., Ntshangase, N., 2005. Sociocultural influences on infant feeding decisions among HIV-infected women in rural Kwa-Zulu Natal, South Africa. Matern Child Nutr 1, 2–10. doi:10.1111/j.1740-8709.2004.00001.x

UK Group on Transmitted HIV Drug Resistance, 2005. Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study. BMJ 331, 1368. doi:10.1136/bmj.38665.534595.55

Van den Broeck, J., Cunningham, S.A., Eeckels, R., Herbst, K., 2005. Data cleaning: detecting, diagnosing, and editing data abnormalities. PLoS Med. 2. doi:10.1371/journal.pmed.0020267

Xu, L., Pozniak, A., Wildfire, A., Stanfield-Oakley, S.A., Mosier, S.M., Ratcliffe, D., Workman, J., Joall, A., Myers, R., Smit, E., Cane, P.A., Greenberg, M.L., Pillay, D., 2005. Emergence and Evolution of Enfuvirtide Resistance following Long-Term Therapy Involves Heptad Repeat 2 Mutations within gp41. Antimicrob Agents Chemother 49, 1113–1119. doi:10.1128/AAC.49.3.1113-1119.2005

Amin, J., Kaye, M., Skidmore, S., Pillay, D., Cooper, D.A., Dore, G.J., 2004. HIV and hepatitis C coinfection within the CAESAR study. HIV Med. 5, 174–179. doi:10.1111/j.1468-1293.2004.00207.x

Anand, S., Bärnighausen, T., 2004. Human resources and health outcomes: cross-country econometric study. Lancet 364, 1603–1609. doi:10.1016/S0140-6736(04)17313-3

Argeseanu, S., 2004. Risks, Amenities, and Child Mortality in Rural South Africa. African Population Studies 19, 13–33.

Bhaskaran, K., Pillay, D., Walker, A.S., Fisher, M., Hawkins, D., Gilson, R., McLean, K., Porter, K., UK Register of HIV Seroconverters, 2004. Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters. AIDS 18, 1471–1473.

Bland, R.M., Rollins, N.C., Van den Broeck, J., Coovadia, H.M., Child Health Group, 2004. The use of non-prescribed medication in the first 3 months of life in rural South Africa. Trop. Med. Int. Health 9, 118–124. doi:10.1046/j.1365-3156.2003.01148.x

Camlin, C.S., Garenne, M., Moultrie, T.A., 2004. Fertility trend and pattern in a rural area of South Africa in the context of HIV/AIDS. Afr J Reprod Health 8, 38–54.

Cane, P.A., Aitkin, C., Ward, K., Clarke, J., Parmar, S., Zuckerman, M., Smith, M., Tilston, P., O’Shea, S., Pillay, D., 2004. Pilot scheme for performance assessment of HIV-1 genotypic resistance testing in the UK. Commun Dis Public Health 7, 24–29.

Cassol, S., Welz, T., 2004. Dried blood spot technology for CD4+ T-cell counting. The Lancet 363, 1075. doi:10.1016/S0140-6736(04)15851-0

Coutsoudis, A., Rollins, N., Adhikari, M., Bobat, R., Bland, R., 2004. The prevention of mother-to-child HIV transmission programme and infant feeding practices. S. Afr. Med. J. 94, 70.

Dedicoat, M., Newton, R., Alkharsah, K.R., Sheldon, J., Szabados, I., Ndlovu, B., Page, T., Casabonne, D., Gilks, C.F., Cassol, S.A., Whitby, D., Schulz, T.F., 2004. Mother-to-child transmission of human herpesvirus-8 in South Africa. J. Infect. Dis. 190, 1068–1075. doi:10.1086/423326

De Oliveira, T., Salemi, M., Gordon, M., Vandamme, A.-M., van Rensburg, E.J., Engelbrecht, S., Coovadia, H.M., Cassol, S., 2004. Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design? Genetics 167, 1047–1058. doi:10.1534/genetics.103.018135

De Onis, M., Onyango, A.W., Van den Broeck, J., Chumlea, W.C., Martorell, R., 2004. Measurement and standardization protocols for anthropometry used in the construction of a new international growth reference. Food Nutr Bull 25, S27–36.

Dumans, A.T., Soares, M.A., Machado, E.S., Hué, S., Brindeiro, R.M., Pillay, D., Tanuri, A., 2004. Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance. J. Infect. Dis. 189, 1232–1238. doi:10.1086/382483

Ekman, B., 2004. Community-based health insurance in low-income countries: a systematic review of the evidence. Health Policy Plan 19, 249–270. doi:10.1093/heapol/czh031

Gandhi, M.N., Welz, T., Ronsmans, C., 2004. Severe acute maternal morbidity in rural South Africa. Int J Gynaecol Obstet 87, 180–187. doi:10.1016/j.ijgo.2004.07.012

Grimwade, K., French, N., Mbatha, D.D., Zungu, D.D., Dedicoat, M., Gilks, C.F., 2004. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS 18, 547–554.

Herrero-Martínez, E., Sabin, C.A., Lee, C.A., Jones, I.M., Pillay, D., Emery, V.C., 2004. The effect of highly active antiretroviral therapy for HIV on the anti-HCV specific humoral immune response. J. Med. Virol. 72, 187–193. doi:10.1002/jmv.10578

Hosegood, V., McGrath, N., Herbst, K., Timaeus, I.M., 2004. The impact of adult mortality on household dissolution and migration in rural South Africa. AIDS 18, 1585–1590.

Hosegood, V., Vanneste, A.-M., Timaeus, I.M., 2004. Levels and causes of adult mortality in rural South Africa: the impact of AIDS. AIDS 18, 663–671.

Hué, S., Clewley, J.P., Cane, P.A., Pillay, D., 2004. HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS 18, 719–728.

Jack, C., Lalloo, U., Karim, Q.A., Karim, S.A., El-Sadr, W., Cassol, S., Friedland, G., 2004. A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting. J. Acquir. Immune Defic. Syndr. 36, 929–934.

Kauchali, S., Rollins, N., Bland, R., Van den Broeck, J., Child Health Group, 2004. Maternal perceptions of acute respiratory infections in children under 5 in rural South Africa. Trop. Med. Int. Health 9, 644–650. doi:10.1111/j.1365-3156.2004.01238.x

Kauchali, S., Rollins, N., Van den Broeck, J., Child Health Group, 2004. Local beliefs about childhood diarrhoea: importance for healthcare and research. J. Trop. Pediatr. 50, 82–89. doi:10.193/tropej/50.2.82

Kent, D.M., Mwamburi, D.M., Bennish, M.L., Kupelnick, B., Ioannidis, J.P.A., 2004. Clinical trials in sub-Saharan Africa and established standards of care: a systematic review of HIV, tuberculosis, and malaria trials. JAMA 292, 237–242. doi:10.1001/jama.292.2.237

Livesley, N., Morris, C.N., 2004. Antiretroviral therapy in the private sector of resource-limited settings. AIDS 18, 581–582.

Lurie, M., Harrison, A., Wilkinson, D., Karim, S.A., 2004. Circular migration and sexual networking in rural KwaZulu/Natal: implications for the spread of HIV and other sexually transmitted diseases. doi:http://hdl.handle.net/1885/40199

MacLennan, C., Dunn, G., Huissoon, A.P., Kumararatne, D.S., Martin, J., O’Leary, P., Thompson, R.A., Osman, H., Wood, P., Minor, P., Wood, D.J., Pillay, D., 2004. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363, 1509–1513. doi:10.1016/S0140-6736(04)16150-3

McMichael, T., Campbell-Lendrum, D., Kovats, S., Edwards, S., Wilkinson, P., Edmonds, N., Nicholls, R., Hales, S., Tanser, F., Le Seur, D., Schlesinger, M., Andronova, N., 2004. Global climate change, in: Comparative Quantification of Health Risks: Global and Regional Burden of Disease due to Selected Major Risk Factors. World Health Organization, Geneva, pp. 1543–1650.

Ndinda, C., 2004. Sweat equity: women’s participation in subsidised housing in South Africa. Insight 34, 58–64.

Newell, M.-L., Coovadia, H., Cortina-Borja, M., Rollins, N., Gaillard, P., Dabis, F., Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children, 2004. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364, 1236–1243. doi:10.1016/S0140-6736(04)17140-7

Pao, D., Andrady, U., Clarke, J., Dean, G., Drake, S., Fisher, M., Green, T., Kumar, S., Murphy, M., Tang, A., Taylor, S., White, D., Underhill, G., Pillay, D., Cane, P., 2004. Long-term persistence of primary genotypic resistance after HIV-1 seroconversion. J. Acquir. Immune Defic. Syndr. 37, 1570–1573.

Papathakis, P.C., Rollins, N.C., 2004. Are WHO/UNAIDS/UNICEF-recommended replacement milks for infants of HIV-infected mothers appropriate in the South African context? Bull. World Health Organ. 82, 164–171.

Rodgers, A., Ezzati, M., Vander Hoorn, S., Lopez, A.D., Lin, R.-B., Murray, C.J.L., Comparative Risk Assessment Collaborating Group, 2004. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med. 1. doi:10.1371/journal.pmed.0010027

Rollins, N., Meda, N., Becquet, R., Coutsoudis, A., Humphrey, J., Jeffrey, B., Kanshana, S., Kuhn, L., Leroy, V., Mbori-Ngacha, D., McIntyre, J., Newell, M.-L., Ghent IAS Working Group on HIV in Women and Children, 2004. Preventing postnatal transmission of HIV-1 through breast-feeding: modifying infant feeding practices. J. Acquir. Immune Defic. Syndr. 35, 188–195.

Sivak-Callcott, J.A., Livesley, N., Nugent, R.A., Rasmussen, S.L., Saeed, P., Rootman, J., 2004. Localised invasive sino-orbital aspergillosis: characteristic features. Br J Ophthalmol 88, 681–687. doi:10.1136/bjo.2003.021725

Winston, A., Pozniak, A., Mandalia, S., Gazzard, B., Pillay, D., Nelson, M., 2004. Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase. AIDS 18, 949–951.

2003 Publications

Bennish, M.L., 2003. Cholera, in: Oxford Textbook of Medicine. Oxford University Press, Oxford, pp. 515–21.

Biggar, R.J., Cassol, S., Kumwenda, N., Lema, V., Janes, M., Pilon, R., Senzani, V., Yellin, F., Taha, T.E., Broadhead, R.L., 2003. The risk of human immunodeficiency virus–1 infection in twin pairs born to infected mothers in Africa. Journal of Infectious Diseases 188, 850–855.

Bland, R.M., Rollins, N.C., Solarsh, G., Van den Broeck, J., Coovadia, H.M., Child Health Group, 2003. Maternal recall of exclusive breast feeding duration. Arch. Dis. Child. 88, 778–783. doi:10.1136/adc.88.9.778

Brambilla, D., Jennings, C., Aldrovandi, G., Bremer, J., Comeau, A.M., Cassol, S.A., Dickover, R., Jackson, J.B., Pitt, J., Sullivan, J.L., Butcher, A., Grosso, L., Reichelderfer, P., Fiscus, S.A., 2003. Multicenter Evaluation of Use of Dried Blood and Plasma Spot Specimens in Quantitative Assays for Human Immunodeficiency Virus RNA: Measurement, Precision, and RNA Stability. J Clin Microbiol 41, 1888–1893. doi:10.1128/JCM.41.5.1888-1893.2003

Camlin, C.S., Chimbwete, C.E., 2003. Does knowing someone with AIDS affect condom use? An analysis from South Africa. AIDS Educ Prev 15, 231–244.

Case, A., Hosegood, V., Lund, F., 2003. Child support grant study findings. Children First 51, 45–49.

Chakrabarti, S., Milligan, D.W., Pillay, D., Mackinnon, S., Holder, K., Kaur, N., McDonald, D., Fegan, C.D., Waldmann, H., Hale, G., Rickinson, A., Steven, N., 2003. Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. Blood 102, 839–842. doi:10.1182/blood.V102.3.839

Chelule, P.K., Gordon, M., Palanee, T., Page, T., Mosam, A., Coovadia, H.M., Cassol, S., 2003. MDR1 and CYP3A4 polymorphisms among African, Indian, and white populations in KwaZulu-Natal, South Africa. Clin. Pharmacol. Ther. 74, 195–196. doi:10.1016/S0009-9236(03)00151-6

Coutsoudis, A., Pillay, K., Spooner, E., Coovadia, H.M., Pembrey, L., Newell, M.L., 2003. Morbidity in children born to women infected with human immunodeficiency virus in South Africa: does mode of feeding matter? Acta Paediatr. 92, 890–895.

Coutsoudis, A., Rollins, N., 2003. Breast-feeding and HIV transmission: the jury is still out. J. Pediatr. Gastroenterol. Nutr. 36, 434–442.

Dedicoat, M., 2003. Occupational exposure to HIV. N. Engl. J. Med. 349, 1091–1092; author reply 1091–1092.

Dedicoat, M., Grimwade, K., Newton, R., Gilks, C., 2003a. Changes in the patient population attending a primary health care clinic in rural South Africa between 1991 and 2001. S. Afr. Med. J. 93, 777–778.

Dedicoat, M., Sitas, F., Newton, R., 2003. Cancer in rural KwaZulu-Natal. S. Afr. Med. J. 93, 846–847.

Dedicoat, M., Vaithilingum, M., Newton, R., 2003. Treatment of Kaposi’s sarcoma in HIV-1 infected individuals with emphasis on resource poor settings. Cochrane Database Syst Rev CD003256. doi:10.1002/14651858.CD003256

De Oliveira, T., Engelbrecht, S., Janse van Rensburg, E., Gordon, M., Bishop, K., zur Megede, J., Barnett, S.W., Cassol, S., 2003. Variability at Human Immunodeficiency Virus Type 1 Subtype C Protease Cleavage Sites: an Indication of Viral Fitness? J Virol 77, 9422–9430. doi:10.1128/JVI.77.17.9422-9430.2003

De Oliveira, T., Miller, R., Tarin, M., Cassol, S., 2003. An integrated genetic data environment (GDE)-based LINUX interface for analysis of HIV-1 and other microbial sequences. Bioinformatics 19, 153–154. doi:10.1093/bioinformatics/19.1.153

Gilleece, Y., Torti, C., Mandalia, S., Gazzard, B.G., Pillay, D., Pozniak, A.L., 2003. The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients. HIV Med. 4, 305–310.

Goga, A.E., Bland, R.M., Rollins, N.C., Coovadia, H.M., 2003. Exclusive breast-feeding--a pipe dream? S. Afr. Med. J. 93, 602–603.

Gonzalez, L.M.F., Brindeiro, R.M., Tarin, M., Calazans, A., Soares, M.A., Cassol, S., Tanuri, A., 2003. In Vitro Hypersusceptibility of Human Immunodeficiency Virus Type 1 Subtype C Protease to Lopinavir. Antimicrob Agents Chemother 47, 2817–2822. doi:10.1128/AAC.47.9.2817-2822.2003

Gordon, M., de Oliveira, T., Bishop, K., Coovadia, H.M., Madurai, L., Engelbrecht, S., Janse van Rensburg, E., Mosam, A., Smith, A., Cassol, S., 2003. Molecular Characteristics of Human Immunodeficiency Virus Type 1 Subtype C Viruses from KwaZulu-Natal, South Africa: Implications for Vaccine and Antiretroviral Control Strategies. J Virol 77, 2587–2599. doi:10.1128/JVI.77.4.2587-2599.2003

Grimwade, K., French, N., Mbatha, D.D., Zungu, D.D., Dedicoat, M., Gilks, C.F., 2003. Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatr. Infect. Dis. J. 22, 1057–1063. doi:10.1097/01.inf.0000101188.95433.60

Grimwade, K., Swingler,  null, G,  null, 2003. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV. Cochrane Database Syst Rev CD003108. doi:10.1002/14651858.CD003108

Herbst, K., Burn, A., Nzimande, N., 2003. Public Health Data Sources, in: South African Health Review 2002. Health Systems Trust, pp. 373–388.

Hilderbrand, K., Goemaere, E., Coetzee, D., 2003. The prevention of mother-to-child HIV transmission programme and infant feeding practices. S. Afr. Med. J. 93, 779–781.

Horwood, C., Liebeschuetz, S., Blaauw, D., Cassol, S., Qazi, S., 2003. Diagnosis of paediatric HIV infection in a primary health care setting with a clinical algorithm. Bull. World Health Organ. 81, 858–866.

Hosegood, V., Campbell, O.M.R., 2003. Body mass index, height, weight, arm circumference, and mortality in rural Bangladeshi women: a 19-y longitudinal study. Am. J. Clin. Nutr. 77, 341–347.

Kent, D.M., McGrath, D., Ioannidis, J.P.A., Bennish, M.L., 2003. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda. Clin. Infect. Dis. 37, S13–24. doi:10.1086/375368

Kent, D.M., Mwamburi, M., Cash, R.A., Rabin, T.L., Bennish, M.L., 2003. Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers. Am J Bioeth 3, W11. doi:10.1162/152651603322874898

Livesley, N., Morris, C., 2003. Antiretroviral therapy in a primary care clinic in rural South Africa. AIDS 17, 2005–2006. doi:10.1097/01.aids.0000088173.01779.45

Lurie, M.N., Williams, B.G., Zuma, K., Mkaya-Mwamburi, D., Garnett, G.P., Sweat, M.D., Gittelsohn, J., Karim, S.S.A., 2003. Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS 17, 2245–2252. doi:10.1097/01.aids.0000088197.77946.ba

Lurie, M.N., Williams, B.G., Zuma, K., Mkaya-Mwamburi, D., Garnett, G., Sturm, A.W., Sweat, M.D., Gittelsohn, J., Abdool Karim, S.S., 2003b. The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis 30, 149–156.

McMichael, A.J., Campbell-Lendrum, D., Kovats, S., Edwards, S., Wilkinson, P., Wilson, 2003. Comparative quantification of health risks: global and regional burden of disease due to selected major risk factors. pp. 1543–649.

Moitse, S., Hosegood, V., 2003. Accessing grants: The never ending story. Children First 49, 3–5.

Moodley, P., Sturm, P.D., Connolly, C., Sturm, A.W., 2003. Identification of women at high STD risk among STD clinic attendees: implications for STD programmes. International Journal of STD & AIDS 14, 526–31.

Moodley, P., Sturm, P.D.J., Vanmali, T., Wilkinson, D., Connolly, C., Sturm, A.W., 2003a. Association between HIV-1 infection, the etiology of genital ulcer disease, and response to syndromic management. Sex Transm Dis 30, 241–245.

Moodley, P., Wilkinson, D., Connolly, C., Sturm, A.W., 2003b. Influence of HIV-1 coinfection on effective management of abnormal vaginal discharge. Sex Transm Dis 30, 1–5.

Mwaba, P., Cassol, S., Nunn, A., Pilon, R., Chintu, C., Janes, M., Zumla, A., 2003. Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients. Lancet 362, 2067–2068. doi:10.1016/S0140-6736(03)15103-3

Mwaba, P., Cassol, S., Pilon, R., Chintu, C., Janes, M., Nunn, A., Zumla, A., 2003. Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients. Lancet 362, 1459–1460. doi:10.1016/S0140-6736(03)14693-4

Ndinda, C., 2003. Housing delivery in Ntuthukoville, South Africa : successes and problems. Journal of International Women’s Studies 5, 29–41.

Sabin, C.A., Wilkins, E., Murphy, M., Fisher, M., de Ruiter, A., Easterbrook, P.J., Leen, C., Vlahakis, E., Cane, P.A., Li, X., Pillay, D., UK Expanded Access Amprenavir Programme, 2003. Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patients. Antivir. Ther. (Lond.) 8, 301–308.

Salemi, M., de Oliveira, T., Courgnaud, V., Moulton, V., Holland, B., Cassol, S., Switzer, W.M., Vandamme, A.-M., 2003. Mosaic genomes of the six major primate lentivirus lineages revealed by phylogenetic analyses. J. Virol. 77, 7202–7213. doi:10.1128/JVI.77.13.7202-7213.2003

Soares, M.A., de Oliveira, T., Brindeiro, R.M., Diaz, R.S., Sabino, E.C., Brigido, L., Pires, I.L., Morgado, M.G., Dantas, M.C., Barreira, D., Teixeira, P.R., Cassol, S., Tanuri, A., Brazilian Network for Drug Resistance Surveillance, 2003. A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS 17, 11–21. doi:10.1097/01.aids.0000042595.93174.a4

Tanser, F.C., Sharp, B., le Sueur, D., 2003. Potential effect of climate change on malaria transmission in Africa. Lancet 362, 1792–1798. doi:10.1016/S0140-6736(03)14898-2

Taylor, S., Cane, P., Huéhttp://doi.org/10.1016/S0140-6736(03)14898-2, S., Xu, L., Wrin, T., Lie, Y., Hellmann, N., Petropoulos, C., Workman, J., Ratcliffe, D., Choudhury, B., Pillay, D., 2003. Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations. AIDS Res. Hum. Retroviruses 19, 353–361. doi:10.1089/088922203765551700

Taylor, S., Sadiq, S.T., Weller, I., Kaye, S., Workman, J., Cane, P.A., Bennett, J., Copas, A.J., Drake, S.M., Pillay, D., 2003. Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections. Antivir. Ther. (Lond.) 8, 479–483.

Troe, J.W.M., Versteegh, F.G.A., Mooi-Kokenberg, E. a. N.M., Van den Broeck, J., 2003. No effect of cromoglycate treatment in hospitalized infants with respiratory syncytial virus bronchiolitis. Pediatr. Pulmonol. 36, 170. doi:10.1002/ppul.10334

Vaughan, H.E., Cane, P., Pillay, D., Tedder, R.S., 2003. Characterization of HIV type 1 clades in the Caribbean using pol gene sequences. AIDS Res. Hum. Retroviruses 19, 929–932. doi:10.1089/088922203322493120

Vegelin, A.L., Brukx, L.J.C.E., Waelkens, J.J., Van den Broeck, J., 2003. Influence of knowledge, training and experience of observers on the reliability of anthropometric measurements in children. Ann. Hum. Biol. 30, 65–79.

Venkatesan, P., Dedicoat, M., Innes, J.A., Ellis, C.J., 2003. Seasonality of presentation of imported Plasmodium vivax malaria in Birmingham, UK. Trans. R. Soc. Trop. Med. Hyg. 97, 550.

Willumsen, J.F., Filteau, S.M., Coutsoudis, A., Newell, M.-L., Rollins, N.C., Coovadia, H.M., Tomkins, A.M., 2003. Breastmilk RNA viral load in HIV-infected South African women: effects of subclinical mastitis and infant feeding. AIDS 17, 407–414. doi:10.1097/01.aids.0000042972.95433.6b

Zungu, S., Moitse, S., Hosegood, V., 2003. Social grants in rural areas: Beating a path through a maze of bureaucracy. Children First 7.

Abdool Karim, S., Abdool Karim, Q., Adhikari, M., Cassol, S., Chersich, M., Cooper, P., Coovadia, A., Coovadia, H., Cotton, M., Coutsoudis, A., Hide, W., Hussey, G., Maartens, G., Madhi, S., Martin, D., Pettifor, J.M., Rollins, N., Sherman, G., Thula, S., Urban, M., Velaphi, S., Williamson, C., 2002. Vertical HIV transmission in South Africa: translating research into policy and practice. Lancet 359, 992–993.

Bärnighausen, T., Sauerborn, R., 2002. One hundred and eighteen years of the German health insurance system: are there any lessons for middle- and low-income countries? Soc Sci Med 54, 1559–1587.

Biggar, R.J., Janes, M., Pilon, R., Roy, R., Broadhead, R., Kumwenda, N., Taha, T.E.T., Cassol, S., 2002. Human immunodeficiency virus type 1 infection in twin pairs infected at birth. J. Infect. Dis. 186, 281–285. doi:10.1086/341453

Bland, R.M., Rollins, N.C., Coutsoudis, A., Coovadia, H.M., Child Health Group, 2002. Breastfeeding practices in an area of high HIV prevalence in rural South Africa. Acta Paediatr. 91, 704–711.

Choudhury, B., Pillay, D., Taylor, S., Cane, P.A., 2002. Analysis of HIV-1 variation in blood and semen during treatment and treatment interruption. J. Med. Virol. 68, 467–472. doi:10.1002/jmv.10247

Coutsoudis, A., Goga, A.E., Rollins, N., Coovadia, H.M., Child Health Group, 2002. Free formula milk for infants of HIV-infected women: blessing or curse? Health Policy Plan 17, 154–160. doi:10.1093/heapol/17.2.154

Dabis, F., Orne-Gliemann, J., Perez, F., Leroy, V., Newell, M.L., Coutsoudis, A., Coovadia, H., Working Group on Women and Child Health, 2002. Improving child health: the role of research. BMJ 324, 1444–1447.

Ezzati, M., Lopez, A.D., Rodgers, A., Vander Hoorn, S., Murray, C.J.L., Comparative Risk Assessment Collaborating Group, 2002. Selected major risk factors and global and regional burden of disease. Lancet 360, 1347–1360. doi:10.1016/S0140-6736(02)11403-6

Gibb, D.M., Walker, A.S., Kaye, S., De Rossi, A., Ait-Khaled, M., Pillay, D., Muñoz-Fernandez, M.A., Loveday, C., Compagnucci, A., Dunn, D.T., Babiker, A.G., 2002. Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial). Antivir. Ther. (Lond.) 7, 293–303.

Goga, A.E., Bland, R., Rooyen, H.V., Rollins, N.C., Coovadia, H.M., 2002. A Breastfeeding Support Strategy in an HIV Endemic Area, in: Davis, M.K., Isaacs, C.E., Hanson, L.Å., Wright, A.L. (Eds.), Integrating Population Outcomes, Biological Mechanisms and Research Methods in the Study of Human Milk and Lactation, Advances in Experimental Medicine and Biology. Springer US, pp. 259–260.

Khan, W.A., Saha, D., Rahman, A., Salam, M.A., Bogaerts, J., Bennish, M.L., 2002. Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial. Lancet 360, 1722–1727. doi:10.1016/S0140-6736(02)11680-1

Leav, B.A., Mackay, M.R., Anyanwu, A., O’ Connor, R.M., Cevallos, A.M., Kindra, G., Rollins, N.C., Bennish, M.L., Nelson, R.G., Ward, H.D., 2002. Analysis of sequence diversity at the highly polymorphic Cpgp40/15 locus among Cryptosporidium isolates from human immunodeficiency virus-infected children in South Africa. Infect. Immun. 70, 3881–3890. doi:10.1128/IAI.70.7.3881-3890.2002

Moodley, P., Connolly, C., Sturm, A.W., 2002. Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J. Infect. Dis. 185, 69–73. doi:10.1086/338027

Moodley, P., Martin, I.M.C., Ison, C.A., Sturm, A.W., 2002. Typing of Neisseria gonorrhoeae reveals rapid reinfection in rural South Africa. J. Clin. Microbiol. 40, 4567–4570. doi:10.128/JCM.40.12.4567-4570.2002

Moodley, P., Pillay, C., Nzimande, G., Coovadia, Y.M., Sturm, A.W., 2002. Lower dose of ciprofloxacin is adequate for the treatment of Neisseria gonorrhoeae in KwaZulu Natal, South Africa. Int. J. Antimicrob. Agents 20, 248–252. doi:http://dx.doi.org/10.1016/S0924-8579(02)00195-4

Moodley, P., Wilkinson, D., Connolly, C., Moodley, J., Sturm, A.W., 2002. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin. Infect. Dis. 34, 519–522. doi:10.1086/338399

Newton, R., Sitas, F., Dedicoat, M., Ziegler, J.L., 2002. HIV Infection and Cancer, in: DVM, M.E., PharmD, S.M., DSc, P.J.K.D., MD, R.G.M., Tlou, S.D., Holme, M. (Eds.), AIDS in Africa. Springer US, pp. 386–404.

O’Donnell, M.R., Bacos, D., Bennish, M.L., 2002. Nutritional response to the 1998 Bangladesh flood disaster: Sphere minimum standards in disaster response. Disasters 26, 229–241.

Pillay, A., Liu, H., Ebrahim, S., Chen, C.Y., Lai, W., Fehler, G., Ballard, R.C., Steiner, B., Sturm, A.W., Morse, S.A., 2002. Molecular typing of Treponema pallidum in South Africa: cross-sectional studies. J. Clin. Microbiol. 40, 256–258. doi:10.1128/JCM.40.1.256-258.2002

Pillay, D., Walker, A.S., Gibb, D.M., de Rossi, A., Kaye, S., Ait-Khaled, M., Muñoz-Fernandez, M., Babiker, A., 2002. Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial. J. Infect. Dis. 186, 617–625. doi:10.1086/342680

Rollins, N.C., Dedicoat, M., Danaviah, S., Page, T., Bishop, K., Kleinschmidt, I., Coovadia, H.M., Cassol, S.A., Child Health Group, 2002. Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South Africa. Lancet 360. doi:10.1016/S0140-6737(02)09599-5

Rothberg, M., Bennish, M.L., Kao, J.S., Wong, J.B., 2002. Do the benefits of varicella vaccination outweigh the long-term risks? A decision-analytic model for policymakers and pediatricians. Clin. Infect. Dis. 34, 885–894. doi:10.1086/338956

Sadiq, S.T., Taylor, S., Kaye, S., Bennett, J., Johnstone, R., Byrne, P., Copas, A.J., Drake, S.M., Pillay, D., Weller, I., 2002. The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS 16, 219–225.

Sekokotla, D.M., Maluleke, F.R., Mbananga, N.D., Herbst, A.J., 2002. Completeness of data on daily patient encounter forms at Mankweng Hospital. S. Afr. Med. J. 92, 954–956.

Smit, J., McFadyen, L., Zuma, K., Preston-Whyte, E., 2002. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa. Soc Sci Med 55, 1511–1522.

Smit, J., McFedyen, L., Harrison, A., Zuma, K., 2002. Where is the condom? Contraceptive practice in a rural district of South Africa. Afr J Reprod Health 6, 71–78.

Solarsh, G.C., Benzler, J., Hosegood, V., Tanser, F., Vanneste, A.-M., 2002. Hlabisa DSS, South Africa, in: Population, Health and Survival at INDEPTH Sites. International Development Research Centre, Ottawa, pp. 213–220.

Sturm, P.D.J., Moodley, P., Nzimande, G., Balkistan, R., Connolly, C., Sturm, A.W., 2002. Diagnosis of bacterial vaginosis on self-collected vaginal tampon specimens. Int J STD AIDS 13, 559–563. doi:10.1258/095646202760159693

Tanser, F.C., 2002. The application of GIS technology to equitably distribute fieldworker workload in a large, rural South African health survey. Trop. Med. Int. Health 7, 80–90. doi:10.1046/j.1365-3156.2002.00825.x

Tanser, F.C., Le Sueur, D., 2002. The appplication of geographical information systems to important public health problems in Africa. International Journal of Health Geographics 1, 4.

Tanser, F., Le Sueur, D., 2002. The application of geographical information systems to important public health problems in Africa. Int J Health Geogr 1, 4–4. doi:10.1186/1476-072X-1-4

Williams, B.G., Gouws, E., Lurie, M., Crush, J., 2002. Spaces of vulnerability: migration and HIV/AIDS in South Africa, Southern Africa Migration Project Policy Series (SAMP). Idasa, Cape Town.

Winston, A., Mandalia, S., Pillay, D., Gazzard, B., Pozniak, A., 2002. The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients. AIDS 16, 2087–2089.

Xu, L., Hué, S., Taylor, S., Ratcliffe, D., Workman, J.A., Jackson, S., Cane, P.A., Pillay, D., 2002. Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patients. AIDS 16, 1684–1686.

Zimbabwe, B., South Africa (Zimbasa) Dysentery Study Group, 2002. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children. Pediatr. Infect. Dis. J. 21, 1136–1141. doi:10.1097/01.inf.0000040824.83814.a9

Zur Megede, J., Engelbrecht, S., de Oliveira, T., Cassol, S., Scriba, T.J., van Rensburg, E.J., Barnett, S.W., 2002. Novel evolutionary analyses of full-length HIV type 1 subtype C molecular clones from Cape Town, South Africa. AIDS Res. Hum. Retroviruses 18, 1327–1332. doi:10.1089/088922202320886370

Allen, U., Conway, B., Lapointe, N., Read, S., King, S., Forbes, J., Marshall, C., Stephens, D., Wells, G., Cassol, S., Canadian Pediatric AIDS Research Group, 2001. High prevalence of genotypic zidovudine resistance among HIV-infected Canadian children. Acta Paediatr. 90, 823–824.

Barlow, K.L., Tatt, I.D., Cane, P.A., Pillay, D., Clewley, J.P., 2001. Recombinant strains of HIV type 1 in the United Kingdom. AIDS Res. Hum. Retroviruses 17, 467–474. doi:10.1089/088922201750102607

Bennish, M.L., Keusch, G., 2001. Shigellosis, in: Essentials of Tropical Infectious Diseases. Churchill Livingstone, New York, pp. 156–160.

Biggar, R.J., Broadhead, R., Janes, M., Kumwenda, N., Taha, T.E., Cassol, S., 2001. Viral levels in newborn African infants undergoing primary HIV-1 infection. AIDS 15, 1311–1313.

Cane, P.A., de Ruiter, A., Rice, P., Wiselka, M., Fox, R., Pillay, D., 2001. Resistance-Associated Mutations in the Human Immunodeficiency Virus Type 1 Subtype C Protease Gene from Treated and Untreated Patients in the United Kingdom. J Clin Microbiol 39, 2652–2654. doi:10.1128/JCM.39.7.2652-2654.2001

De Oliveira, T., Cassol, S., 2001. Changing dynamics of HIV subtype distribution in Africa. Brazilian Journal of Infectious Diseases 5, 24–27.

Dladla, A.N., Hiner, C.A., Qwana, E., Lurie, M., 2001. Speaking to rural women: The sexual partnerships of rural South African women whose partners are migrants. Society in Transition 32, 79–82. doi:10.1080/21528586.2001.10419032

Filteau, S.M., Rollins, N.C., Coutsoudis, A., Sullivan, K.R., Willumsen, J.F., Tomkins, A.M., 2001. The effect of antenatal vitamin A and beta-carotene supplementation on gut integrity of infants of HIV-infected South African women. J. Pediatr. Gastroenterol. Nutr. 32, 464–470.

Grimwade, K., Gilks, C., 2001. Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries. Curr. Opin. Infect. Dis. 14, 507–512.

Guerrant, R.L., Van Gilder, T., Steiner, T.S., Thielman, N.M., Slutsker, L., Tauxe, R.V., Hennessy, T., Griffin, P.M., DuPont, H., Sack, R.B., Tarr, P., Neill, M., Nachamkin, I., Reller, L.B., Osterholm, M.T., Bennish, M.L., Pickering, L.K., Infectious Diseases Society of America, 2001. Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis. 32, 331–351. doi:10.1086/318514

Harrison, A., Xaba, N., Kunene, P., Ntuli, N., 2001. Understanding young women’s risk for HIV/AIDS: Adolescent sexuality and vulnerability in rural KwaZulu/Natal. Society in Transition 32, 69–78. doi:10.1080/21528586.2001.10419031

Lurie, M., 2001. Migration and the spread of HIV in South Africa, in: Department of International Health. Johns Hopkins University, Baltimore.

Matthews, G.V., Pillay, D., Cane, P., Ratcliffe, D., Gazzard, B., Nelson, M., 2001. Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1. Clin. Infect. Dis. 33, 2049–2054. doi:10.1086/322655

Matthews, P., Fletcher, J., 2001. Sexually transmitted infections in primary care: a need for education. Br J Gen Pract 51, 52–56.

McFadyen, M.L., Smit, J.A., Kubeka, M., Majola, M.P., 2001. Quinine is not a proven contraceptive although often used as such. South African Pharmaceutical Journal 68, 15–21.

Moodley, P., Hoppenbrouwers, J., Bohlken, L., Sturm, A.W., 2001. Emergence of TetM-mediated tetracycline resistance in rural South Africa. J. Antimicrob. Chemother. 48, 142–143.

Moodley, P., Pillay, C., Goga, R., Kharsany, A.B., Sturm, A.W., 2001. Evolution in the trends of antimicrobial resistance in Neisseria gonorrhoeae isolated in Durban over a 5 year period: impact of the introduction of syndromic management. J. Antimicrob. Chemother. 48, 853–859.

Moodley, P., Sturm, A.W., 2001. Ciprofloxacin resistance in Neisseria gonorrhoeae. Lancet 357, 1295–1296. doi:10.1016/S0140-6736(00)04443-3

Moodley, P., Wilkinson, D., Connolly, C., Sturm, A.W., 2001. Impact of HIV-1 infection on response to treatment of sexually transmitted infections. AIDS 15, 542–543.

Mutimer, D., Feraz-Neto, B., Harrison, R., O’Donnell, K., Shaw, J., Cane, P., Pillay, D., 2001. Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir. Gut 49, 860–863. doi:10.1136/gut.49.6.860

Rollins, N.C., Filteau, S.M., Coutsoudis, A., Tomkins, A.M., 2001. Feeding mode, intestinal permeability, and neopterin excretion: a longitudinal study in infants of HIV-infected South African women. J. Acquir. Immune Defic. Syndr. 28, 132–139.

Skelton, J.R., Matthews, P.M., 2001. Teaching sexual history taking to health care professionals in primary care. Med Educ 35, 603–608.

Smit, J., Gray, A., McFadyen, L., Zuma, K., 2001. Counting the costs: Comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa. BMC Health Serv Res 1. doi:10.1186/1472-6963-1-4

Smit, J., McFadyen, L., Beksinska, M., de Pinho, H., Morroni, C., Mqhayi, M., Parekh, A., Zuma, K., 2001. Emergency contraception in South Africa: knowledge, attitudes, and use among public sector primary healthcare clients. Contraception 64, 333–337.

Tanser, F., Hosegood, V., Benzler, J., Solarsh, G., 2001. New approaches to spatially analyse primary health care usage patterns in rural South Africa. Trop. Med. Int. Health 6, 826–838.

Taylor, S., Back, D.J., Drake, S.M., Workman, J., Reynolds, H., Gibbons, S.E., White, D.J., Pillay, D., 2001. Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. J. Antimicrob. Chemother. 48, 351–354.

Taylor, S., Ferguson, N.M., Cane, P.A., Anderson, R.M., Pillay, D., 2001. Dynamics of seminal plasma HIV-1 decline after antiretroviral treatment. AIDS 15, 424–426.

UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance, 2001. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ 322, 1087–1088.

Chakrabarti, S., Collingham, K.E., Fegan, C.D., Pillay, D., Milligan, D.W., 2000. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplant. 26, 305–307. doi:10.1038/sj.bmt.1702508

Chakrabarti, S., Collingham, K.E., Holder, K., Oyaide, S., Pillay, D., Milligan, D.W., 2000. Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy. Clin. Infect. Dis. 31, 1516–1518. doi:10.1086/317482

Chakrabarti, S., Collingham, K.E., Stevens, R.H., Pillay, D., Fegan, C.D., Milligan, D.W., 2000. Isolation of viruses from stools in stem cell transplant recipients: a prospective surveillance study. Bone Marrow Transplant. 25, 277–282. doi:10.1038/sj.bmt.1702164

Chakrabarti, S., Pillay, D., Ratcliffe, D., Cane, P.A., Collingham, K.E., Milligan, D.W., 2000. Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance. J. Infect. Dis. 181, 2055–2058. doi:10.1086/315524

Chikobvu, P., Steinberg, W.J., Joubert, G., Viljoen, J.I., Coetzee, M., Kriel, J., Ryst, E. van der, 2000. Lessons learned in establishing a randomised controlled trial to investigate the effect of vitamin A on vertical transmission of HIV-1. Southern African Journal of Epidemiology & Infection 15, 19–22.

Corr, P., Couper, I., Beningfield, S.J., Mars, M., 2000. A simple telemedicine system using a digital camera. J Telemed Telecare 6, 233–236.

Engels, E.A., Bennish, M.L., Falagas, M.E., Lau, J., 2000. Typhoid fever vaccines. Vaccine 18, 1433–1434.

Fraser, H.S.F., McGrath, S.J.D., 2000. Information technology and telemedicine in sub-Saharan Africa. BMJ 321, 465–466.

Gray, A., Smit, J., 2000. Improving access to HIVrelated drugs in South Africa: a case of colliding interests. Review of African Political Economy 27, 583–590. doi:10.1080/03056240008704492

Harrison, A., Smit, J.A., Myer, L., 2000. Prevention of HIV/AIDS in South Africa: a review of behaviour change interventions, evidence and options for the future. South African Journal of Science 96.

Mark, L., 2000. Migration and AIDS in Southern Africa: a review. South African Journal of Science 96, 343–7.

Moodley, P., Sturm, A.W., 2000. Sexually transmitted infections, adverse pregnancy outcome and neonatal infection. Semin Neonatol 5, 255–269. doi:10.1053/siny.2000.0026

Muir, D., White, D., King, J., Verlander, N., Pillay, D., 2000. Predictive value of the ultrasensitive HIV viral load assay in clinical practice. J. Med. Virol. 61, 411–416.

Mutimer, D., Dowling, D., Cane, P., Ratcliffe, D., Tang, H., O’Donnell, K., Shaw, J., Elias, E., Pillay, D., 2000a. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection. Antivir. Ther. (Lond.) 5, 273–277.

Mutimer, D., Pillay, D., Cook, P., Ratcliffe, D., O’Donnell, K., Dowling, D., Shaw, J., Elias, E., Cane, P.A., 2000. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy. J. Infect. Dis. 181, 713–716. doi:10.1086/315238

Mutimer, D., Pillay, D., Shields, P., Cane, P., Ratcliffe, D., Martin, B., Buchan, S., Boxall, L., O’Donnell, K., Shaw, J., Hubscher, S., Elias, E., 2000. Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut 46, 107–113. doi:10.1136/gut.46.1.107

Palmarini, M., Hallwirth, C., York, D., Murgia, C., de Oliveira, T., Spencer, T., Fan, H., 2000. Molecular Cloning and Functional Analysis of Three Type D Endogenous Retroviruses of Sheep Reveal a Different Cell Tropism from That of the Highly Related Exogenous  Jaagsiekte Sheep Retrovirus. J Virol 74, 8065–8076.

Pillay, D., Cane, P.A., Shirley, J., Porter, K., 2000. Detection of drug resistance associated mutations in HIV primary infection within the UK. AIDS 14, 906–908.

Rollins, N.C., 2000. A conference for children. Social Work 36, 9–11.

Rollins, N.C., Filteau, S.M., Elson, I., Tomkins, A.M., 2000. Vitamin A supplementation of South African children with severe diarrhea: optimum timing for improving biochemical and clinical recovery and subsequent vitamin A status. Pediatr. Infect. Dis. J. 19, 284–289.

Rollins, N.C., Filteau, S.M., Tomkins, A.M., 2000. Timing of Vitamin A supplementation during diarrhea. Sight and LIfe 2, 8–19.

Rotchford, K., Lombard, C., Zuma, K., Wilkinson, D., 2000a. Impact on perinatal mortality of missed opportunities to treat maternal syphilis in rural South Africa: baseline results from a clinic randomized controlled trial. Trop. Med. Int. Health 5, 800–804.

Rotchford, K., Strum, A.W., Wilkinson, D., 2000b. Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: systematic review and data synthesis. Sex Transm Dis 27, 243–248.

Ryan, E.T., Dhar, U., Khan, W.A., Salam, M.A., Faruque, A.S., Fuchs, G.J., Calderwood, S.B., Bennish, M.L., 2000. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am. J. Trop. Med. Hyg. 63, 12–20.

Singhal, S., Shaw, J.C., Ainsworth, J., Hathaway, M., Gillespie, G.M., Paris, H., Ward, K., Pillay, D., Moss, P.A., Mutimer, D.J., 2000. Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients. Transplantation 69, 2251–2259.

Tanser, F., Lesueur, D., Solarsh, G., Wilkinson, D., 2000. HIV heterogeneity and proximity of homestead to roads in rural South Africa: an exploration using a geographical information system. Trop. Med. Int. Health 5, 40–46.

Tanser, F., Palmer, A.R., 2000. Vegetation mapping of the Great Fish River basin, South Africa: Integrating spatial and multi-spectral remote sensing techniques. Applied Vegetation Science 3, 197–204. doi:10.2307/1478998

Taylor, S., van Heeswijk, R.P., Hoetelmans, R.M., Workman, J., Drake, S.M., White, D.J., Pillay, D., 2000. Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men. AIDS 14, 1979–1984.